<ead xmlns="urn:isbn:1-931666-22-9" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:isbn:1-931666-22-9 http://www.loc.gov/ead/ead.xsd">
  <eadheader countryencoding="iso3166-1" dateencoding="iso8601" langencoding="iso639-2b" repositoryencoding="iso15511">
    <eadid>FA1103A.xml</eadid>
    <filedesc>
      <titlestmt>
        <titleproper type="filing">Rockefeller University collection of the Medical Letter publication, 1996-2004</titleproper>
        <titleproper>A Guide to the Rockefeller University collection of the Medical Letter publication, 1996-2004 <num>FA1103A</num></titleproper>
      </titlestmt>
      <publicationstmt>
        <publisher>Rockefeller Archive Center</publisher>
        <address>
          <addressline>15 Dayton Avenue</addressline>
          <addressline>Sleepy Hollow 10591</addressline>
          <addressline>archive@rockarch.org</addressline>
          <addressline>URL: <extptr xlink:href="http://www.rockarch.org" xlink:show="new" xlink:title="http://www.rockarch.org" xlink:type="simple"/></addressline>
        </address>
      </publicationstmt>
    </filedesc>
    <profiledesc>
      <creation>This finding aid was produced using ArchivesSpace on <date>2016-10-07 02:29:17 -0400</date>.</creation>
      <descrules>Describing Archives: A Content Standard</descrules>
    </profiledesc>
  </eadheader>
  <archdesc level="collection">
    <did>
      <langmaterial>
        <language langcode="eng">English</language>
      </langmaterial>
      <repository>
        <corpname>Rockefeller Archive Center</corpname>
      </repository>
      <unittitle>Rockefeller University collection of the Medical Letter publication</unittitle>
      <origination label="creator">
        <corpname role="aut" source="lcnaf">Rockefeller University</corpname>
      </origination>
      <origination label="creator">
        <corpname role="aut" source="lcnaf">Medical Letter, Inc</corpname>
      </origination>
      <unitid>FA1103A</unitid>
      <physdesc altrender="whole">
        <extent altrender="materialtype spaceoccupied">122.5 Cubic Feet</extent>
      </physdesc>
      <unitdate normal="1996/2004" type="inclusive">1996-2004</unitdate>
    </did>
    <processinfo id="aspace_4f6518ea8bae3b64eb48a7b6e5a4ac82">
      <head>Processing Information</head>
      <p>Minimal processing</p>
    </processinfo>
    <prefercite id="aspace_08d6bd5a3343d88ae174562240e1c48c">
      <head>Preferred Citation</head>
      <p>Information regarding the Rockefeller Archive Center's preferred elements and forms of citation can be found at <extref href="http://www.rockarch.org/research/citations.php">http://www.rockarch.org/research/citations.php</extref></p>
    </prefercite>
    <accessrestrict id="aspace_8e22992d16c1acad66ec2350a423e469">
      <head>Conditions Governing Access</head>
      <p>Records more than 25 years old are open for research with select materials restricted as noted. Brittle or damaged items are available at the discretion of RAC.</p>
    </accessrestrict>
    <fileplan id="aspace_b18026630ad0911a346cf5ce064ebdd5">
      <head>File Plan</head>
      <p>Former Classification: I 891-U</p>
    </fileplan>
    <otherfindaid id="aspace_80d67a066600f6ef1d33e75468f27af6">
      <head>Other Finding Aids</head>
      <p>For additional Medical Letter materials open for research see:</p>
      <p>FA241 Rockefeller University collection of the Medical Lettter publication</p>
    </otherfindaid>
    <scopecontent id="aspace_96fc3f4b0ecc38c530137eb411f39ada">
      <head>Scope and Contents</head>
      <p>Contents includes: original manuscripts, reprints, advertising and package inserts, sources check, consultatnts drafts, manufacturers replies, and bibliography.</p>
    </scopecontent>
    <bioghist id="aspace_6c159867ba2a2151b8b7399752c3890b">
      <head>Biographical / Historical</head>
      <p>The Medical Letter on Drugs and Therapeutics is an independent, non-profit publication providing unbiased critical evaluation of drugs in terms of their effectiveness, adverse effects and possible alternative medications.</p>
    </bioghist>
    <userestrict id="aspace_37e428481bbdbecee9f5c722527c7cfc">
      <head>Conditions Governing Use</head>
      <p>Use agreement is required prior to providing access. See RAC Head of Reference for assistance.</p>
    </userestrict>
    <dsc>
      <c id="aspace_722d135ab2e6b9a0415068e6118db069" level="file">
        <did>
          <unittitle>TML, 38-9 - Acarbose for diabetes mellitus</unittitle>
          <unitdate type="inclusive">1996 February 2</unitdate>
          <container id="aspace_5ea10e3ebf492a4bef63ed94b7fba112" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="aspace_c3b1e43e632af2b6525f2e882ce37c80" parent="aspace_5ea10e3ebf492a4bef63ed94b7fba112" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_6413d819e0f61297a55139d343bc6b2f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_8e0dd5900ff39bfca71872aabc11f428" level="file">
        <did>
          <unittitle>TML, 38-55 - Acetaminophen, NSAIDs and Alcohol</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="aspace_c16c0b23c7a63ea7530cdf41d15c1aaf" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="aspace_9e98f775c95ac0ce2541d510da8830f0" parent="aspace_c16c0b23c7a63ea7530cdf41d15c1aaf" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_656f8049cade326890b44a882a172390">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_92bb9fbbd017dace4f8bbbdfdcec0a7a" level="file">
        <did>
          <unittitle>TML, 38-43 - Acute reactions to Drugs of Abuse</unittitle>
          <unitdate type="inclusive">1996 May 10</unitdate>
          <container id="aspace_1b6a84335d057d471e0a4b591be7a31e" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="aspace_a1ffa5cab6c7fcfbe89217b0c63f3541" parent="aspace_1b6a84335d057d471e0a4b591be7a31e" type="folder">8-12</container>
        </did>
        <accessrestrict id="aspace_ca3616172a78ef218806617937be4ae3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_299c68349552c9c16b93a8a4762f739e" level="file">
        <did>
          <unittitle>TML, 38-35 - New drugs for HIV</unittitle>
          <unitdate type="inclusive">1996 April 12</unitdate>
          <container id="aspace_254156dc81c78c715dbedea4193b54c2" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="aspace_90eec20c6c9ca24f5e92f61fcbe20d57" parent="aspace_254156dc81c78c715dbedea4193b54c2" type="folder">13-17</container>
        </did>
        <accessrestrict id="aspace_86a00cb09aea1b9f00fe35947afa8c0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c5fa85f3bd2884f1a9dfd36830a4fb4d" level="file">
        <did>
          <unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="aspace_d8200b677159be288e51e5a892e62446" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="aspace_b6506b33c1d16e88303bc2507150f9e8" parent="aspace_d8200b677159be288e51e5a892e62446" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_6490910db6cb9773d516babe0e3ba2c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_25c672276d8de231f00bfa483bb42cb2" level="file">
        <did>
          <unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="aspace_4fa130c1b2d9c7ae7ac94f3723dcc361" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_49ae886262fd8bcd45a0ce2befc6e80b" parent="aspace_4fa130c1b2d9c7ae7ac94f3723dcc361" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_2d841e9b213eca4386b5020a0f960ab2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_520cba0819f4d1a661ffbae9d84a72d2" level="file">
        <did>
          <unittitle>TML, 38-61 - Anatrozle for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="aspace_eab4ccda16e140304f0c73afac524f2b" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_df05dee4f1457c5aae4d7330f96a03fc" parent="aspace_eab4ccda16e140304f0c73afac524f2b" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_391e7265783eb309c372f58724caf420">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_b466c2ae20545eb902a029aabfadd4a2" level="file">
        <did>
          <unittitle>TML, 38-25 - Choice of Antimicrobial Drugs</unittitle>
          <unitdate type="inclusive">1996 March 29</unitdate>
          <container id="aspace_01b8d016cffd246eb8af8bd216a95eac" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_ca33da1dfcbafb781d591239fd9d1856" parent="aspace_01b8d016cffd246eb8af8bd216a95eac" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_abc8cefbfb0e5ceded73db45b93e2776">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_ef71891079fc8afb056a13746e052f75" level="file">
        <did>
          <unittitle>TML, 38-52 - Drugs for Cardiac Arrythmias</unittitle>
          <unitdate type="inclusive">1996 August 30</unitdate>
          <container id="aspace_a5898ebbead53e5ec11400188bc8e971" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_0db89a0f78c38910e5b14e99154cb8a3" parent="aspace_a5898ebbead53e5ec11400188bc8e971" type="folder">10-16</container>
        </did>
        <accessrestrict id="aspace_e9ba90f8f6e01a82041a2cb46e749402">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_630284f8fa9310d4604f35f82942ec99" level="file">
        <did>
          <unittitle>TML, 38-52 - Azelaic acid a new topical drug for acne</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="aspace_c0d1ef86357df4b99c3bac1eb6985330" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_8b320f3603538535297cec90499be8f6" parent="aspace_c0d1ef86357df4b99c3bac1eb6985330" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_7d350d2c114c77a5007cc5bd6bef48d0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_4b06c4e94eeae1bbd7e893099db3bb23" level="file">
        <did>
          <unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="aspace_1d1f3610ed9fd1ed5b3f34687bb19738" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_3ceedd0bd7bf11512cd9324f95102e4b" parent="aspace_1d1f3610ed9fd1ed5b3f34687bb19738" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_c9d5e1a415d2921805aa74b729504b02">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_cdf8cc07b4cfdaccc7c2d14cfe460d41" level="file">
        <did>
          <unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="aspace_8c6f51c423d967db365fc32b944862e6" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_7b46e326691f41167af0d731c9119bf4" parent="aspace_8c6f51c423d967db365fc32b944862e6" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_bc8ec69f68ddfbb05692b444a9d33f73">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_8e8440ccfa5de303b70df4a8556b7da1" level="file">
        <did>
          <unittitle>TML, 38-103 - Bone Density Testing</unittitle>
          <unitdate type="inclusive">1996 November 26</unitdate>
          <container id="aspace_eaec5b2580bd0c1be3f01e736b84e556" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_da0fbbe737f937f633812e2198792921" parent="aspace_eaec5b2580bd0c1be3f01e736b84e556" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_9371d9820f979006c113e8341494696d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_2bc3e056d1f8fa2492e7303d95310131" level="file">
        <did>
          <unittitle>TML, 37-109 - Dirithromycin</unittitle>
          <unitdate type="inclusive">1995 November 24</unitdate>
          <container id="aspace_5a43ce53e8206051520d3de7fcc6c5fb" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_13256bd231644fb44f4e7e522d52c7c2" parent="aspace_5a43ce53e8206051520d3de7fcc6c5fb" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_70e63df474c05d465a52ed6834a63c2e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_404e68490aeea4bc03276bd2e1972297" level="file">
        <did>
          <unittitle>TML, 38-108 - Calcium Supplements</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="aspace_dbc9b3ff4d167d34c791a6f0aa09809a" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_cc18427ce7c1a45975687ef5ef09740b" parent="aspace_dbc9b3ff4d167d34c791a6f0aa09809a" type="folder">8-12</container>
        </did>
        <accessrestrict id="aspace_6397bcfd119b8dee01530ad0c01d2fe0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_787f855d64193a39aa5fa640c29b09f9" level="file">
        <did>
          <unittitle>TML, 38-40 - Radiofrequency cather abilation for treatment of cardiac arrhythmias</unittitle>
          <unitdate type="inclusive">1996 April 26</unitdate>
          <container id="aspace_3425269ad05f758107a94e077e22e6e1" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_5740b3b2c47b4d9434432da06cc28e64" parent="aspace_3425269ad05f758107a94e077e22e6e1" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_9407b24c4bbb8b9a8280fd95b434f402">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_6ee9fed32bd765fba31910157fc457da" level="file">
        <did>
          <unittitle>TML, 38-23 - Cetibuten - a new oral cephalosporin</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="aspace_9672b4b4629906379ddddde57a0248a3" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_e53b52cb76a8549712d8bebd8cabbf83" parent="aspace_9672b4b4629906379ddddde57a0248a3" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_fe428baa314a27bf86569a7a685bf75c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_cf9669d33a59dba3ffbe8f50f22fca78" level="file">
        <did>
          <unittitle>TML, 38-84 - Cefepime (Maxime) - a new parenteral cephalosporin</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="aspace_cebda1640160c3b28067194bcc5ed6fc" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="aspace_ac4d4d88439674ef2447349953c984b0" parent="aspace_cebda1640160c3b28067194bcc5ed6fc" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_cd47248ae2cfc55d2fb4424654263054">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_7dd0747a03e955ecdd43cb4fc77cc296" level="file">
        <did>
          <unittitle>TML, 38-46 - Chlorzoxazone hepatotoxsicity</unittitle>
          <unitdate type="inclusive">1996 May 10</unitdate>
          <container id="aspace_f7faef8288a9c600f9b9339f04235c98" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="aspace_4034b6cf77692763eeed9d385c5802ff" parent="aspace_f7faef8288a9c600f9b9339f04235c98" type="folder">5</container>
        </did>
        <accessrestrict id="aspace_2fb3ed462271aeec0fb14801053de435">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_9050bc8c28970ad791e377582e9c079c" level="file">
        <did>
          <unittitle>TML, 38-67 - Choice of Lipid-Lowering drugs</unittitle>
          <unitdate type="inclusive">1996 August 2</unitdate>
          <container id="aspace_88369e9be12fba5f5610e67f44ced796" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="aspace_7298f0e4e2e2fb73b12d6e1b77d10d4e" parent="aspace_88369e9be12fba5f5610e67f44ced796" type="folder">6-13</container>
        </did>
        <accessrestrict id="aspace_88da501863cd117b47bcae321e4b3b00">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_5c5e7299af1de05e46453f0fea0e1720" level="file">
        <did>
          <unittitle>TML, 38-21 - Cetirizine - a new antihistamine</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="aspace_5d9a56eb0befaee315c57d404c26e2c6" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="aspace_bf3ddc38b5995e4db216bf7a4f406479" parent="aspace_5d9a56eb0befaee315c57d404c26e2c6" type="folder">14-18</container>
        </did>
        <accessrestrict id="aspace_0f7c6d142759503d2196573bb0b89f9a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f91362447d7a3cdff68d7ebac520b38" level="file">
        <did>
          <unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="aspace_3e72c2381f66120bf35dd749c14d2e3c" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="aspace_cc4b7cb14a0e4d0cb591bf27a9ee4e78" parent="aspace_3e72c2381f66120bf35dd749c14d2e3c" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_4e5c9545497b1cea799d01d6d8e16965">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c714362a04b8f852b521155e586e0af2" level="file">
        <did>
          <unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="aspace_23ce776f4c5621e96fdcb47b708fbb56" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_8fd4a282377d0bc596ea3ed0c71944ff" parent="aspace_23ce776f4c5621e96fdcb47b708fbb56" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_a545b57ddc41b86449988949e310c707">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_484f5bda82347b92c1fd763adae1bf8a" level="file">
        <did>
          <unittitle>TML, 38-64 - Dexfenfluramine for obesity</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="aspace_a380b5d8832e13559ad3e44cca0340e9" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_627d20db30b485d836b27ca1e70d7b52" parent="aspace_a380b5d8832e13559ad3e44cca0340e9" type="folder">2-5</container>
        </did>
        <accessrestrict id="aspace_0ae4223f8a683f538d4cd77c366f1250">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_8d0423127d33593f9f53a6262dc9f97c" level="file">
        <did>
          <unittitle>TML, 38-87 - Docetaxel (Taxotere) for advanced breast cancer</unittitle>
          <unitdate type="inclusive">1996 September 27</unitdate>
          <container id="aspace_bbf31c3611894b102d27e65f827bd1ac" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_efedb094b37809c55a493540052455b9" parent="aspace_bbf31c3611894b102d27e65f827bd1ac" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_ed7cc80f5cac6080418667469e63fcc5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_a348057f4e83121c70f8e63e18862273" level="file">
        <did>
          <unittitle>TML, 38-14 - Epoprostenol for primary pulmonary hypertension</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="aspace_8cd0822d20085e96a2e27626e8a86b4b" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_d56f18441dc88b6842179962db130a21" parent="aspace_8cd0822d20085e96a2e27626e8a86b4b" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_9060f4c1941e62cde507283711c42123">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_4fb37dc500fa2658eede9f802e9df8f8" level="file">
        <did>
          <unittitle>TML, 38-95 - Fexofenadine</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="aspace_af603d9b28ae642ec32d2e48322fda4f" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_3172b88b9c24373a41b68332bb912d2d" parent="aspace_af603d9b28ae642ec32d2e48322fda4f" type="folder">11-12</container>
        </did>
        <accessrestrict id="aspace_a8ff5bd8f8c9a8beb936876d0ab13404">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_64be8e3eb6b9a7f019087998bc44abd8" level="file">
        <did>
          <unittitle>TML, 37-13 - Fluvoxamine for obsessive compulsive disorder</unittitle>
          <unitdate type="inclusive">1995 February 17</unitdate>
          <container id="aspace_c9203f7aac5747c8ad94cff43515af76" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_6feff63011c802a590fbd00d8de5aac0" parent="aspace_c9203f7aac5747c8ad94cff43515af76" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_695bcbd1bf632b907b932d7960966f9f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_892b6eca462f2e15ad9ec8aa8eca30aa" level="file">
        <did>
          <unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="aspace_cc42c3e29b6fb64f46206600b4df6fb6" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_8b4726de709bead40c2350d163566fec" parent="aspace_cc42c3e29b6fb64f46206600b4df6fb6" type="folder">17-21</container>
        </did>
        <accessrestrict id="aspace_beb3673044e9a99bc1e5e6f80a600a9c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_35c106caf84841f600db741ede502382" level="file">
        <did>
          <unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="aspace_03aab3ebff954fecd9c71f0983f55eff" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_f3a7b81ffa76ff91fc92ed187ce36e76" parent="aspace_03aab3ebff954fecd9c71f0983f55eff" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_f54d8351e9c7683733c760ddc9c6386f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c02c90545e46d220940cf2a507e0a28" level="file">
        <did>
          <unittitle>TML, 38-10 - Systematic antifungal drugs</unittitle>
          <unitdate type="inclusive">1996 February 2</unitdate>
          <container id="aspace_41348580574b0a3a31cc2c3e2836af5f" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_51d553013be170344c50c577ae2a8c89" parent="aspace_41348580574b0a3a31cc2c3e2836af5f" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_24650d75f7a4fe5ddaf748532b77d1c8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_af3d9dfc1b1412c493e47fcf1216a75b" level="file">
        <did>
          <unittitle>TML, 38-102 - Gemcitabine for treatment of pancreatic cancer</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="aspace_93e1f96bdf589232e32a46e550ae7825" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_a89835a22d9454fc5a2de2071f6ac878" parent="aspace_93e1f96bdf589232e32a46e550ae7825" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_7105d2dd194378e7c1b806e1786142c0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_237f462175824d3b36e04281c83344ac" level="file">
        <did>
          <unittitle>TML, 38-47 - Glimepiride for NIDDM</unittitle>
          <unitdate type="inclusive">1996 May 24</unitdate>
          <container id="aspace_294ea32a6067ac51970fc2aee5db3164" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_70bba471eafdec304b8899be17003ae3" parent="aspace_294ea32a6067ac51970fc2aee5db3164" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_d0c68415f609b87b8e322217b54f482b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_f5f43d18d02fa3b8ac7f25b5d2f4bf4e" level="file">
        <did>
          <unittitle>TML, 38-92 - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">1996 October 11</unitdate>
          <container id="aspace_0c2965daa3a58dfd302a10bdce24a494" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_691a082fcda207ced24955049e50eec7" parent="aspace_0c2965daa3a58dfd302a10bdce24a494" type="folder">9-13</container>
        </did>
        <accessrestrict id="aspace_a3631f3ddc4c9deaa183f2128f324ec8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_df185de80953b9ba72734fc53563026f" level="file">
        <did>
          <unittitle>TML, 37-73 - Grapefruit juice interactions with drugs</unittitle>
          <unitdate type="inclusive">1995 August 18</unitdate>
          <container id="aspace_f5d54f7525c184a56aee0f43d870ea2b" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_d4fbf86f233b4c14978ed230aa6e5036" parent="aspace_f5d54f7525c184a56aee0f43d870ea2b" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_ee2185b1e98265927be53db9e0fa2dda">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_9ea393808d7941a34a9237ff7d3e21d0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="aspace_87767c23570abec9e4ac5314a2bae8c4" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_ebaea0f8d17b0755d335bca282628044" parent="aspace_87767c23570abec9e4ac5314a2bae8c4" type="folder">17-20</container>
        </did>
        <accessrestrict id="aspace_052ebcc34a91845237e97c0df53775e3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_b5728f730c61991eb3d049832355c05c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="aspace_74d8a36075e430dbbc9c0d340ee2d5c0" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_36bdbfbda06c460c2e67e6b792806179" parent="aspace_74d8a36075e430dbbc9c0d340ee2d5c0" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_8725ceb0317248c73c37ce2386f5e01b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_34fded3e81407289cef7298c43db888c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Pain</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="aspace_1585d9fc3d4d818c69abbc6174e11e27" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_7207537c5b02dada48e3136400acaebc" parent="aspace_1585d9fc3d4d818c69abbc6174e11e27" type="folder">3-7</container>
        </did>
        <accessrestrict id="aspace_fd6c1b22c3706f5ee95e16758bf6f9f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_73f114dc6e630afb990634a443031d95" level="file">
        <did>
          <unittitle>TML, 37-95 - OTC H2 Blockers for heartburn</unittitle>
          <unitdate type="inclusive">1995 October 27</unitdate>
          <container id="aspace_1181d89710c6585653b0bc80bd72e665" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_d66bd5bfabc2cfd20a3f690f97b3b2e2" parent="aspace_1181d89710c6585653b0bc80bd72e665" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_6f9d54ac52d448a971ae1e70ff68a5a9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_e3ff759a8063b390ff0175205e40649d" level="file">
        <did>
          <unittitle>TML, 38-6 - Rho (D) IV Immune Globulin</unittitle>
          <unitdate type="inclusive">1996 January 19</unitdate>
          <container id="aspace_36ea740bf2785cfb4b5c8612cce9b873" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_f115f45b3b420f7febcb28954daf62c8" parent="aspace_36ea740bf2785cfb4b5c8612cce9b873" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_ce939d07fa2fe96e5b623cff81c37a02">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_343b5e9d7ba1058f32a08341d9be9f4a" level="file">
        <did>
          <unittitle>TML, 38-17 - Advice for Travelers</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="aspace_7fc6445a0411d39558946c698bb4be7f" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_561179ada0581a44b65cb7fd03bb6ad1" parent="aspace_7fc6445a0411d39558946c698bb4be7f" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_c3bea7a676bd5b9981068ccf42242297">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_314ebfe0a12d0bad31002df2bbabf782" level="file">
        <did>
          <unittitle>TML, 37-98 - Influenza Vaccine, 1995-1996</unittitle>
          <unitdate type="inclusive">1995 September 1</unitdate>
          <container id="aspace_44a733a21105b12d1956df2c216d2baa" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_36effee42afbd365f18a1277fe736b7e" parent="aspace_44a733a21105b12d1956df2c216d2baa" type="folder">17</container>
        </did>
        <accessrestrict id="aspace_aaa5f55ecc1b4da36b3c2d152b9841b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_fa30b8e25d30bd60ee7b9207731748dd" level="file">
        <did>
          <unittitle>TML, 38-86 - Influenza Vaccine, 1996-1997</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="aspace_b2e47f709a0bfa36e6e67cfc175ea156" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_a5dbe190cbbcd5f196e8b2c9bf683ec5" parent="aspace_b2e47f709a0bfa36e6e67cfc175ea156" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_5726a4d76a933c3152d68d2618f96f58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_76dcb6a56a7b5f83636afb906304e3de" level="file">
        <did>
          <unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="aspace_3cdc05a36ec913a8b6ef98a6d055c715" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_b405d54c62b442faa6d2c4aae53fff84" parent="aspace_3cdc05a36ec913a8b6ef98a6d055c715" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_c85f0b8357c82829d2a4eb5e651846cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_bcfc06fa9fa8a02872f2c29e1146f46b" level="file">
        <did>
          <unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="aspace_09e1c66c951831acdcfcae4715a344a6" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_ee373fbd3a739a9b4ed63df85936053b" parent="aspace_09e1c66c951831acdcfcae4715a344a6" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_5afb2bc4dd74607653137719b41bcbd1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_ca2a00af5d69b29922032ebf4abb0fa9" level="file">
        <did>
          <unittitle>TML, 38-63 - Interferon beta IA for relapsing multiple sclerosis</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="aspace_0d73c9428fc9ba17d59b106f93a4fa67" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_295199f64da5dec6bc44023d85674136" parent="aspace_0d73c9428fc9ba17d59b106f93a4fa67" type="folder">5-6</container>
        </did>
        <accessrestrict id="aspace_03343319e99b7f0ef24a7fc83ce57bad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c90350a57c09afa4b1edf8990faf82c4" level="file">
        <did>
          <unittitle>TML, 38-5 - Intraconazole for onychomycosis</unittitle>
          <unitdate type="inclusive">1996 January 19</unitdate>
          <container id="aspace_72d3fad921db9ee99522265c65d02e08" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_fa17188234dd68689ba881dea197f369" parent="aspace_72d3fad921db9ee99522265c65d02e08" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_a3ae42f0dfac2f6884835c0dd4cbe74b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_838bd206e5b57f1350c9a04ae42f2583" level="file">
        <did>
          <unittitle>TML, 38-100 - Latanoprost - A topical prostaglandin for glaucoma</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="aspace_ea8e4be9d63208660bee17b38b86679b" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_b19fd3d85157143324d0e10f810d3adc" parent="aspace_ea8e4be9d63208660bee17b38b86679b" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_2e48e9ac6a735700c373ee378f599caa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_45a205e5a189cb71c6708535b75c4937" level="file">
        <did>
          <unittitle>TML, 38-97 - Lispro - A rapid onset insulin</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="aspace_68ac939d80863dff1dc9c8ecc170ce80" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_b32b09285a9d9abed04c612487d69c62" parent="aspace_68ac939d80863dff1dc9c8ecc170ce80" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_0c7d5401af543b0c0983defbe212a6e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_2cbe2967f283fa20d7d713e0125238d8" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="aspace_0ce1e105eb134e0aeaedf3e148639672" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_b09f26fff210193eb6edde48581c4854" parent="aspace_0ce1e105eb134e0aeaedf3e148639672" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_25976cdf1f32d7fc8a1e78cb2f48d34d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_f7093bc2141bbd10998f3dc5ff41875b" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="aspace_71f9924d8169edcdc7564464e851142d" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="aspace_7eced34ef3689dba1075c2be71bb0bdb" parent="aspace_71f9924d8169edcdc7564464e851142d" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_5de98fca91cbe16591ff580840223c8c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_e7f67d0b2048a576bdc2a8c6ef1f5674" level="file">
        <did>
          <unittitle>TML, 38-13 - Nisoldipine - a new calcium-channel blocker for hypertension</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="aspace_a7b70533cb55782e074b92ca9f7e801c" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="aspace_f994c0ea0075a593a41cfe2d8fe093ee" parent="aspace_a7b70533cb55782e074b92ca9f7e801c" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_310f0f0a8b17bda4d5be0d11e8e3909a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ab086d0742f0a6f31a054d358cbefcf" level="file">
        <did>
          <unittitle>TML, 35-62 - Nedocromil for asthma</unittitle>
          <unitdate type="inclusive">1993 July 9</unitdate>
          <container id="aspace_042d08c77c75fdf483f24d5f19eb0edc" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="aspace_23e3ea67ed0738a594649a316e2241b5" parent="aspace_042d08c77c75fdf483f24d5f19eb0edc" type="folder">8-12</container>
        </did>
        <accessrestrict id="aspace_d876b6e0e035d2d97ee9711f878a831c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_9f3042b173404cf6a3ccd9df900d20c0" level="file">
        <did>
          <unittitle>TML, 38-1 - New drugs for osteoporosis</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="aspace_31dda636db320867cff3d700b79a4104" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="aspace_7da73e7f779d27eacdb1cea717ad3193" parent="aspace_31dda636db320867cff3d700b79a4104" type="folder">13-18</container>
        </did>
        <accessrestrict id="aspace_059f4c0e348f3f79f9eac8942a1b7673">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_e20404fc9c2c5857d90b819cb9c70cc0" level="file">
        <did>
          <unittitle>TML, 38-53 - Prostatron</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="aspace_db6220f4d071903a4e838a8f27594962" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="aspace_c728510822d0a83cdff99c16b45458e6" parent="aspace_db6220f4d071903a4e838a8f27594962" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_fa8555c81ed0ff184e52c7e939db327c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_cbfa8d04b93b4e3d89a843bbf9e3d7f8" level="file">
        <did>
          <unittitle>TML, 38-107 - Pallidotomy for Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="aspace_ed8ebd7f939113913d99d4d6c89e87c8" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_f23fa3e525f65883c4f871f77870008e" parent="aspace_ed8ebd7f939113913d99d4d6c89e87c8" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_6ec525e7fd9b38dcd1bce23ad46d101c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c1416d4fc58c7899cbc27ca73d15c172" level="file">
        <did>
          <unittitle>TML, 38-57 - Simethicone for gastrointestinal gas</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="aspace_bb52a7dc5c7888debd784cdcae9ff162" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_fa52c36a08c6505bad563281540515c6" parent="aspace_bb52a7dc5c7888debd784cdcae9ff162" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_76d78aedee8d1ddf219a07affe27bb10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_26af25957e59124a08f91eba499fc700" level="file">
        <did>
          <unittitle>TML, 38-106 - Sodium Phenylbutyrate for urea cycle enzyme deficiencies</unittitle>
          <unitdate type="inclusive">1996 November 22</unitdate>
          <container id="aspace_00a4d3f5f4d94ac40abb08d9160a840c" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_e7cfcc7f21eb58de811c5c544d38b77b" parent="aspace_00a4d3f5f4d94ac40abb08d9160a840c" type="folder">6-7</container>
        </did>
        <accessrestrict id="aspace_8f55e867e223cf7fc8c205180e5bb1b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_4273a72d699f99aeabfcab12d5bde513" level="file">
        <did>
          <unittitle>TML, 38-72 - Terabinafine for onychomycosis</unittitle>
          <unitdate type="inclusive">1996 August 16</unitdate>
          <container id="aspace_fd7cc31d4ec47495fc6e8f5fcfc598a1" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_375ba23ec82b721f1071e6a78de61560" parent="aspace_fd7cc31d4ec47495fc6e8f5fcfc598a1" type="folder">8-11</container>
        </did>
        <accessrestrict id="aspace_f99d89a3af0b743be45c7d543c9a47b3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_afa8fcead3849c57e46148fac07fdf16" level="file">
        <did>
          <unittitle>TML, 38-49 - Androderm (Testosterone patches)</unittitle>
          <unitdate type="inclusive">1996 May 24</unitdate>
          <container id="aspace_4596cba36c0dc0d0535dcf5c551dc98f" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_920b6dbe0be47ff55867c8a383def0fd" parent="aspace_4596cba36c0dc0d0535dcf5c551dc98f" type="folder">12-15</container>
        </did>
        <accessrestrict id="aspace_6c9daad633f6ca6f23f9cb9675ec5725">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_e83fc33c009862fb85873ce44225451e" level="file">
        <did>
          <unittitle>TML, 38-96 - Toptecan hydrochloride for metastic ovarian cancer</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="aspace_a124c0f9246bd3d78b6ce77e761bcd9e" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_17cbc7aa904e65e1c6a0c33c043d728b" parent="aspace_a124c0f9246bd3d78b6ce77e761bcd9e" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_f4f4ca0b76dee28258679841660c3e53">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_1d1e2499f47a2c5a2498c508251c060e" level="file">
        <did>
          <unittitle>TML, 38-3 - Valacyclovir</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="aspace_4befd659567691b579575b73346e18d1" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_19cb8c5316f9b2c4934e974b1713938e" parent="aspace_4befd659567691b579575b73346e18d1" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_5e026f0f926c42121383574e48a743ca">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_e3cd99c272218799e02c72a5e28f33c9" level="file">
        <did>
          <unittitle>TML, 38-3 - Valacyclovir</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="aspace_d3f21eeb624c2681f9f5aee7460fd29d" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_da417135ce200046aa7fce32392c354e" parent="aspace_d3f21eeb624c2681f9f5aee7460fd29d" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_ed67782a99870c0e712a42cf95c5cfc7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_2146f075bfb01adf0c99fddbe6268b26" level="file">
        <did>
          <unittitle>TML, 38-104 - Trandolapril - An ACE inhibitor for treatment of hypertension</unittitle>
          <unitdate type="inclusive">1996 November 22</unitdate>
          <container id="aspace_d278fecb971744a12a378355e87996bf" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_50389c031a27e3489b4e3b698cd4892a" parent="aspace_d278fecb971744a12a378355e87996bf" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_a1dd4aa7256167e609397b035b7478d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_7a2f268994b16b4876604d64167ade0b" level="file">
        <did>
          <unittitle>TML, 38-71 - Umbilical cord blood for bone marrow transplantation</unittitle>
          <unitdate type="inclusive">1996 August 16</unitdate>
          <container id="aspace_07d05eda580c1bb5418f8659d50d993c" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_2e2c34470305e4efb317d90265abc702" parent="aspace_07d05eda580c1bb5418f8659d50d993c" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_c284795ebfbae6dd142f49e2c3d64449">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c7fa6ad1765f84becedf7fbe8dae1981" level="file">
        <did>
          <unittitle>TML, 38-51 - Clarithromycine and omeprazole of helliobacter pylori</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="aspace_b22116ecb41d9850994715790d15cd25" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_60f83c586785bc03af9b5025de30a3f3" parent="aspace_b22116ecb41d9850994715790d15cd25" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_d93e4e485f03621de43519409ecd0ebb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_d2847f832cf8b7dfa8bae10d4079561b" level="file">
        <did>
          <unittitle>TML, 38-15 - New Uses of Thalidomide</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="aspace_bc34fbb2c8df28f25b1c3aa83f94cfae" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_e9b46a804677113770ead518aac43374" parent="aspace_bc34fbb2c8df28f25b1c3aa83f94cfae" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_5a934c0b2b5e5cf25f836a73de95c999">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_07f911d357717fedb196ba2a95b08c6f" level="file">
        <did>
          <unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="aspace_55240d99ffaf9e1a36e4640faec7825f" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_b933f7f1f8906d8469744c59097ef04f" parent="aspace_55240d99ffaf9e1a36e4640faec7825f" type="folder">15-19</container>
        </did>
        <accessrestrict id="aspace_7ad69902cf7b5b84adb8b1470b88ef97">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c0d2ae8c9a59eb2afc81bad688a8e0d9" level="file">
        <did>
          <unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="aspace_8d212d95eb74ea288f7ab315314366de" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_b0519b12d83c0d9850413f8ca18318be" parent="aspace_8d212d95eb74ea288f7ab315314366de" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_42570c5418d18c7d11e5ecb6d56fc38d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_0d91fc0adca0e054072c6a3fff1ac1f6" level="file">
        <did>
          <unittitle>TML, 38-65 - Drugs past their expiration date</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="aspace_7c367980eea3db78a35e81b5eccf9bed" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_ed2577b35e130ac2ecb923951979769b" parent="aspace_7c367980eea3db78a35e81b5eccf9bed" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_861175c1c60e1d08ff94909fca12e380">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_b6e8488842fc6d3ed56539b8c5e7c344" level="file">
        <did>
          <unittitle>TML, 38-38 - Ibutilide</unittitle>
          <unitdate type="inclusive">1996 April 12</unitdate>
          <container id="aspace_e9b3e9d722d35adb18e411b992398ca2" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_e22413e845a861a7223c16571d15878b" parent="aspace_e9b3e9d722d35adb18e411b992398ca2" type="folder">5-6</container>
        </did>
        <accessrestrict id="aspace_d854aa1bc446941f011a8970567a2b37">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_93c5ceb8486269a6440d4a1164bd8a19" level="file">
        <did>
          <unittitle>TML, 38-91 - DHEA</unittitle>
          <unitdate type="inclusive">1996 October 11</unitdate>
          <container id="aspace_ad3968f30e348aa68601ef17354e46a0" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_f970cb48e76ce92c8b995eb070ce6ec3" parent="aspace_ad3968f30e348aa68601ef17354e46a0" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_0b753cb331038a0a1193ae254361f43e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_489aaa51c24f7c3822366d6381860b83" level="file">
        <did>
          <unittitle>TML, 38-88 - Meropenem - A new parenteral broad-spectrum antibiotic</unittitle>
          <unitdate type="inclusive">1996 September 27</unitdate>
          <container id="aspace_36be78f4dffdf753d71403404d1c10b1" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_a1c38108e67338cd32503e9b8d6d5407" parent="aspace_36be78f4dffdf753d71403404d1c10b1" type="folder">10-14</container>
        </did>
        <accessrestrict id="aspace_06a4c2f05bc64d8b4ee6a3b07e593fe9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_3a54f51aec4a83bee985f1670be2aff6" level="file">
        <did>
          <unittitle>TML, 38-39 - Methotrexate and Misoprostol for abortion</unittitle>
          <unitdate type="inclusive">1996 April 26</unitdate>
          <container id="aspace_ca984f91ee41dbf2e6ab94b08ef8ca90" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_e4ec29c29266252ccffbded7bcce6290" parent="aspace_ca984f91ee41dbf2e6ab94b08ef8ca90" type="folder">15</container>
        </did>
        <accessrestrict id="aspace_6b3edef9531f4a2fde2d3628c5d7cdd0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_43193a32312eb0204d12fd64fa6b6993" level="file">
        <did>
          <unittitle>TML, 38-111 - Zafirlukast for asthma</unittitle>
          <unitdate type="inclusive">1996 December 20</unitdate>
          <container id="aspace_48830c4b819e7b12dfc281c1efddb629" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_58e89a1cbbee63d74d7b2b9f62dc75b4" parent="aspace_48830c4b819e7b12dfc281c1efddb629" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_13e892949bbc4a48ce8c4285b3b1007e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_49b7007dcadc3c636c88f299dc526e0d" level="file">
        <did>
          <unittitle>TML, 31-83 - Samarium 153 lexidronam for painful bone metastases</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="aspace_f5bc2abb7c49d6521928c655f49a5f43" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="aspace_5fe88589fb9ef627f774e01b83efe38c" parent="aspace_f5bc2abb7c49d6521928c655f49a5f43" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_592e1bece31e2f3f6b5ae1b6e1a8011e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_61b0c640e3f013a34c64133724020fa2" level="file">
        <did>
          <unittitle>TML, 38-69 - Drugs for non-HIV viral infections</unittitle>
          <unitdate type="inclusive">1997 August 1</unitdate>
          <container id="aspace_09c159882283044b1ef509fe52a1f603" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="aspace_a61a3dfcb012b2dd512a23f5726e58a9" parent="aspace_09c159882283044b1ef509fe52a1f603" type="folder">4-12</container>
        </did>
        <accessrestrict id="aspace_84c4988675afd57f7b095139aa7bfdfe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_133977107f40fa3272c401b7abcc89de" level="file">
        <did>
          <unittitle>TML, 39-18 - Zileuton for asthma</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="aspace_39dcb48548c7b7f2c03bb6a70dee017e" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="aspace_aca1a515dd1247997756108052cbcece" parent="aspace_39dcb48548c7b7f2c03bb6a70dee017e" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_4717fa288dd120e806e05499350ddf6f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_be46a606b805462c6cc03b6ec8b2c39e" level="file">
        <did>
          <unittitle>TML, 39-9 - Zinc for the common cold</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="aspace_38b31895a05d22113a01489bf903223f" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="aspace_17294a47247fa14b1cab7e3fb5c05e4f" parent="aspace_38b31895a05d22113a01489bf903223f" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_ad1088be46d6652eb0405e32258a0bf9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_1a7499e6fbd604c0b75b6d778dc5c0f9" level="file">
        <did>
          <unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="aspace_99b6d4bd132606345a7ecdcfb7745d14" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="aspace_46b9ade627f7609819565f9208aa0094" parent="aspace_99b6d4bd132606345a7ecdcfb7745d14" type="folder">18-20</container>
        </did>
        <accessrestrict id="aspace_ebe0ac100a42ac94570bd02c0e0ccdbb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_c3fee2e8cf6e2d58695098807e086dab" level="file">
        <did>
          <unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="aspace_16b6b86de99473b0008fe38311fda8f6" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_0dfe830cfbf405205f475bd28b55f89e" parent="aspace_16b6b86de99473b0008fe38311fda8f6" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_898d939f278bc6e6c335eb092f07c5a8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_393de6e6b75d4f4817695af30349dd68" level="file">
        <did>
          <unittitle>TML, 39-80 - Ropivocaine - a new local anesthetic</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="aspace_880a766c233c276b21d2b7156e61e237" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_9d062afb625fa67fc7ccfaae0f126fff" parent="aspace_880a766c233c276b21d2b7156e61e237" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_7af0a96e2cfe06eaffa6999f5bfd2c77">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_4be741eb1bacb7f18527f5b2df647302" level="file">
        <did>
          <unittitle>TML, 39-41 - Levofloxacin and sparfloxacin</unittitle>
          <unitdate type="inclusive">1997 April 25</unitdate>
          <container id="aspace_3734ce081501bc279f01627f1e0cab74" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_8585100bec28cba188fbee23632375b1" parent="aspace_3734ce081501bc279f01627f1e0cab74" type="folder">5-10</container>
        </did>
        <accessrestrict id="aspace_7550d2d00d3b056285daa384c568544b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b81fc7aadd5fecc407e846095655da0e" level="file">
        <did>
          <unittitle>TML, 39-10 - Lasers in dermatologic surgery</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="aspace_a9e9347e9777e34b63c2a74f87759165" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_e50fa8bc4b6d27e0953a1fc6195e1524" parent="aspace_a9e9347e9777e34b63c2a74f87759165" type="folder">11-15</container>
        </did>
        <accessrestrict id="aspace_0f1f31dc544a7820b6b3740572840e2c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_d6a872b6263ad2beca76d2809d741c78" level="file">
        <did>
          <unittitle>TML, 39-84 - Skin surgery with lasers - an additional note</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="aspace_63b6cf65013e65be6db7ce253a8c5963" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_79875162ed2267afca0454108686c340" parent="aspace_63b6cf65013e65be6db7ce253a8c5963" type="folder">16</container>
        </did>
        <accessrestrict id="aspace_37b13c54d0d04ba5299304f96256cfc0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_62572ae54e7b47c32783a5b7f9f92261" level="file">
        <did>
          <unittitle>TML, 39-51 - Topiramate for epilepsy</unittitle>
          <unitdate type="inclusive">1997 May 23</unitdate>
          <container id="aspace_5a65b4ac4d3b2832246b155668156ce0" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_200f515f55c4bb2fe97667a89d75a15e" parent="aspace_5a65b4ac4d3b2832246b155668156ce0" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_1f453b72cb65c772c8bbcb8b965fc251">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_bbfc9de7adb6df0701f6173947f38bd2" level="file">
        <did>
          <unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="aspace_0efc0b994134856fdd4eaf07dd09ea69" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_ffd46d78332217d189aa721909f0b93b" parent="aspace_0efc0b994134856fdd4eaf07dd09ea69" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_63c006cdd8a94fd253916b0a5c2fcbfc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_6b378b12b2f16c81d85d36343d81a41b" level="file">
        <did>
          <unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="aspace_5fc47a25b86ccafde2703c8c32b6a9f5" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_600b0e4f342d4a4215ebdaba340e57fa" parent="aspace_5fc47a25b86ccafde2703c8c32b6a9f5" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_62290c3388efd25a1b03329c60a4c2c5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_bf256a51de793456a4c7d083f141288c" level="file">
        <did>
          <unittitle>TML, 39-65 - Tiludronate for Paget's disease of bone</unittitle>
          <unitdate type="inclusive">1997 July 18</unitdate>
          <container id="aspace_abd2985eda0087079fa07192905c87d5" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_dd1b5ef1111b4aad51ce6020daf32e8b" parent="aspace_abd2985eda0087079fa07192905c87d5" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_a0af36cf2f0f39c3b6bf43a2f3d1a8f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_e50c791d98c44790d8141d27cd4cfcab" level="file">
        <did>
          <unittitle>TML, 39-62 - Tizanidine for spasticity</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="aspace_f146eb475552dba0669a3aa3b07e23d5" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_aee4a05bb385d8dc844d95c93584f7b3" parent="aspace_f146eb475552dba0669a3aa3b07e23d5" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_264d6479c0b4544b7007e8c452a7cee5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_12444cf584e83734f66bfc290040544a" level="file">
        <did>
          <unittitle>TML, 39-49 - Troglitazone for non-insulin-dependent diabetes mellitus</unittitle>
          <unitdate type="inclusive">1997 May 23</unitdate>
          <container id="aspace_64740de278a4052184f4e07409436fd5" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_dd7ccccbd845a35a9ad050b4773f670d" parent="aspace_64740de278a4052184f4e07409436fd5" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_c2dbaf70c1400524b9601ade32d9aa09">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_64f0edfa5bd3b5159911a74e751d912b" level="file">
        <did>
          <unittitle>TML, 39-43 - Valsartan for hypertension</unittitle>
          <unitdate type="inclusive">1997 April 25</unitdate>
          <container id="aspace_f50e7a57530c36dabcc012103f6c4127" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_40b183a4b7d5232edb865355fc1a9a16" parent="aspace_f50e7a57530c36dabcc012103f6c4127" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_d5a76faf4ca30d9de5137cfcad807f6e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_eb014687998353d0fb60326357526127" level="file">
        <did>
          <unittitle>TML, 39-1 - Drugs for treatment of peptic ulcers</unittitle>
          <unitdate type="inclusive">1997 January 3</unitdate>
          <container id="aspace_57702574f75bee2fa2c4bf41f3534cee" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_a5e02eb4ab79f6c4ac6f6003d7b5fcad" parent="aspace_57702574f75bee2fa2c4bf41f3534cee" type="folder">15-20</container>
        </did>
        <accessrestrict id="aspace_1fcec8ea591c0f4b6123d11e89e69ddb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_3436a17eac9c6f31692eb5d354b51a44" level="file">
        <did>
          <unittitle>TML, 39-109 - Pramipexole and Ropinirole for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="aspace_2605e6c1d0a9e8a1e6afacb977c889ce" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="aspace_d7db08cc2cab078c6a99fa596240b840" parent="aspace_2605e6c1d0a9e8a1e6afacb977c889ce" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_9f23fe9c137d23133c2b5049c5b64530">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_ea94f0229ffb76d4e8a48dbf172eec36" level="file">
        <did>
          <unittitle>TML, 39-105 - New drugs for psoriasis</unittitle>
          <unitdate type="inclusive">1997 November 7</unitdate>
          <container id="aspace_146df21936115d4eb9e88c4730894e49" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="aspace_ba464ad3e2da7e407cd21b18f7c7e3d1" parent="aspace_146df21936115d4eb9e88c4730894e49" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_d1471d567708b0ca9a5c6d93f5f254f0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_12f50952f7ba8eb3afd7e492d332b4a1" level="file">
        <did>
          <unittitle>TML, 39-33 - New drugs for psychiatric disorders</unittitle>
          <unitdate type="inclusive">1997 April 11</unitdate>
          <container id="aspace_20ac402e947b5b1e6f8aad5b7fff99b0" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="aspace_d2aabfc08c0d70258ca6c8b9ce163e16" parent="aspace_20ac402e947b5b1e6f8aad5b7fff99b0" type="folder">9-15</container>
        </did>
        <accessrestrict id="aspace_dbaf4673299ed575f189876448054a58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_123a71748e8ade20af228276bab2d8b6" level="file">
        <did>
          <unittitle>TML, 39-117 - Quetiapine for schizophrenia</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="aspace_9fe6239fded1ed9e4f1155dea419c824" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="aspace_f44ad1103b8fed313b2dbe9e5cebb551" parent="aspace_9fe6239fded1ed9e4f1155dea419c824" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_8bbc739b2ed931419befe4ab8eb4eb63">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_498df0f2d9dce92679b2aa347629be3f" level="file">
        <did>
          <unittitle>TML, 39-17 - Reteplase (Retavase)</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="aspace_d0e8f6cda4ebc8a4ee1894373270769b" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="aspace_0f5313f5969c90da2e5c20b239a94be6" parent="aspace_d0e8f6cda4ebc8a4ee1894373270769b" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_b2dca34162d6868414a816046edfdff2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_6ba7d8b0dcb752d130b074f42b440dd7" level="file">
        <did>
          <unittitle>TML, 39-53 - Donepezil (Aricept) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="aspace_54b7bd08e525824dc65f532b3df68d1b" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="aspace_423c68599c3fdac0bb5e9855ce91363a" parent="aspace_54b7bd08e525824dc65f532b3df68d1b" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_6532d645696e8a65297e0563e103f695">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_7c2e04e9e7b332289a442e6977a1f7d9" level="file">
        <did>
          <unittitle>TML, 39-81 - Diagnostic tests for HIV</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="aspace_cf186ee74c08eaad1aad9d7c5bed2409" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="aspace_685e4edd590415192e699aa6fa508eca" parent="aspace_cf186ee74c08eaad1aad9d7c5bed2409" type="folder">6-10</container>
        </did>
        <accessrestrict id="aspace_9570ef3f38bf3a851322c3c3fb7d17cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_fdd2b028e08760f46ba2467c4b638924" level="file">
        <did>
          <unittitle>TML, 39-21 - Drugs of Choice - Cancer Chemotherapy</unittitle>
          <unitdate type="inclusive">1997 March 14</unitdate>
          <container id="aspace_e36bf0b3f52e0cec19d6c53d57ce0a5a" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="aspace_5f41512a639e8f383410d48d511ff0d4" parent="aspace_e36bf0b3f52e0cec19d6c53d57ce0a5a" type="folder">11-16</container>
        </did>
        <accessrestrict id="aspace_28f03f207bd6c378f505103883232f68">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_42935bf2b5b11b084838a1252d3b3db8" level="file">
        <did>
          <unittitle>TML, 39-77 - Bupropion for smoking cessation</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="aspace_9904106bcd823727b63fbd2a415ad1b9" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="aspace_5dd23739f5e7f717399ac8a2b5a805d2" parent="aspace_9904106bcd823727b63fbd2a415ad1b9" type="folder">17</container>
        </did>
        <accessrestrict id="aspace_6c0f62c3539d7b57d8122eb2501ba830">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_be3b6c8f67d8d9c4ef7e3226b17983fb" level="file">
        <did>
          <unittitle>TML, 39-63 - Topical butenafine for tinea pedis</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="aspace_1d2b44b21a465daafa7144518c7e6fb8" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_6a6f8b116133c637aa3fa680b25be7b7" parent="aspace_1d2b44b21a465daafa7144518c7e6fb8" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_5cc6b055d5b6e621ab0c71131fdd66e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_856acb144bbba7a94b1cb63f73185f43" level="file">
        <did>
          <unittitle>TML, 39-56 - Pentosan</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="aspace_5c13d48992b9f0bc249c8c20d160fab5" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_61ae67170fee28496e379a802868f340" parent="aspace_5c13d48992b9f0bc249c8c20d160fab5" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_9279dfdd8fa0fb9cdb6e31006d0ff6a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_afd34d20934d1be77bfc49f4d1241183" level="file">
        <did>
          <unittitle>TML, 39-103 - Mibefradil - a new calcium-channel blocker</unittitle>
          <unitdate type="inclusive">1997 November 7</unitdate>
          <container id="aspace_f5f17adc857aadfe4ae57ff4eaea7f76" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_64a1afb2d959a4a9d2c3a9bb90a4832c" parent="aspace_f5f17adc857aadfe4ae57ff4eaea7f76" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_bc77a13d4a14fc45f23bfb7a5bb57c5d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_de42e2f43ebae331da9c0b8180abb87c" level="file">
        <did>
          <unittitle>TML, 39-59 - Midodrine for orthostatic hypotension</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="aspace_894209572a9b91b534ca76c7f04beae9" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_4a4536cb53dc2c3041cd8469924d10ba" parent="aspace_894209572a9b91b534ca76c7f04beae9" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_01d73c68e8dd39b1c0b73b6d7700c7a0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_96ceef3812b648bc28698beed66c5d75" level="file">
        <did>
          <unittitle>TML, 39-47 - Treatment of Lyme disease</unittitle>
          <unitdate type="inclusive">1997 May 9</unitdate>
          <container id="aspace_1db1b8444815adb9a9324b275cb3880f" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_7538d2e1abfd70a164bff3a40e58c566" parent="aspace_1db1b8444815adb9a9324b275cb3880f" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_1456685e80bfcccf0ad9c93511c65c4d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_eaedccce6a322747a43e566f8dfc2b7d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="aspace_c372df6cb245a1e3c030c3ed54b3a333" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_654e96263467878ccb7e5720a13dd48f" parent="aspace_c372df6cb245a1e3c030c3ed54b3a333" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_640807ffbd5e5ea720da4f60f781a4b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_95b6682482a9d062317fcf262cc7f718" level="file">
        <did>
          <unittitle>TML, 39-85 - Influenza vaccine</unittitle>
          <unitdate type="inclusive">1997 September 12</unitdate>
          <container id="aspace_bd3d6552e12bcd752d84870ca4cc6a98" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_5dcac491473fc85baea4cf727668b0c4" parent="aspace_bd3d6552e12bcd752d84870ca4cc6a98" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_bae55e07ca01b84992a5b395e88b6ccc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c5534af6d0a227ae1ad47876c813383" level="file">
        <did>
          <unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="aspace_48a25f73862eaf8b2be19271ce4085a6" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_ce4665a16811e2ec26c804992389ee49" parent="aspace_48a25f73862eaf8b2be19271ce4085a6" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_071f86249d57b3a639f1f0ac1e82c1db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_8d02c5507ec798ca4d7bb6188acc62a5" level="file">
        <did>
          <unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="aspace_c07e095cc02ec7c3206e7ebcda56786d" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_f9dd1f0abc33f209d944951e87d6d226" parent="aspace_c07e095cc02ec7c3206e7ebcda56786d" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_36454ffdeab70b1b39646403fa3b2960">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_0cdb2a091afd3228142c89eb37d2380a" level="file">
        <did>
          <unittitle>TML, 39-118 - Imiquimod for genital warts</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="aspace_d04bf5ce232754c68aac2b841a1f9035" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_c1e02143d13bd464d4729d2b82b3abd2" parent="aspace_d04bf5ce232754c68aac2b841a1f9035" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_d975c63ad23263fd275260f9460dcf1e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_f4d2ffb826a588ff6c493adbd06a92be" level="file">
        <did>
          <unittitle>TML, 39-64 - Drugs for epilepsy</unittitle>
          <unitdate type="inclusive">1997 February 6</unitdate>
          <container id="aspace_e1c8d4edd935c7100a889e230e1ce80f" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_f2c4ae54cfeaa2307c99402195392007" parent="aspace_e1c8d4edd935c7100a889e230e1ce80f" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_c20b70cbd97aa855e62537fb259a09f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_028b89ba84e332c879eab9899c191875" level="file">
        <did>
          <unittitle>TML, 39-66 - Fosfomycin for urinary tract infections</unittitle>
          <unitdate type="inclusive">1997 July 18</unitdate>
          <container id="aspace_fd54d74a508f9cb156067f5a80b84438" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_5fcd3d22fd02273cc7d60e77bba6b7ed" parent="aspace_fd54d74a508f9cb156067f5a80b84438" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_e0aa9d9341298313dcd22b6a4157d3bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_73ee7f93d0af26d64d0c1fc7ba0c7201" level="file">
        <did>
          <unittitle>TML, 39-86 - Systemic antifungal drugs</unittitle>
          <unitdate type="inclusive">1997 September 12</unitdate>
          <container id="aspace_fd18b3c666db143eb8f475b944541a93" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_e6d5a186c880688974c1c4b1d0ff19e2" parent="aspace_fd18b3c666db143eb8f475b944541a93" type="folder">10-13</container>
        </did>
        <accessrestrict id="aspace_226ecab6ab43654c9c5dd63a5e3e2b52">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_6bf77dfe11efd36cf8146b826560cb4c" level="file">
        <did>
          <unittitle>TML, 39-61 - Glatiramer acetate for relapsing mutiple sclerosis</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="aspace_7239ff1d10b84ee2f9b7459467763d56" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_0199b2ec0c4fa49fabcc4fc6a197d220" parent="aspace_7239ff1d10b84ee2f9b7459467763d56" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_58267fbb42c582dd03ac8830411c1803">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_f36ff800dacbd73013d42dab42cf5f5b" level="file">
        <did>
          <unittitle>TML, 38-6 - Drugs for head lice</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="aspace_d7d53faf55fe697e97bc813313685c6c" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_e5b6b6451d6d2f8195c6a20cd908e216" parent="aspace_d7d53faf55fe697e97bc813313685c6c" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_92296119b0cbe67e59973a003090f421">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_e13f3fa0ec576057f7033815a81111e1" level="file">
        <did>
          <unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="aspace_74097ef9e67c2597d034da423c5d46ba" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_b90bd7682a6e77ec898c0b0f1849357c" parent="aspace_74097ef9e67c2597d034da423c5d46ba" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_e7cb03a6203eb58d2833529692c66d60">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_dfc2de9cdb5bf3a8437e564fa717ffbd" level="file">
        <did>
          <unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="aspace_2dd6187111d84fe7558acc1d2bc9d2a1" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_0a04d7b277bfe0ef3d48d7432b6f7c5c" parent="aspace_2dd6187111d84fe7558acc1d2bc9d2a1" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_d913972842d3a79acf9b906df7f951e7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_95d8be151e4ef26242db019df375f791" level="file">
        <did>
          <unittitle>TML, 39-94 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">1997 November 1</unitdate>
          <container id="aspace_7ce79275e55fef1145f3e6a984c87a65" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_d2c8df6be84fb76965600499e3e9e374" parent="aspace_7ce79275e55fef1145f3e6a984c87a65" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_2db96bdb2ad3f2367bdf1559b5ea1133">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_f8696aa81da52173ff18b97bd7eb4067" level="file">
        <did>
          <unittitle>TML, 39-19 - Adapalene for acne</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="aspace_047008ec169b5480035a4c879ce7af2c" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_fc9833300400867c2ed06e619214582d" parent="aspace_047008ec169b5480035a4c879ce7af2c" type="folder">6-7</container>
        </did>
        <accessrestrict id="aspace_cefd2ab82f2cd38f2cef5b4253fea1fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_d3c8f38c2b75ab98def9cb12e7933ba3" level="file">
        <did>
          <unittitle>TML, 39-29 - Atorvastatin - a new lipid-lowering drug</unittitle>
          <unitdate type="inclusive">1997 March 28</unitdate>
          <container id="aspace_c36bdedf9534475a45e3059beacc1142" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_1f2458e24f75437fb43dea8c8d9d9b07" parent="aspace_c36bdedf9534475a45e3059beacc1142" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_f50e6cdc96d78aa80586f8c46bb4b44f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b2a72d06fe2be2cec8bad5a6a0fda27b" level="file">
        <did>
          <unittitle>TML, 39-45 - Azelastine nasal spray for allergic rhinitis</unittitle>
          <unitdate type="inclusive">1997 May 9</unitdate>
          <container id="aspace_321d17e1bab5dbb85fea82197ade2899" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_5d43889fe67125ca34fc1b163893a8d4" parent="aspace_321d17e1bab5dbb85fea82197ade2899" type="folder">10-13</container>
        </did>
        <accessrestrict id="aspace_2c8bdc164c637c083bf92b35d52554fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_36e76c3b20aacff333ba5d98cfca27de" level="file">
        <did>
          <unittitle>TML, 39-12 - Betaine for homocystinuria</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="aspace_fe7cba51ab4bdc7325f112b442e506c4" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_d50d75fc67bbecbf60911bb7b9bae837" parent="aspace_fe7cba51ab4bdc7325f112b442e506c4" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_55bd4c86ccf4811f99aac2673693e945">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_e4ca902373c4579a78db0d3b8d513633" level="file">
        <did>
          <unittitle>TML, 39-93 - Bromfenac for analgesia</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="aspace_6c5fb7db64eade0fcb1ac0d24a2d6743" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_e8c708a6dcc14fc2ed5c22fe8df0bfa8" parent="aspace_6c5fb7db64eade0fcb1ac0d24a2d6743" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_18bd5ce580d159e1acce03ad34266cc9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_1a9cef87a6b1f62bf27f90e19d47c4e1" level="file">
        <did>
          <unittitle>TML, 39-54 - Brimonidine - an alpha2-agonist for glaucoma</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="aspace_9db215f00bb0013d2faa904b4211a7d6" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_7c727640fced2d9bcab36b411d02ca95" parent="aspace_9db215f00bb0013d2faa904b4211a7d6" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_c12a956b010223394c6ca9d2025942d6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_56fc5093674d1372e80ed218ae8bd368" level="file">
        <did>
          <unittitle>TML, 39-13 - Safety of channel blockers</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="aspace_8e64b0dfa6c34c87f78bd486f9b77c19" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_6f736758ff73dcbcf5745b2afe83a013" parent="aspace_8e64b0dfa6c34c87f78bd486f9b77c19" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_12b089183fda270bbeecc135b190b589">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_1f85013ec13e639596b728f22f1aafc4" level="file">
        <did>
          <unittitle>TML, 39-13 - Safety of channel blockers</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="aspace_e1c0fbd3058ae43bb83f07859964c2e2" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_b7b3857375b2b571f3313ea80b48a36d" parent="aspace_e1c0fbd3058ae43bb83f07859964c2e2" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_8a33d90a046f00da2d8b9b030020c09e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b4a11be555144c67db801913b3a95361" level="file">
        <did>
          <unittitle>TML, 39-58 - Cabergoline for hyperprolactinemia</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="aspace_8e28d6a2ab539713c648522a56d3c862" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_a9f2566532d4adb442e2be859c4eb363" parent="aspace_8e28d6a2ab539713c648522a56d3c862" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_300ca74e312c726f3bc6c5c2409ffa88">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_8fa954deb6dc2ce7385244a3d8abc5a9" level="file">
        <did>
          <unittitle>TML - Dovonex</unittitle>
          <unitdate type="inclusive">1993</unitdate>
          <container id="aspace_1d8eb3b51e24e5bdde329535af05d3e0" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_3cdea884a3d82961d9a12a80583eaf8b" parent="aspace_1d8eb3b51e24e5bdde329535af05d3e0" type="folder">7</container>
        </did>
        <accessrestrict id="aspace_7ed0890a439df753466be5a70bc31770">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_c70f3345ad4c90f6af9d560ffb1f3777" level="file">
        <did>
          <unittitle>TML, 39-108 - Olopatadine for allergic conjunctivitis</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="aspace_053089d69ac091c3836a2f5dee670449" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_f9ff8f3f432456c1bf3686bc187e2792" parent="aspace_053089d69ac091c3836a2f5dee670449" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_7e05d25159387c3bcb0a7a1a1a57fbe9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f25168045c3874b852fc2566864c22b" level="file">
        <did>
          <unittitle>TML, 37-1 - Drugs for asthma</unittitle>
          <unitdate type="inclusive">1996 January 6</unitdate>
          <container id="aspace_e8ec569b36619803351d6d36b021321f" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_6680b7f433fced4e5403894acbb460dd" parent="aspace_e8ec569b36619803351d6d36b021321f" type="folder">10-14</container>
        </did>
        <accessrestrict id="aspace_5124cbd46d2a439f4f59c00468b6016b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_dbe0049fdc51d967d42b54af228c58ae" level="file">
        <did>
          <unittitle>TML, 39-32 - Intra-transurethral Alprostadil for impotence</unittitle>
          <unitdate type="inclusive">1997 March 28</unitdate>
          <container id="aspace_5d9f43cdda151f6f02fdf9373f51a652" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_ae8c78f59a7ae6feabc6036a597ea00a" parent="aspace_5d9f43cdda151f6f02fdf9373f51a652" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_108454fd852ec91b5893f1a78b4694b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_3fff697896297fb5b3e546b99c7bb615" level="file">
        <did>
          <unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="aspace_dddc0d8c2c626bd323f216317c8825fd" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_bc3c34b03fe645b9aed9b6b4e95f70a9" parent="aspace_dddc0d8c2c626bd323f216317c8825fd" type="folder">17-21</container>
        </did>
        <accessrestrict id="aspace_6e01c10d6e482faec33ca1e6f744b4e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_ac009d8a6eba90db98f499f6852dd496" level="file">
        <did>
          <unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="aspace_d1a4740649161a4ee58123aeb285bbbc" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="aspace_9f4518af2b43f391f3207593a615df66" parent="aspace_d1a4740649161a4ee58123aeb285bbbc" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_1cdb7a1ff11f6e216e339e64f20c58a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_364c7d8d424593144cdef790c4e94d75" level="file">
        <did>
          <unittitle>TML, 39-111 - AIDS - Drugs for HIV infection</unittitle>
          <unitdate type="inclusive">1997 December 12</unitdate>
          <container id="aspace_590a6c98bb2dfe13cc56ff3ac9a4e0e6" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="aspace_1304c8b79da608bfcc69e1faca2cc0ba" parent="aspace_590a6c98bb2dfe13cc56ff3ac9a4e0e6" type="folder">4-9</container>
        </did>
        <accessrestrict id="aspace_a96e0ada70322de7df279993ca3ff3a5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_fe5bfd483d4da9cb09abcd8d8e9114e4" level="file">
        <did>
          <unittitle>TML, 39-97 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1997 October 24</unitdate>
          <container id="aspace_1693bd41a24ce4d2eed79bf6db9775fe" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="aspace_6b8b58dff39142f66640512746f92807" parent="aspace_1693bd41a24ce4d2eed79bf6db9775fe" type="folder">10-15</container>
        </did>
        <accessrestrict id="aspace_ce3e85fc72e05bedc7f21da6973965b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_6568c1026445dec6f8e364671c21bd39" level="file">
        <did>
          <unittitle>TML, 39-120 - Anagrelide for essential thrombocythemia</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="aspace_b3f132153f47f77f59b4be5f806256cc" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="aspace_0e9d6b619f35eb4840886763b4c6e40a" parent="aspace_b3f132153f47f77f59b4be5f806256cc" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_8df589a9af326009da84ebecd5cf8932">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b0b4f71d2ecf84b337ced4a504f89306" level="file">
        <did>
          <unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="aspace_c84c08926ec0b775d88edb4a1c973df4" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="aspace_310d3a9bb7f96cb2bcf1b3241d7f0710" parent="aspace_c84c08926ec0b775d88edb4a1c973df4" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_8df622f363be5b50961c92589e209dc4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b1ac2f651904161cd98b8d42f99e3aa1" level="file">
        <did>
          <unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="aspace_f4ad31c19f156c503c3a72ab8ada160c" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="aspace_6716ffabb852b5c60ed6f72e4ea99cf1" parent="aspace_f4ad31c19f156c503c3a72ab8ada160c" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_181d3a4b218653d1790e4861871f62dd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_edca2ebba2d38b14ec07a5b9c16a0276" level="file">
        <did>
          <unittitle>TML, 39-89 - Carvedilol for heart failure</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="aspace_94e44a073d3927aee611e54ce80fb231" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="aspace_e32d03e7fbeb9739f89e607ff532c419" parent="aspace_94e44a073d3927aee611e54ce80fb231" type="folder">5-9</container>
        </did>
        <accessrestrict id="aspace_f5705dc19e306f206ec780b8d160e15c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_3f1ba5c10401cadfc440c87da71224cb" level="file">
        <did>
          <unittitle>TML, 39-57 - Topical penciclovir for herpes labialis</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="aspace_17540311b9180f09a88f1a7ee96ffa13" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="aspace_b9562217c13db77bdd873e628bde7b97" parent="aspace_17540311b9180f09a88f1a7ee96ffa13" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_053d8eeeb8327c9a50460b4a07f88f4f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_6311bd1ab3c17838b525980881eb7804" level="file">
        <did>
          <unittitle>TML, 38-17 - Drugs for migraine</unittitle>
          <unitdate type="inclusive">1995 March 3</unitdate>
          <container id="aspace_2e6f68858a58ffcd0c0890540f514236" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="aspace_01451e696b737fb1fe6dcde1dd5847d5" parent="aspace_2e6f68858a58ffcd0c0890540f514236" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_3d255045a576ae1c355c7f2fcc48b4a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_d46efc5621917384073357b190321659" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="aspace_9397c200fe851d99485ecda282b952bf" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="aspace_f82b829105c3e566838094bff09542ef" parent="aspace_9397c200fe851d99485ecda282b952bf" type="folder">17-21</container>
        </did>
        <accessrestrict id="aspace_663777121320adda427992b307d1db2f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_fa4a7928ccfffaadb72cf4771e4d8edc" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="aspace_04aee02181f55abd3d97853dc3bdd12e" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aspace_01261740c2f03ca7b899891372f9d83e" parent="aspace_04aee02181f55abd3d97853dc3bdd12e" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_702b01fd73a7deda0a72869d6f566a47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_318ae2efe1275c93a47e9ae522f706ea" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="aspace_1804a29ae2a46efd982733bb1f1992d3" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aspace_0e78d82a5ebfc6ee4ef566b6a5986905" parent="aspace_1804a29ae2a46efd982733bb1f1992d3" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_f2ea2b6f0f794d84b25ea1befb0a8255">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b4b3b22e307f4ce6c5d2eb8f6d664d9c" level="file">
        <did>
          <unittitle>TML, 38-5 - Olanzapine for schizophrenia</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="aspace_ac4a43a641a1c266bd4b7ab9b8b5c54d" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aspace_20e7835ab3a57bc957f48a6878699d87" parent="aspace_ac4a43a641a1c266bd4b7ab9b8b5c54d" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_54d3d516459a5d0fc04e78b00339b8f9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b5cf0dfe90fdcc6067f140e30b6809d1" level="file">
        <did>
          <unittitle>TML, 38-113 - Mirtazapine - a new anti-depressant</unittitle>
          <unitdate type="inclusive">1996 December 20</unitdate>
          <container id="aspace_a0db9f880b755e38075dff79c699750a" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aspace_7807d0ceda2bb873b1394e81504d56f1" parent="aspace_a0db9f880b755e38075dff79c699750a" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_6a61863bdf42f359838de02eb3140260">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_c2e1fc197d7490d826da206b516a38a5" level="file">
        <did>
          <unittitle>TML, 40-5 - Drugs of Choice - Rheumatoid Arthritis</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="aspace_722b3f6dd91d9c4a99e609f02cd71247" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aspace_e43e0edb5d95c84c150bbbe7fbfcbba7" parent="aspace_722b3f6dd91d9c4a99e609f02cd71247" type="folder">10-16</container>
        </did>
        <accessrestrict id="aspace_5d151812a70ad7aab1e31b15864a8198">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_fc12244326436c163ce3062f2ee5441e" level="file">
        <did>
          <unittitle>TML, 40-59 - Clopidogrel for reduction of artherosclerotic events</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="aspace_0ba41299b1758c5af1a4768286dd837c" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_9df0e18073acae4ecc6036596b084092" parent="aspace_0ba41299b1758c5af1a4768286dd837c" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_010c90cf26351f4881154a4f6ad41ad3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_b00d90227ff22e5ebe7df4b968c6ec73" level="file">
        <did>
          <unittitle>TML, 40-113 - Citalopram for depression</unittitle>
          <unitdate type="inclusive">1998 December 4</unitdate>
          <container id="aspace_bf4bd57cb6b24aa33b43ba884778fca2" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_96cadb06552164b09f14e6b8d7e14a2b" parent="aspace_bf4bd57cb6b24aa33b43ba884778fca2" type="folder">4-8</container>
        </did>
        <accessrestrict id="aspace_e132e378e63282bf8014cd21bd84bf26">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_85788caeb20c27238d916bb497645405" level="file">
        <did>
          <unittitle>TML, 40-52 - Anthrax vaccine</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="aspace_611b44df22170845816f9dd817c74229" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_1ae265d7a4a654fc5e7b47c33918b49f" parent="aspace_611b44df22170845816f9dd817c74229" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_0a33ad6cdce119b325c656b5c6f11151">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_7481cf56a926bcaa665f596bebcba058" level="file">
        <did>
          <unittitle>TML, 40-63 - Ginkgo Biloba for dementia</unittitle>
          <unitdate type="inclusive">1998 June 19</unitdate>
          <container id="aspace_5ce524c98bf0e3d46ed9aab09d3ecd5d" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_f874ea5d971a4f83e37a4e2ec7fc34d8" parent="aspace_5ce524c98bf0e3d46ed9aab09d3ecd5d" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_16e326bcc4bc4a1b019667382b3e42a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_276f7a6dda26470f835e467b2e300373" level="file">
        <did>
          <unittitle>TML, Sildenafil - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_c27c578184660b969739644e8c4a7cc5" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_4a3487d3719240a8941b84c7ab1d6cb3" parent="aspace_c27c578184660b969739644e8c4a7cc5" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_c072f69e2c5f4579df7b9a32a2d6638a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_8d9d5a14ea3c38a9bcf53eea15278788" level="file">
        <did>
          <unittitle>TML, 40-69 - Hyaluronan injections for osteoarthritis of the knee</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="aspace_afa9dfebb574a8c7b14c4b875591e6ce" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_e25ebde8d6d89d4895c30d96a46bd57b" parent="aspace_afa9dfebb574a8c7b14c4b875591e6ce" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_548bd13d1ee4dd091a7071fb17973086">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_e605d151c50d15b7436fa8b95fabcc04" level="file">
        <did>
          <unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="aspace_0e393c07b0596733ed2226f92df354dd" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_d950506e418478a45967c4a24181207e" parent="aspace_0e393c07b0596733ed2226f92df354dd" type="folder">20-21</container>
        </did>
        <accessrestrict id="aspace_72272d08b8d2095400f484d84b5c8623">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_a2c45fce823914fd5f240eb8ce64a6d3" level="file">
        <did>
          <unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="aspace_c8488016af7ceb221df2cfc301f505f3" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_86641ad95c8fa784849f7ce30da143b1" parent="aspace_c8488016af7ceb221df2cfc301f505f3" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_e61fbc122231a69d11de05471824b4f7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_58fc0933c16d75f16f20c226741f40fc" level="file">
        <did>
          <unittitle>TML, 40-21 - Drugs that cause psychiatric symptoms</unittitle>
          <unitdate type="inclusive">1998 February 13</unitdate>
          <container id="aspace_494042c91c2f2e254f1f03c85a66417d" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_41279c9dfb22028dfb7c1aa0c8de5b53" parent="aspace_494042c91c2f2e254f1f03c85a66417d" type="folder">2-5</container>
        </did>
        <accessrestrict id="aspace_cd18c294101a7fb036bca53986751b48">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_f466040faafb3cd515b6f7e5924186a3" level="file">
        <did>
          <unittitle>TML, 40-47 - Advice for Travelers</unittitle>
          <unitdate type="inclusive">1998 April 24</unitdate>
          <container id="aspace_e8261270bcb10fc860c7e1081d866e1a" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_bce5730276ada3c482f9eca2600fbec8" parent="aspace_e8261270bcb10fc860c7e1081d866e1a" type="folder">6-9</container>
        </did>
        <accessrestrict id="aspace_d3ea0598c816f490bd7b26c48572450a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_d9d7051c247d055cb3a4caa57119bc34" level="file">
        <did>
          <unittitle>TML, 40-68 - Fenofibrate</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="aspace_972ee597663b360eb7545df06df6b758" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_c45b4eba4ba7842620e870a8a7f016f7" parent="aspace_972ee597663b360eb7545df06df6b758" type="folder">10-13</container>
        </did>
        <accessrestrict id="aspace_a905e6ecf288f2137eb025ea245ec0aa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_0902f98f4048374d057a60de2d1b7855" level="file">
        <did>
          <unittitle>TML, 40-30 - Trovafloxacin</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="aspace_853c464688bfe8011dcfd1939279dbe1" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_dffde4da611851de68c1179341554925" parent="aspace_853c464688bfe8011dcfd1939279dbe1" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_d64cfc2f0c18fe44c79492b16479dde8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_40a127b41aba4ab1210aebb60355f7eb" level="file">
        <did>
          <unittitle>TML - Tuberculosis - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_1fc54e86f8a4eb96c0d462c66cf10f49" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_89826fea709d4bfb26e41bac33f2e22a" parent="aspace_1fc54e86f8a4eb96c0d462c66cf10f49" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_aa2e94224c5f71c8078141e7e709d476">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_2821241f88ab33b4108c2fb8ef546a03" level="file">
        <did>
          <unittitle>TML - Tuberculosis - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_b99a41c6ae99a2cb078793238f2b6630" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_91c138cdef4ae49901f9c209f3c217b4" parent="aspace_b99a41c6ae99a2cb078793238f2b6630" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_0fedc35030a79ffd7934a9d9c5acbe14">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_a5e3fba9d86330d4c75e3f31b4844108" level="file">
        <did>
          <unittitle>TML, 40-51 - Sildenafil - An oral drug for impotence</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="aspace_84b086c3e9e30c58bdf75759bc023389" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_f0fce77d7596137f0d577b126c5c99ed" parent="aspace_84b086c3e9e30c58bdf75759bc023389" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_c2a74a29c84ba08cf5bbb6cb60889b41">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_41484f1614916c304d00c6a0e2776c25" level="file">
        <did>
          <unittitle>TML, 40-67 - Sucralose - a new artificial sweetner</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="aspace_d4803c6d0ba5e04b1bf1b7bee0b8272b" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_acac5189ec32f918b5e707679da216fb" parent="aspace_d4803c6d0ba5e04b1bf1b7bee0b8272b" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_9e54423aecee12c7635588555d8c357f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_18a33071dfc9246e7c9a4f9970fc624f" level="file">
        <did>
          <unittitle>TML, 40-17 - Grepafloxacin - a new fluoroquinolone</unittitle>
          <unitdate type="inclusive">1998 January 30</unitdate>
          <container id="aspace_29ba34a0ef63050246b3fae1b6f35817" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_41a0b5c900e421b6eb54ac835406f155" parent="aspace_29ba34a0ef63050246b3fae1b6f35817" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_bc7dcf48bb1a978d5d8891678f65f0b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_95bd003fd739d4b3a6ffdfb96fae1bc6" level="file">
        <did>
          <unittitle>TML, 40-55 - Repaglinide for type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="aspace_6a3150ce57a37709daaa4e842f596e08" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_4518c6c952c76a35baf5e19fe3df252f" parent="aspace_6a3150ce57a37709daaa4e842f596e08" type="folder">10-12</container>
        </did>
        <accessrestrict id="aspace_ea7f89c9aaeab7997ab0ab65a3fbabdf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_c689105113c5b23ebb896f340bf02ea0" level="file">
        <did>
          <unittitle>TML, 40-62 - Crystal Ear hearing aid</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="aspace_ea88aa6af79aff67ffa78e4349ea2ef0" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_6eb9328bb5c2df0b4c54cbf4ea97e837" parent="aspace_ea88aa6af79aff67ffa78e4349ea2ef0" type="folder">13</container>
        </did>
        <accessrestrict id="aspace_dc4b7b184944400de9cfe92635a05ead">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_705d7bf07e8ff402ef32c0df389a3828" level="file">
        <did>
          <unittitle>TML, 40-89 - Antiplatelet</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="aspace_d6a81406a7ceb7a2cbe684e24e259e82" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_cff869f4a16ccb7cde727a6241fa705e" parent="aspace_d6a81406a7ceb7a2cbe684e24e259e82" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_ae0c798c535816e3564f3b350306c0eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_cc4045365330c91030e2afc2941ff362" level="file">
        <did>
          <unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="aspace_53e73a1ebf51a4131900ec949ea5700d" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_f8c83f29a115fe6eedd5c2acabd9d04a" parent="aspace_53e73a1ebf51a4131900ec949ea5700d" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_d3830363a0deac040fb1a2187fcc43a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_74cd9f3df4304220a489f3cd523e97f4" level="file">
        <did>
          <unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="aspace_b98b91ebc6ae5936146431874cc3a9c9" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_54398dfd025c8f6721823fda458ea210" parent="aspace_b98b91ebc6ae5936146431874cc3a9c9" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_78f65a64160f8c684e6ad4a73eb82afd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_8f7886d013678b0f444c0e7ce3af676b" level="file">
        <did>
          <unittitle>TML, 40-65 - Rituximab for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">1998 June 19</unitdate>
          <container id="aspace_0c73b86ba44e1c70b2893ff32bf8f044" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_505550202801f4be20295819b542a1b4" parent="aspace_0c73b86ba44e1c70b2893ff32bf8f044" type="folder">2</container>
        </did>
        <accessrestrict id="aspace_8e2b80b72a52938a5c321da498c8b722">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_236c02b396ea229adb1f079d93029f01" level="file">
        <did>
          <unittitle>TML, 40-32 - Sibutramine for obesity</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="aspace_303cffdd3ae4854099642104df44ebbd" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_59ffd18b397cc451f75c223624cade41" parent="aspace_303cffdd3ae4854099642104df44ebbd" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_83216716b614ac8cc38fcaa01b43355e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_34d5d1374a9121f748a24968ebe6c128" level="file">
        <did>
          <unittitle>TML, 40-27 - Zolmitriptan for migraine</unittitle>
          <unitdate type="inclusive">1998 February 27</unitdate>
          <container id="aspace_3d3b474384b3b83efd592bf8fe28246a" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_31d30246a2d0779f6fbc4d5d4d885372" parent="aspace_3d3b474384b3b83efd592bf8fe28246a" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_9f78fcde35549e85ae6f6ddddad23091">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_f1f292c6e674c3d7e6f2610c2dbf9aec" level="file">
        <did>
          <unittitle>TML, 40-73 - Becaplermin - Platelet-derived growth factor for diabetic ulcers</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="aspace_b8b38c9ca863f9dbb92290e9b2abd2f6" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_2767c0d6318c94566d533db184c81fb4" parent="aspace_b8b38c9ca863f9dbb92290e9b2abd2f6" type="folder">9</container>
        </did>
        <accessrestrict id="aspace_a90cd7de6fbf79e2a9a41d8e6d5f1884">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_fae1826f224dc5554dd9d77d43d63320" level="file">
        <did>
          <unittitle>TML, 40-19 - Arbutamine for stress testing</unittitle>
          <unitdate type="inclusive">1998 January 2</unitdate>
          <container id="aspace_b4ac1ebe440324d35231d9adb5841021" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_7546c9993abee971e77db67a9bdeb85a" parent="aspace_b4ac1ebe440324d35231d9adb5841021" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_3cf800c016782dc93e3a36b622f7b36c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_b4e4ab750a7b095f09a475bb6f5bb4c1" level="file">
        <did>
          <unittitle>TML, 40-75 - Vitamin supplements</unittitle>
          <unitdate type="inclusive">1998 July 31</unitdate>
          <container id="aspace_56390ee164b857225cbfcada77fb9431" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_1684dbd5919fb150c1eb84a31350cf2a" parent="aspace_56390ee164b857225cbfcada77fb9431" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_59259d5d91da3a2acb6cb86529f69bd9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_06914f95afdacb00ca224c63b35cc3e5" level="file">
        <did>
          <unittitle>TML, 40-92 - Gliadel wafers for treatment of brain tumors</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="aspace_e9387342acb7d1398905e23ee0b3aee3" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_8a3ba7b1a613b217b8d49513ff460a91" parent="aspace_e9387342acb7d1398905e23ee0b3aee3" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_e29a7c4b92a2feed9fd0b7e0a0bb8f72">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_f35a3fcbf2b099a50baf329b7d2a8f36" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_e080b2e1c1facc43510b5471f101cb00" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_8b3392dec86fbd78248b2c295a57bb4c" parent="aspace_e080b2e1c1facc43510b5471f101cb00" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_0093f9f9cae39c07366f1e9c0c119fa4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_bc19dc00f1b6834157cb02e6fcfef4a4" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_71e96c6c1837aba243cfe0fcd532ad77" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aspace_e31b6344a38a0ca40e15a44dde37fcb7" parent="aspace_71e96c6c1837aba243cfe0fcd532ad77" type="folder">1-5</container>
        </did>
        <accessrestrict id="aspace_530223b01deda9e053da32d105382b18">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_559cb584a41d6690a7e856498ab89795" level="file">
        <did>
          <unittitle>TML, 40-106 - Trastuzumab for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1998 November 6</unitdate>
          <container id="aspace_53a06a76a525a31b45d898acf4507606" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aspace_b86161f98c827c611f3afe8040f69037" parent="aspace_53a06a76a525a31b45d898acf4507606" type="folder">6-7</container>
        </did>
        <accessrestrict id="aspace_cf7ce77fd85e6bc2a2e126d922cb2364">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_ece2250f2916521ae284b1830da4848e" level="file">
        <did>
          <unittitle>TML, 40-114 - Three new drugs for HIV infection</unittitle>
          <unitdate type="inclusive">1998 December 4</unitdate>
          <container id="aspace_a4fe81dcb26cd5107330dea622c5ef70" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aspace_317a2ffe744369833aa35736cdaafff4" parent="aspace_a4fe81dcb26cd5107330dea622c5ef70" type="folder">8-11</container>
        </did>
        <accessrestrict id="aspace_4e7f5d2236f53f8ccc2b28a5bf8873c1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_7dd5458e0da29270a7d0b887632c23ac" level="file">
        <did>
          <unittitle>TML, Sexually Trasmitted Diseases - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_fb36800c1b1e9982d71946ead4fdd286" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aspace_d721d326dbc1904c3040ba2063f535ff" parent="aspace_fb36800c1b1e9982d71946ead4fdd286" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_0b261ea329af56d20325ac31bcf03cbe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_6e5b03bb37f1b1e46c63603fddb7f5a0" level="file">
        <did>
          <unittitle>TML, 40-53 - Dolasetron</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="aspace_66f1872dbb80e7653ec44676bb47711a" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aspace_5cd04a01d74a673c565979da16704e08" parent="aspace_66f1872dbb80e7653ec44676bb47711a" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_2f191b313a6f595b28c9d77fec25b021">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_b33fb65d9a2e71bddfa4f269d47aeef6" level="file">
        <did>
          <unittitle>TML, 40-18 - Irbesartan for hypertension</unittitle>
          <unitdate type="inclusive">1998 January 30</unitdate>
          <container id="aspace_209b118e1945ad986a88167fb99df0e1" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="aspace_97912591ddfa76aa41555cafbf5deda3" parent="aspace_209b118e1945ad986a88167fb99df0e1" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_5fe32f0354336c745f49eaad8ec99c60">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_6332598d843148b2b6fcca7483c23ff2" level="file">
        <did>
          <unittitle>TML, 40-33 - The Choice of Antibacterial Drugs</unittitle>
          <unitdate type="inclusive">1998 March 27</unitdate>
          <container id="aspace_89436fe2911974285d7f018cecaa280a" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="aspace_03c346ec51c7e74e3017da5fd94cdbe7" parent="aspace_89436fe2911974285d7f018cecaa280a" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_4de55d18dd59d1c77f9f4fdd38e7a4d2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_6062e376e8011b03bf27092730e8219d" level="file">
        <did>
          <unittitle>TML, 40-93 - New monoclonal antibodies to prevent transplant rejection</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="aspace_5d7a0c156bf54bf2bc3ec79f6ac202e7" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="aspace_3b1524d7eb1c0c2a1b7f627059842ffa" parent="aspace_5d7a0c156bf54bf2bc3ec79f6ac202e7" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_a10e4c82bc99d39cee6a7ddd1ca31b10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_de828b3fc932777396bebd27f5fab7dd" level="file">
        <did>
          <unittitle>TML, 40-117 - Choice of lipid-lowering drugs</unittitle>
          <unitdate type="inclusive">1998 December 18</unitdate>
          <container id="aspace_261e3bec64eab0f523d0efdc7762a4e4" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="aspace_0d3f3a6abeabf83c069be9b37d4be21d" parent="aspace_261e3bec64eab0f523d0efdc7762a4e4" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_ec87238d62e4af8195602bcb6756e8f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_0bba41a40cc25a8da0e7a635fb7e3df8" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_5c9d020f803b6df7b22ee1dabe625a09" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="aspace_a2c8ef7ad81cbaba5d3d982365d8e44a" parent="aspace_5c9d020f803b6df7b22ee1dabe625a09" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_e69b8784cca126a51aa694fe76fa93ef">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_13029629c9a2c8c4645ba910bddc0ec5" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_816766a3fad392fb8c1f35dd833aaaa3" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_f53e6860d5935d44d898a625a7d1e0a7" parent="aspace_816766a3fad392fb8c1f35dd833aaaa3" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_efd535a28d84b26cb3f39bdbca07f951">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_c768307fb6b27100b14034cebd5227a9" level="file">
        <did>
          <unittitle>TML, 40-43 - Toremifene and Letrozole for advance breast cancer</unittitle>
          <unitdate type="inclusive">1998 April 10</unitdate>
          <container id="aspace_ed494d823c8a35af7e57c6e676fa7f37" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_43e63fdf6110347c3edb3484d1aa97b8" parent="aspace_ed494d823c8a35af7e57c6e676fa7f37" type="folder">4-8</container>
        </did>
        <accessrestrict id="aspace_4fead382cbe8272480e24c54bdac4aa5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_edbc39d29ce93f5d2d89c1070b90a888" level="file">
        <did>
          <unittitle>TML, 40-95 - Brinzolamide for glaucoma</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="aspace_45f05422bf718f0c163fa4751ef0ae75" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_8916074e9b63f6e97f7f8e4374ade2ca" parent="aspace_45f05422bf718f0c163fa4751ef0ae75" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_4761d1070aff6ae3d4f74655713baaa7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_6d7c66707bdf53045a7ff953d6e108d3" level="file">
        <did>
          <unittitle>TML, 40-45 - Tigabine for epilepsy</unittitle>
          <unitdate type="inclusive">1998 April 10</unitdate>
          <container id="aspace_ef8e915427a5b6c286c5cfab747beca2" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_e51f3210d2a660de1bbd9ffa2f110a86" parent="aspace_ef8e915427a5b6c286c5cfab747beca2" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_94fdedf900cf20f12d378b25deedc2ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_a07a54028f90ac0076d2802b57942911" level="file">
        <did>
          <unittitle>TML, 40-64 - A new rabies vaccine</unittitle>
          <unitdate type="inclusive">1998 June 14</unitdate>
          <container id="aspace_ae3ba04ef92baa4e12d6a00272c232c1" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_71c55b0ae9463c075e0bd866d2c331f2" parent="aspace_ae3ba04ef92baa4e12d6a00272c232c1" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_47ed997eea8759fcee2c1c993e8bbb47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_3bd95f95656aa72b9a953a7b60fc1ff8" level="file">
        <did>
          <unittitle>TML, 40-29 - Raloxifene for postmenopausal osteoporosis</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="aspace_4c567d9e082e295252f9899e87214735" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_ff220478878fba979d94ed49fd0abad7" parent="aspace_4c567d9e082e295252f9899e87214735" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_072da8fc19d0e0c642d2808e0b9452ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_fa4c88d1fa307e4c1c36721c687359e5" level="file">
        <did>
          <unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="aspace_75469ed767d526e67984f8fe74b71683" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_d99a331d6c4ac0a2f9679c79790747c3" parent="aspace_75469ed767d526e67984f8fe74b71683" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_4326873ad2b2259141a757cbab189cb2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_b31307f7682d799e34699487a403a926" level="file">
        <did>
          <unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="aspace_054cabc0cfde0d07e27d00aa4be34bfd" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_581b418faa92084c3f412090d39c6020" parent="aspace_054cabc0cfde0d07e27d00aa4be34bfd" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_2802926a9875868eb77bbf4162293dea">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_c0f605353f7f9186d9e181b0e5a7b35c" level="file">
        <did>
          <unittitle>TML, 40-15 - Budesonide turbuhaler for asthma</unittitle>
          <unitdate type="inclusive">1998 January 16</unitdate>
          <container id="aspace_7655dfd0d15a4728d13ffa321a9833c4" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_ebf99c7ed41b19202aa0529d4024521f" parent="aspace_7655dfd0d15a4728d13ffa321a9833c4" type="folder">3-8</container>
        </did>
        <accessrestrict id="aspace_63c818b79b8463447ba0a35c3ed08e0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_fc1c9413add7682bf34765d07e37871c" level="file">
        <did>
          <unittitle>TML - Cholesterol-Lowering - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_f1ad8565bf93cd8eb6b3230fdff589f9" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_a989cfb0c620117ca2a966f59b632f7d" parent="aspace_f1ad8565bf93cd8eb6b3230fdff589f9" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_263b366a38ae16d96e1447c8e1c8953b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_9212aaed4209e15330e340d1c8675d23" level="file">
        <did>
          <unittitle>TML - Parasitic Infections - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_081a980fbf008ce294e88fda171d05cb" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_ec46e99d0ae0fa33d74c231e7727d95f" parent="aspace_081a980fbf008ce294e88fda171d05cb" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_5db4f9b0242f10ed336d20896e08899c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_367ee47d6747fc683d4571ad991fcb28" level="file">
        <did>
          <unittitle>TML - Malaria - Drugs for parastic infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_73fb0b06583cd2347d1fce8a2767b9d9" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_3da565d7c482034383242970041523de" parent="aspace_73fb0b06583cd2347d1fce8a2767b9d9" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_e3f66807c02c01517706efbf9eeaff5f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_d64c5c233f60d11993a1dd5cef9c5ec4" level="file">
        <did>
          <unittitle>TML - Antimicrobial drugs - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_0ae5045eca9f73077210ebd40dce36e6" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_6ab7c66d4917ceef3a37d29be4c272a9" parent="aspace_0ae5045eca9f73077210ebd40dce36e6" type="folder">17</container>
        </did>
        <accessrestrict id="aspace_f6a6fff3786ff1d521cdf342567849ee">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_3d41d005cf4c13e14913cd67a32a5047" level="file">
        <did>
          <unittitle>TML - Antimicrobial drugs - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_edab56177951241dc1da35d368c2e0f5" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_387dbd6c949836a31ba2ece1423e0265" parent="aspace_edab56177951241dc1da35d368c2e0f5" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_8075ff059f0d4d931fa3535cefb097fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_a70dd9355ee98a30aebc26b8daacffc8" level="file">
        <did>
          <unittitle>TML - Psychiatric Symptoms - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_0a6cef4ec28682a8b384460aa6ec508e" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_1dbb7d0917bf85b752ce8c6166a2a37b" parent="aspace_0a6cef4ec28682a8b384460aa6ec508e" type="folder">3</container>
        </did>
        <accessrestrict id="aspace_9dfab18fed33b99b2f9c6ca42c51a487">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_878b0cb8e4fc058b68a1ed9db09469eb" level="file">
        <did>
          <unittitle>TML, 40-109 - Candesartan</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="aspace_fa03dad1ff6b0e59a64743e2cae2cc4b" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_f614d3cf9913a401aeac7528df6049a0" parent="aspace_fa03dad1ff6b0e59a64743e2cae2cc4b" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_ba7cc6a8281cf2cb771c412c8f89cd3f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_e61911867cf616602aa72255f38dc9ba" level="file">
        <did>
          <unittitle>TML, 40-77 - Interleukin-11</unittitle>
          <unitdate type="inclusive">1998 July 31</unitdate>
          <container id="aspace_12d83b0ea8493dbe1372538b19d14bb0" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_814dd567ce32a87c780422c56c9e7db1" parent="aspace_12d83b0ea8493dbe1372538b19d14bb0" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_4f66d0ee0cc0c75d98d5ce57dfee6a86">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_4f7233bf7c77fcfc22d806ea70169968" level="file">
        <did>
          <unittitle>TML, 40-85 - Cefdinir</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="aspace_073f098277637cd493e3e2004f15d63f" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_72ca001afd1ffec1d71cd95f4809766f" parent="aspace_073f098277637cd493e3e2004f15d63f" type="folder">10-12</container>
        </did>
        <accessrestrict id="aspace_028c35e32d1addf3672d48cb03ad70d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_910ff3d576f61dcba1783abe6210dff1" level="file">
        <did>
          <unittitle>TML, 40-79 - Drugs for pain</unittitle>
          <unitdate type="inclusive">1998 August 14</unitdate>
          <container id="aspace_c7a9baa7826c6eacff9d2e56de3806e3" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_c09e21ad8b2008b2b065664c3b3fef40" parent="aspace_c7a9baa7826c6eacff9d2e56de3806e3" type="folder">13-17</container>
        </did>
        <accessrestrict id="aspace_72993e3876c2683037ab6df23f908193">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_960c1722fd9da508635b32ac38c60f80" level="file">
        <did>
          <unittitle>TML, 40-87 - Risedronate</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="aspace_d462bc1f05249f01c5c55c4a1f6ae145" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_f777b86c3f5a0f9f77e1845c12665aa4" parent="aspace_d462bc1f05249f01c5c55c4a1f6ae145" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_c3d8c6875a01ba6968c3fea93fe65185">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_8e8879c55ee8242081f7f64851b4db08" level="file">
        <did>
          <unittitle>TML, 40-87 - Risedronate</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="aspace_4e9d597907d9ab0f9b0ecfbbae887ff0" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_0a9d60576ae5fdb5b6a516706cc3ca5c" parent="aspace_4e9d597907d9ab0f9b0ecfbbae887ff0" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_54d5c0c828c3316a8382b3f15461804c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_5d664f33dcd2cabbe962a4227379c390" level="file">
        <did>
          <unittitle>TML, 40-94 - Lepirudin for heparin-induced thrombocytopenia</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="aspace_1d0adee66c78c9b1f4396f1e3c828ffa" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_d5472f24484d0f7a90807b563bd3d6b3" parent="aspace_1d0adee66c78c9b1f4396f1e3c828ffa" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_df311ee9e0d78fb33b148774389da7c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_3d76a36572332e4c480702f762cc9918" level="file">
        <did>
          <unittitle>TML, 40-25 - Propecia and Rogaine Extra Stength for Alopecia</unittitle>
          <unitdate type="inclusive">1998 February 27</unitdate>
          <container id="aspace_27c22be2123cd4dd322354ca838bb930" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_2f181da6f8e340be2f86ab097e2d83c2" parent="aspace_27c22be2123cd4dd322354ca838bb930" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_c3ab3185c9cf9153482322e821491aa5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_affe7599f3c787d823e95823bfc0cbfc" level="file">
        <did>
          <unittitle>TML, 40-106 - Capecitabine for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1998 November</unitdate>
          <container id="aspace_5665ed20a26220046d1a572b613fab9b" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_e236eb1fbcddc84f396d313fdbc220d5" parent="aspace_5665ed20a26220046d1a572b613fab9b" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_544789c77c743995f3e1041b8e18aab6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_2e2e66929019d8531954a7ad095700fb" level="file">
        <did>
          <unittitle>TML, 40-13 - Cerivastatin for hypercholesterolemia</unittitle>
          <unitdate type="inclusive">1998 January 16</unitdate>
          <container id="aspace_d45a47f1f03b4f1aa2c9f652eb97edc7" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_3bcc21d870ff2aa3c0960b8d83313151" parent="aspace_d45a47f1f03b4f1aa2c9f652eb97edc7" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_c00a8622a08054369fa43b3f435559cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_4043d39a1cb0cf7a9edea397c7574337" level="file">
        <did>
          <unittitle>TML, 40-101 - Tolterodine for overactive bladder</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="aspace_a75d2d236457398dfd91a3372ab65403" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_fb1e2a47b3eb2a1dc57f34850b03c2b9" parent="aspace_a75d2d236457398dfd91a3372ab65403" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_5ed653620eb193653bb7be17c3823301">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_e5341af61e6a0539c242e29242b615c6" level="file">
        <did>
          <unittitle>TML, 40-102 - An Emergency Contraceptive Kit</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="aspace_dc7d4d89d7119f518101bef07c3402f5" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_9761e42ff9ac1c1b6bcdaf4d650606b2" parent="aspace_dc7d4d89d7119f518101bef07c3402f5" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_5f3dbedbdfcd288cd297f8d578fd4ced">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_3f39fb343e118836671bfce7c8c9e0be" level="file">
        <did>
          <unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="aspace_938a16bafe745741e5853d653764fa2f" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_6a6a665697223ef6580985c7a994b727" parent="aspace_938a16bafe745741e5853d653764fa2f" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_a3bdebd3c863cd5e8915acd5b9e97a95">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_e43a7710b28863a0de4803cfd4c0b542" level="file">
        <did>
          <unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="aspace_9a3bd7aaf37114831159871028194183" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_dff8ad795e790815604c35a5bd6b9a40" parent="aspace_9a3bd7aaf37114831159871028194183" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_4b8fa308ff1db3b9b6869466f7f0fe98">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_f487b7ea1e7909af55b4d7eeee8db68c" level="file">
        <did>
          <unittitle>TML, 40-103 - Thalidomide</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="aspace_6f8e81c7dbe5d9b10a3695cf0d693296" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_04cbcd1a3b50c4e3097dbb155e592f00" parent="aspace_6f8e81c7dbe5d9b10a3695cf0d693296" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_afd021cfb4388a63de5e218998fd47c7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_31cfa0b79a02b7866aa0dc7e48743280" level="file">
        <did>
          <unittitle>TML, 40-97 - New Triptans and other drugs for migraine</unittitle>
          <unitdate type="inclusive">1998 October 9</unitdate>
          <container id="aspace_1fa1e1a30d1d5f382e5387b832ed73e0" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_0e1700a06d24029fbc49f09ff9ed21c9" parent="aspace_1fa1e1a30d1d5f382e5387b832ed73e0" type="folder">7-12</container>
        </did>
        <accessrestrict id="aspace_43083e8c7ccdb0aa74b842657cd508ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_f35138cee47bea646beb32b2995d4598" level="file">
        <did>
          <unittitle>TML, 40-91 - Influenza vaccine, 1998-1999</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="aspace_6c6e3ecedbd9cace01339a3d552f8ea8" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_c195514a6d6411aa021478f9b57ca23a" parent="aspace_6c6e3ecedbd9cace01339a3d552f8ea8" type="folder">13</container>
        </did>
        <accessrestrict id="aspace_a29dd57181aa1c5e6c3a1e5d3b488af7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_7c2b7e050833f74d66d0b600d186eae5" level="file">
        <did>
          <unittitle>TML, 40-105 - Creatine and Androstenedione - two "dietary supplements"</unittitle>
          <unitdate type="inclusive">1998 November 6</unitdate>
          <container id="aspace_b5c3242a54385e3f69409cc3db0d6997" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_102ca30d795dea851d3dd15ebe9cc8a8" parent="aspace_b5c3242a54385e3f69409cc3db0d6997" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_bcbeeba99d41f442379b4633e1dc7778">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_a4342729d9ef2567742167972402009f" level="file">
        <did>
          <unittitle>TML, 39-107 - St. John's Wort</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="aspace_66bc3d40daae765c021e32fca97bb82b" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_a34fa17befdc71612eae4ba4871ba20a" parent="aspace_66bc3d40daae765c021e32fca97bb82b" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_f27838dbfd9cecfa9e71bf77f07fe682">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_ddfb397d4b944785854d8ea719c202bd" level="file">
        <did>
          <unittitle>TML, 41-73 - Malathion for treatment of head lice</unittitle>
          <unitdate type="inclusive">1999 August 13</unitdate>
          <container id="aspace_3be2c69548fec6d4710409e757fe3247" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_b6938ca78c6e83011de92d584cc29744" parent="aspace_3be2c69548fec6d4710409e757fe3247" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_854b0f58396665c4e2d4a0465f949fd7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_35b97709b422b46ecdc94c987c5952ec" level="file">
        <did>
          <unittitle>TML, 41-39 - Advice for travelers</unittitle>
          <unitdate type="inclusive">1999 April 23</unitdate>
          <container id="aspace_8b5e3c3849bdee3472909cf54666a87e" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_f00d137cb754ead02f56a82878fdcc9f" parent="aspace_8b5e3c3849bdee3472909cf54666a87e" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_04ad6f830bf72709637049c7b301499d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_f916a9e5c338ff7fc1707311815267f1" level="file">
        <did>
          <unittitle>TML, 41-30 - Modafinil for narcolepsy</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="aspace_742f415c5ee500a03a263817f190ef4f" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_8233b2c0d971ce20d17cefe3f2a9bf4f" parent="aspace_742f415c5ee500a03a263817f190ef4f" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_113f676d893d247079b5e4ff614aec1e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_2fc16ae414cf9dd501de68ee706014d5" level="file">
        <did>
          <unittitle>TML, 41-51 - Levalbuterol for asthma</unittitle>
          <unitdate type="inclusive">1999 June 4</unitdate>
          <container id="aspace_879a7260baa880ff83b2fd8b36fdb78b" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_df18594c391e013f7d6d6a127703c33c" parent="aspace_879a7260baa880ff83b2fd8b36fdb78b" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_17d7935132e18e8bac890aeefcb5960f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_3922b9c381c0b19cb3d63cbe803305a6" level="file">
        <did>
          <unittitle>TML, 41-16 - Mometasone furoate nasal spray for allergic rhinitis</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="aspace_6f43ae2775dcadbee75c76e54f9fe15c" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_44e6c6fe049a69b585d804685fa66d01" parent="aspace_6f43ae2775dcadbee75c76e54f9fe15c" type="folder">11-12</container>
        </did>
        <accessrestrict id="aspace_481e161096febedcc11b1ed837e0109b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_4d4ebb415f82a62d6c6b5091a9afeb7a" level="file">
        <did>
          <unittitle>TML, 41-50 - Vaccine for rotavirus</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="aspace_061b4f81a8eb3da60241fdca1019dcab" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_7ac7d050e5f22be482baf5fcb0d9003e" parent="aspace_061b4f81a8eb3da60241fdca1019dcab" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_b72eb586cf031b15f2ce8b6037f013b2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_65d972dc57e884b250ec76744f2d84f9" level="file">
        <did>
          <unittitle>TML, 41-91 - Two neuraminidase inhibitors for treatment of influenza</unittitle>
          <unitdate type="inclusive">1999 October 8</unitdate>
          <container id="aspace_98f503557a605422481b3964e94fe6fd" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_233ee52e04c1db03459a8a11a5ce56d0" parent="aspace_98f503557a605422481b3964e94fe6fd" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_6e3fe48fdf68db20082fc8bad62e904f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_26fd68ebafc0d8085fe92d2eb77fcbf6" level="file">
        <did>
          <unittitle>TML, 41-93 - Zaleplon for insomnia</unittitle>
          <unitdate type="inclusive">1999 October 8</unitdate>
          <container id="aspace_183705952859af6eea52ad903ce879c7" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_99bb282b55576d2ea944ede3a6dbfcb3" parent="aspace_183705952859af6eea52ad903ce879c7" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_b25acf713bbbe8621cf294856e16ba28">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_ec877eb8397cacf7d82d77f65b127412" level="file">
        <did>
          <unittitle>TML, 41-1 - Tamoxife for the prevention of breast cancer</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="aspace_371f5f7276b22ebb0869aba9b277ae0f" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_99ad32d82ffe44ec39ae0d466f3cc92b" parent="aspace_371f5f7276b22ebb0869aba9b277ae0f" type="folder">5-6</container>
        </did>
        <accessrestrict id="aspace_5090105f2f60079c4d3f971adf860516">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_94ff8cec3e58b5c4d7bd8582a705f051" level="file">
        <did>
          <unittitle>TML, 41-123 - Temozolomide</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="aspace_72f4e7a50ce3b359f9005e8dda987a8b" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_ed09710ed43060d9b09557a537b6769c" parent="aspace_72f4e7a50ce3b359f9005e8dda987a8b" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_7a64776358d5df180bb0a5ddbff0bef7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_a4b43b9f4b92e02c161ee56d03e178c9" level="file">
        <did>
          <unittitle>TML, 41-53 - Interferon plus ribavirin for chronic hepatitis C</unittitle>
          <unitdate type="inclusive">1999 June 4</unitdate>
          <container id="aspace_c41fc578b59a41cdb3652abb17883b0f" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_a8d89f88046e6b7fe50f9f40cb9fec61" parent="aspace_c41fc578b59a41cdb3652abb17883b0f" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_af177345fcae67c9d255185c0a10e870">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_024012e8b7f7de531d716961ead029ce" level="file">
        <did>
          <unittitle>TML, 41-49 - Miglitol for Type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="aspace_d314686bbf3b469dd57da3572e94b0f3" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_5f6f89f2e409838bcc53e03814a5aadc" parent="aspace_d314686bbf3b469dd57da3572e94b0f3" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_d6f81a58c2dc3eaf1f79b5dc23f9a66b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_a9621527ed50246d7a862b61f10afb79" level="file">
        <did>
          <unittitle>TML, 41-110 - Rabeprazole</unittitle>
          <unitdate type="inclusive">1999 November 9</unitdate>
          <container id="aspace_a8c1dc35c241f7556ad873a0f323b63b" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_9257b92394e4ae2f52e9432e5d9e2638" parent="aspace_a8c1dc35c241f7556ad873a0f323b63b" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_fa2239be1fca64f3de4ed0688d43b5a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_fcec222c26512f8ebe8b672bf459fbe9" level="file">
        <did>
          <unittitle>TML, 41-21 - Rifapentine for tuberculosis</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="aspace_67826ebf58e718090d90ab570530519f" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_bfd8a57a0e0f40140890adf430995c3c" parent="aspace_67826ebf58e718090d90ab570530519f" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_5eabb94693fe31a0f053df4c9645327d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_c2530250616ca691ba7d71e8d92ca5e1" level="file">
        <did>
          <unittitle>TML, 41-109 - Quinupristin (Dalfopristin)</unittitle>
          <unitdate type="inclusive">1999 November 19</unitdate>
          <container id="aspace_9f79919e5fc5c54d5df7adff11ec57ca" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_524623dec487229b898218ae8e886ea4" parent="aspace_9f79919e5fc5c54d5df7adff11ec57ca" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_96db099c24d150d666b7ebe07b50d611">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_e80acff708763c79ba27fdf7b90311e5" level="file">
        <did>
          <unittitle>TML, 41-71 - Rosiglitazone for Type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1999 August 13</unitdate>
          <container id="aspace_957cb8f9a0f632829e42687daf413c12" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_15b19940754cf5a4065c8cf4d4f85635" parent="aspace_957cb8f9a0f632829e42687daf413c12" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_165ec4ab5ea0c075fdbea5fe2e192f3d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_703b499487840917db1eeb7a3bbf97c3" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Rheumatoid Arthritis</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_12438140bc956bffd356655365eb1751" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_c33151affb7cc462ea279949f424b736" parent="aspace_12438140bc956bffd356655365eb1751" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_15f525d3017c59fe2b80a8ae96ac839d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_d1121bbf04acf6873bc6f6be66e80e1c" level="file">
        <did>
          <unittitle>TML, 41-59 - Rofecoxib for osteoarthritis and pain</unittitle>
          <unitdate type="inclusive">1999 July 2</unitdate>
          <container id="aspace_a349ecacfc5633e9cb756f2b7c5ab76b" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_59158e2e74c56537e5da10b735e1324e" parent="aspace_a349ecacfc5633e9cb756f2b7c5ab76b" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_11221f9e1bc9230aebbe4b8afe4c8c85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_755deaec93a3a8f46413cdb9d38a9847" level="file">
        <did>
          <unittitle>TML, 41-84 - Pneumococcal vaccine</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="aspace_737f01636930288bfd25bd1aaed65ccb" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_b336ef2b29d726c57c3cf35bbedaab6f" parent="aspace_737f01636930288bfd25bd1aaed65ccb" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_ad40d9598ad03e97e0de7ff5b12324c2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ee2e8ec8ef4a025a102da4125d330c6" level="file">
        <did>
          <unittitle>TML, 41-20 - Homeopathic products</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="aspace_03266bc8b67970d710a85e74ba90e41e" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_d398374b3dfa68759e180051ac0985b2" parent="aspace_03266bc8b67970d710a85e74ba90e41e" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_1d27c989e3d0f4c9ca2d59fcac0ed578">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f8ace5b9ab967ce17459254fb17ca75" level="file">
        <did>
          <unittitle>TML, 41-55 - Orlistat for obesity</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="aspace_a975fd2351867aaa7be84f2bd61e1ac7" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_572e7817c93d70ec10a996d614eaf756" parent="aspace_a975fd2351867aaa7be84f2bd61e1ac7" type="folder">17</container>
        </did>
        <accessrestrict id="aspace_3afad4f5d733d9716d22ba16c44983fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_b2928e0b146edbf6a03684604b2f6230" level="file">
        <did>
          <unittitle>TML, 41-69 - Prosorba column for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="aspace_220769ad562341e21d1778dfed8e7f62" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_91553864efcad958d1561b2a3a424b78" parent="aspace_220769ad562341e21d1778dfed8e7f62" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_f89d8a299f3aa1cb78fdeda3584f26e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_e394fdb910a180949b33fcfe30e8b17c" level="file">
        <did>
          <unittitle>TML, 41-23 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">1999 March 12</unitdate>
          <container id="aspace_70db00c3e47504561b20ee0fbe79532a" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="aspace_83e2dbe62a663b5eed2e7c76050cedc7" parent="aspace_70db00c3e47504561b20ee0fbe79532a" type="folder">1-6</container>
        </did>
        <accessrestrict id="aspace_a85ce10fe729a0b9b0f29f163788bcd8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_1a3e95e6f5eb2cbf5b0cdb530d4df8b2" level="file">
        <did>
          <unittitle>TML, 41-113 - Drugs for non-HIV viral infection</unittitle>
          <unitdate type="inclusive">1999 December 3</unitdate>
          <container id="aspace_145f4a87640216c8b057c6098bfea8f1" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="aspace_1608f828d70b0e6f31264b8ebbe57b77" parent="aspace_145f4a87640216c8b057c6098bfea8f1" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_ddc058cf574899e5d0347e37efa9598e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_e42d2f63edb58feb20931053061b1339" level="file">
        <did>
          <unittitle>TML, 41-112 - Pioglitazone (Actos)</unittitle>
          <unitdate type="inclusive">1999 November 19</unitdate>
          <container id="aspace_3a20d1e5ac80fac43115724600b38556" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="aspace_8d9fb838a217ec9048790b52ba4a84ee" parent="aspace_3a20d1e5ac80fac43115724600b38556" type="folder">11</container>
        </did>
        <accessrestrict id="aspace_2bf75590065032d73df0e0fa13732a7d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_28427104a307e9895b1500110c4ba78c" level="file">
        <did>
          <unittitle>TML, 41-43 - Suncreens - Are they safe and effective</unittitle>
          <unitdate type="inclusive">1999 May 7</unitdate>
          <container id="aspace_297e5f29bcc57bf5a96188373d3053af" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="aspace_fe331e5ebce2f2c17f85ad175be7f45c" parent="aspace_297e5f29bcc57bf5a96188373d3053af" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_d50144a362c7ab5f8c046503c10ecf2a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_a4c7b991a97b85bed8305af27776e491" level="file">
        <did>
          <unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="aspace_41d90b02ba855b23c3abd051afb0e6d7" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="aspace_d4b34d17b7569395249d245b24423bb7" parent="aspace_41d90b02ba855b23c3abd051afb0e6d7" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_9b77ea87c2f2795c19e71f426864b471">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_efd202ef6564adfebc4106108c9561f2" level="file">
        <did>
          <unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="aspace_2266a89b5614fed68ad5e293c81dd951" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_803120151cd96fd1ccac1a467b7bc2d5" parent="aspace_2266a89b5614fed68ad5e293c81dd951" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_6304e26af10a0e94e7ef043fee53ad70">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_5422bbde47d91ace2df22b5b7527a0e6" level="file">
        <did>
          <unittitle>TML, 41-105 - A new ACE inhibitorand two new angiotensin receptor blockers for hypertension</unittitle>
          <unitdate type="inclusive">1999 November 5</unitdate>
          <container id="aspace_3335046cd3fba144d92affe3c8fdff3e" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_6d3c941066a092c13aa0f46bcb38f786" parent="aspace_3335046cd3fba144d92affe3c8fdff3e" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_e16a540da639162df21cb6fa8cf623e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_087aeda452bdc8c1f70b599b752d152a" level="file">
        <did>
          <unittitle>TML, 41-67 - A new conjugated estrogen</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="aspace_7a5d909140d924894be09cb75df9b80f" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_046ab5cd922eed01ece61ea4985dbde7" parent="aspace_7a5d909140d924894be09cb75df9b80f" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_3dd21eec3f06c65a80aa71eae6b88575">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_e1ba3784eccce1db97752b63119a9737" level="file">
        <did>
          <unittitle>TML, 41-15 - Drugs and vaccines against biological warfare</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="aspace_3090408e54626177e2bb019e2da5c639" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_8dec996445d4820f2eae6ab419af2864" parent="aspace_3090408e54626177e2bb019e2da5c639" type="folder">9</container>
        </did>
        <accessrestrict id="aspace_a078c6c919634b8920e26478d73bef6a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_ee9f72d21997962aa5e1d76e60f28954" level="file">
        <did>
          <unittitle>TML, 41-68 - Laser hair removal</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="aspace_d374bea36323f148f56f170f3941a994" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_eeff5a783981ae12d8e7ea11448c6f8b" parent="aspace_d374bea36323f148f56f170f3941a994" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_0797b526bde059f59517ea165bdcb518">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f4d6a53975d9232738144f364667da0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_2d89baa578db92cf804b13c76f19f75c" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_dfe9ed977e7e3977b3080801af2fdc88" parent="aspace_2d89baa578db92cf804b13c76f19f75c" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_ca7184a59b6ddfe5ef00a19434c19c48">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_5db523527161519d86f176dd07137b4b" level="file">
        <did>
          <unittitle>TML, 41-5 - Drugs for Asthma</unittitle>
          <unitdate type="inclusive">1999 January 15</unitdate>
          <container id="aspace_33830e26505b00800b38fd67e46a62e2" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_e663cadf39f1741cbfb7b7936ddb6da8" parent="aspace_33830e26505b00800b38fd67e46a62e2" type="folder">1-5</container>
        </did>
        <accessrestrict id="aspace_24b467056399b27bd316ca395f5c8a5e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_3c1f55d592280bce047dbd773f816697" level="file">
        <did>
          <unittitle>TML, 41-12 - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">1999 January 29</unitdate>
          <container id="aspace_59db23bb446891fc3db594c97b66ed9f" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_a9f1b846c54f9e9fdc43403e768c26b7" parent="aspace_59db23bb446891fc3db594c97b66ed9f" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_a82b9541fad7707df8ff8e0ecec045a1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_a5ef95fdd53a4ad00be13d575b720a90" level="file">
        <did>
          <unittitle>TML, 41-32 - Valrubicin for bladder cancer</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="aspace_4ee288fee32f3c092e89fa10eccd56e2" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_ec82153975461941089c7a84cafadfca" parent="aspace_4ee288fee32f3c092e89fa10eccd56e2" type="folder">9</container>
        </did>
        <accessrestrict id="aspace_1246d47b99a5b28275ca7ac909e04e17">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_c9b5394af1307b91512bebaa47987a03" level="file">
        <did>
          <unittitle>TML, 41-19 - Infliximab (Remicade) for Crohn's disease</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="aspace_343df2d2a17cb85f75a7881901518c92" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_74996a24458e3e2e9b59a0126b0a7f39" parent="aspace_343df2d2a17cb85f75a7881901518c92" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_bceed6a85bb227d8a5c9b54693104fa7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_9431f5004a39b8a0d9a05be98633933b" level="file">
        <did>
          <unittitle>TML, 41-82 - Influenza vaccine, 1999-2000</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="aspace_4898a056f0c128e59bf54c4ad6dd060e" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_cde5eeaca9561f67fb106b16cb16f78e" parent="aspace_4898a056f0c128e59bf54c4ad6dd060e" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_cab250b6e8f335e1e9356ce49870aa0f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_aa75d744d2b7b8eae4e0c83305434171" level="file">
        <did>
          <unittitle>TML, 41-81 - Spironolactone for heart failure</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="aspace_744e68dd957e03fb403b57b1f5b469c4" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_8e2c6696510d531c89dae9c879ba0ab1" parent="aspace_744e68dd957e03fb403b57b1f5b469c4" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_4baffc7980c89aadb8cef585c345f731">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_12a411c26719cadf670414ea9db35b3a" level="file">
        <did>
          <unittitle>TML, 41-2 - Growth-hormone-releasing factor for growth hormone deficiency</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="aspace_9be7c46b8143a1e3937eb7ebb1b63121" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_380f10d1380aafe9bf555a9a4b01da1d" parent="aspace_9be7c46b8143a1e3937eb7ebb1b63121" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_f46608e112550ebc9f422dd17a55e3b3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_50fdbec047db8cdec50f09ae8f09ce33" level="file">
        <did>
          <unittitle>TML, 41-18 - Saw Palmetto for benign prostatic hyperplasia</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="aspace_26924057dc3849fc493d30ba43c9032e" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_86abacef11bf95937564c18da966cf79" parent="aspace_26924057dc3849fc493d30ba43c9032e" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_ebda9b553416d292abf3337874edf243">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_12974761e15d5b5a631f8a1708a1d0e6" level="file">
        <did>
          <unittitle>TML, 41-107 - SAMe for depression</unittitle>
          <unitdate type="inclusive">1999 November 5</unitdate>
          <container id="aspace_843658f2457833f0cb5260dfceccbd3c" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_1c6e1e7112654554f9b94312310e10ad" parent="aspace_843658f2457833f0cb5260dfceccbd3c" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_9f6ccc892b5225ac4e542904aba616bf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_2891c6463578c91c35a01dfbc0867c34" level="file">
        <did>
          <unittitle>TML, 41-3 - Palivizumab (Synagis) for prevention of RSV infection</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="aspace_df05b013b6057d741a85e3595c13a83f" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_4b8ae81aec663788f4de977268175ce1" parent="aspace_df05b013b6057d741a85e3595c13a83f" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_b084224a8b4665a510e8da9d5962cae8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_aa2d0e7ffb5da88f1ad0bda04c4f91da" level="file">
        <did>
          <unittitle>TML, 41:47 - Generic Drugs</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="aspace_936b1ca06e85ea9a3f58866755ed8d18" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_f2f13ac0a9625101a9ea64e30017897c" parent="aspace_936b1ca06e85ea9a3f58866755ed8d18" type="folder">10-15</container>
        </did>
        <accessrestrict id="aspace_d25ac57dbed224f7c437f5c406d80bfb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_d463206ca7312a03520c55b4035d6d7c" level="file">
        <did>
          <unittitle>TML, 41-64 - Amprenavir - a new HIV protease inhibitor</unittitle>
          <unitdate type="inclusive">1999 July 16</unitdate>
          <container id="aspace_29e8522206d06c2087340b70264cecf4" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_4645defd2c847f90bce6b6e10c092f2a" parent="aspace_29e8522206d06c2087340b70264cecf4" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_bebb6703e7e1148e21f6bff4883b5f0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_dacba7e70abbc68ca64fcd4963a6f95a" level="file">
        <did>
          <unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1999 August 27</unitdate>
          <container id="aspace_9f6d6c1c966a050d1e208f0894f5c8c4" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_a49f0e701dbba2824a611dd9d127bcf3" parent="aspace_9f6d6c1c966a050d1e208f0894f5c8c4" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_a555f10f258ebdc237376c5bf299600d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_813dc879c0e4261b5ae728f45f81e536" level="file">
        <did>
          <unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1999 August 27</unitdate>
          <container id="aspace_62555965813bf2a280449293c315f91d" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_14b2b14fa961fe6b182e35b1b02a83f4" parent="aspace_62555965813bf2a280449293c315f91d" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_64327b946a10f94bc40f30737c8f1cd2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_bdc50b4955f16ee4564f9a2f1ecc15ee" level="file">
        <did>
          <unittitle>TML, 41-95 - The Choice of antibacterial drugs</unittitle>
          <unitdate type="inclusive">1999 October 22</unitdate>
          <container id="aspace_8bba980b99c6652c2d39b287a4c32402" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_4a133a741988deb3775a38c54b507597" parent="aspace_8bba980b99c6652c2d39b287a4c32402" type="folder">4-8</container>
        </did>
        <accessrestrict id="aspace_6b1bb72d82bf5bc8c23cfe7d730b6597">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_9edd35ab1f22644cf6c65fedb0f5fd9d" level="file">
        <did>
          <unittitle>TML, 41-63 - Cosmetic use of botulinum toxin</unittitle>
          <unitdate type="inclusive">1999 July 16</unitdate>
          <container id="aspace_3886b34fd0ed8e5572593eef46de29fa" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_8e43620bd7432b3fd7f5a439c68ff346" parent="aspace_3886b34fd0ed8e5572593eef46de29fa" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_dfa20e59cc18902aef49d7b5c22d5eb5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_cadd4aba2aafedf04d2457bcd20ecb68" level="file">
        <did>
          <unittitle>TML, 41-29 - Lyme disease vaccine</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="aspace_2cecf69d87285837ff962d48b72ca3db" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_461e690c70d12f9848b8e3b108653481" parent="aspace_2cecf69d87285837ff962d48b72ca3db" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_ebb5315c0e462b0e2629b5dcb90203c8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_bb27af27ca7507bfd777f78da0d17147" level="file">
        <did>
          <unittitle>TML, 41-121 - Rapid diagnostic tests for influenza</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="aspace_09df1d8ad964b9da793111ec133b5bc6" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_ff41067ff489cf11fe21abe3c2cf2309" parent="aspace_09df1d8ad964b9da793111ec133b5bc6" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_86662934e660af89d7aeaa4e4d013446">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_cf44b51a4bbfd2f5063743b63c4a93e3" level="file">
        <did>
          <unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">1999 September 24</unitdate>
          <container id="aspace_7a4cd7f58948953480eaed7aa71ec62c" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_d374afb03b4fe4053f2e70f79c574df7" parent="aspace_7a4cd7f58948953480eaed7aa71ec62c" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_53ace92e24d776a3c07d0e679ac418eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_98fd7e915d5c04bccf9bfee05be98149" level="file">
        <did>
          <unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">1999 September 24</unitdate>
          <container id="aspace_7f9aeb06e51f2e6386d8f0671aa741a6" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="aspace_e49ec548b8bb17fa6831b537718d6363" parent="aspace_7f9aeb06e51f2e6386d8f0671aa741a6" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_4fa538c8b0c22de3e0eea7db981ae287">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_47b865bf089a172b75b4d43ce7a1e447" level="file">
        <did>
          <unittitle>TML, 41-33 - Depression and anxiety</unittitle>
          <unitdate type="inclusive">1999 April 9</unitdate>
          <container id="aspace_5007ff55eed04ccba0235676f03ce62c" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="aspace_5a8539e87c910c257f2823066c598ee1" parent="aspace_5007ff55eed04ccba0235676f03ce62c" type="folder">4-13</container>
        </did>
        <accessrestrict id="aspace_b0f422d658f31862e120da53fa05b6f9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_71225c0666898a85e784b2cb281888c6" level="file">
        <did>
          <unittitle>TML, 41-122 - Corneal surgery for correction of refractive errors</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="aspace_e69d1b1c9e2a39b4a185a94e76c09eaf" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="aspace_55207f01c2a24138e90b581565bade16" parent="aspace_e69d1b1c9e2a39b4a185a94e76c09eaf" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_383c5c203f77ebf4dd9e3dfe67c24cf7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_45f2b2be0a5f877794d8dab41d1e2c89" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_4b3bc0f710089e2c82f1752f504df6d0" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="aspace_0967c90ac77d7db972428dec2f3ff1cc" parent="aspace_4b3bc0f710089e2c82f1752f504df6d0" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_149a9e74e2c2eb4d35105c1043e77fd1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_59f39d33e558df2c7a53b2df2d17a4ae" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_e832952ddfa23b3cbc74b51650854496" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="aspace_58d9a982e02575905016a69ee89f2143" parent="aspace_e832952ddfa23b3cbc74b51650854496" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_6cab2eae0fd66d97ea7c349b2f4718db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_8d82b612550e56f5febd997b649248f6" level="file">
        <did>
          <unittitle>TML - Drugs for Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_d8888ed8095e9356b83fba450db102e6" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="aspace_a8bc981e472d6007bb484757134f98b9" parent="aspace_d8888ed8095e9356b83fba450db102e6" type="folder">4-9</container>
        </did>
        <accessrestrict id="aspace_9ea5dcafb096eb9d1dba6ab8571932c7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_729c9bb0e1660ceb032fe6da8350333c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice for cancer chemotherapy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_cc0c4c9a037e42e110c3d7de9984745d" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="aspace_47555d6de6ec4d24867ea4d0b742de24" parent="aspace_cc0c4c9a037e42e110c3d7de9984745d" type="folder">10-16</container>
        </did>
        <accessrestrict id="aspace_5ad67e35d3361f03756bfe78c6e60019">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_737148b055ba101acbd8ee7df7c07e4c" level="file">
        <did>
          <unittitle>TML, 41-44 - Cilostazol for intermittent claudication</unittitle>
          <unitdate type="inclusive">1999 May 7</unitdate>
          <container id="aspace_2a013438816768d9e5837cb28f3b8537" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="aspace_84011ca943da34d28508fbcafa8e7cb9" parent="aspace_2a013438816768d9e5837cb28f3b8537" type="folder">17-20</container>
        </did>
        <accessrestrict id="aspace_91985532c77a98b2be6619b3829a2c87">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_6e0f28a2b5a8cac84be32ec338816dac" level="file">
        <did>
          <unittitle>TML, 41-11 - Celecoxib for arthritis</unittitle>
          <unitdate type="inclusive">1999 January 29</unitdate>
          <container id="aspace_0be374a330e24b88295b7b77f4b31e9e" label="Mixed Materials (A0000000075888)" type="box">46</container>
          <container id="aspace_20472948e17938bd4b411f205c618979" parent="aspace_0be374a330e24b88295b7b77f4b31e9e" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_5220646ffa341e43aaef650d57ef5cbb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_47ee2aa0e1414311aab659a0b7791d48" level="file">
        <did>
          <unittitle>TML, 41-61 - Drug interactions</unittitle>
          <unitdate type="inclusive">1999 July 2</unitdate>
          <container id="aspace_ba08034b83a9d54896af106d8f779f4e" label="Mixed Materials (A0000000075945)" type="box">103</container>
          <container id="aspace_a67c8fdb564ac853299a9ed6e0b20303" parent="aspace_ba08034b83a9d54896af106d8f779f4e" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_2310dca3aaada449df04e476753e097f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_ca7a582ccc3762635c6b2b1ab49c2e38" level="file">
        <did>
          <unittitle>TML, 42-51 - Ciclopirox (Penlac) nail lacquer for onychomysis</unittitle>
          <unitdate type="inclusive">2000 June 12</unitdate>
          <container id="aspace_83ac5369a8b5d0f4b9aa46f31264dbc9" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_bca69db1e785d618ba01175dcff60108" parent="aspace_83ac5369a8b5d0f4b9aa46f31264dbc9" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_9580c594e1986354a883d0b4d0b71bc3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_4b13f0ecb976a0758dff29129231c5ab" level="file">
        <did>
          <unittitle>TML, 42-70 - Cevimeline (Evoxac) for dry mouth</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="aspace_7b3daf8c27508336d6762b571ea1dbf4" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_d030066649702717260142bbd82478b5" parent="aspace_7b3daf8c27508336d6762b571ea1dbf4" type="folder">3</container>
        </did>
        <accessrestrict id="aspace_ab5ca835a64facd8b0328a6bddeaa9db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_65fedbec948e0fc83c65d93e86ad6afd" level="file">
        <did>
          <unittitle>TML, 42-13 - Sirolimus (Rapamune) for transplant rejection</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="aspace_bf4d0c79b37daaaf648115799d02601b" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_3d9230627f7bc6e3c56a8d9590d08fcf" parent="aspace_bf4d0c79b37daaaf648115799d02601b" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_7082abcbc2a52e308ef67322853d8731">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_43b3f1afcb8ce7fdcc73ea538a9dcaef" level="file">
        <did>
          <unittitle>TML, 42-56 - Drug interactions with St. John's Wort</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="aspace_baf5f6006145c6b714c07fec1f0f6a78" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_311a0158365aecf76b0488b1f0569d3a" parent="aspace_baf5f6006145c6b714c07fec1f0f6a78" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_fc05579a4affa53f15f6bf7701c8c36c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_13d9761c756a2fe7adb0ccd2bd89e5c3" level="file">
        <did>
          <unittitle>TML, 42-27 - Curosurf</unittitle>
          <unitdate type="inclusive">2000 March 20</unitdate>
          <container id="aspace_f0bc588052d8512755e0893df566c11c" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_357f5a777959544f436b591e21f3120e" parent="aspace_f0bc588052d8512755e0893df566c11c" type="folder">10-12</container>
        </did>
        <accessrestrict id="aspace_a42091b45287859d025abbb92f4814dc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_c1fd925b81d971c06ec273ef08f3cb74" level="file">
        <did>
          <unittitle>TML, 42-81 - Photodynamic therapy with veterfporfin (Visudyne) for macular degeneration</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="aspace_4c2bc369ef5295c93f4e790193eb7853" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_3adf378bfa515cefec565e8107f18b61" parent="aspace_4c2bc369ef5295c93f4e790193eb7853" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_25831287c40dd007e7ad4f179aa90da2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_259c3ccf591bab51ffdaba3a9994e765" level="file">
        <did>
          <unittitle>TML, 42-57 - Drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2000 July 10</unitdate>
          <container id="aspace_05e663e54472452726b67976309e504d" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_330ce05c886cc1674c03b4cb21bbbb95" parent="aspace_05e663e54472452726b67976309e504d" type="folder">16-20</container>
        </did>
        <accessrestrict id="aspace_162cb0e7647f4a98954f5445c257c882">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_62b6871b865b6d75c47266161b21cb21" level="file">
        <did>
          <unittitle>TML, 42-113 - Phenylpropanolamine</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="aspace_6f9a86bc147c48a3078926c894d761bb" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_458949fea32da374a9775a64fe77124f" parent="aspace_6f9a86bc147c48a3078926c894d761bb" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_3a8380c96fc7714fa7d33e8fc9eda5f1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_7e8cf0d2095db89bdcf602dcfa388b37" level="file">
        <did>
          <unittitle>TML, 42-94 - Zonisamide (Zonegran) for epilepsy</unittitle>
          <unitdate type="inclusive">2000 August 1</unitdate>
          <container id="aspace_415aca1842686326caa23cc84a05555a" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_a3aaf06d66e1f8f51040f74e443a8b40" parent="aspace_415aca1842686326caa23cc84a05555a" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_af9a344f43755a6c943435e3e709888a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_505b60f40ff960c724ff856e304ce951" level="file">
        <did>
          <unittitle>TML, 42-10 - Emergency Contraception - Plan B</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="aspace_37a3419957917edb6eb15300a9cf4dfd" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_e5f2125a155bd3db1ce803e6b1e3cca5" parent="aspace_37a3419957917edb6eb15300a9cf4dfd" type="folder">5</container>
        </did>
        <accessrestrict id="aspace_3cd71612bf2f98b55022fa5ad125e9e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_86b41328d3a3f3bd0b39258221d169af" level="file">
        <did>
          <unittitle>TML, 42-42 - Oral contraceptives</unittitle>
          <unitdate type="inclusive">2000 May 15</unitdate>
          <container id="aspace_b6cdc1bc82fe43f663820f603721ce6c" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_8a04cd04a2eea52605888086b24bb531" parent="aspace_b6cdc1bc82fe43f663820f603721ce6c" type="folder">6-11</container>
        </did>
        <accessrestrict id="aspace_362a441b3fc8d8a82b31585a57ea0665">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_5af9d8711bf691d44ab3b1e5bb256681" level="file">
        <did>
          <unittitle>TML, 42-17 - Phytoestrogens</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="aspace_326c68e1debc67dda2837da810de06e8" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_15169d5c2b32b174ebc58e08c5f4616d" parent="aspace_326c68e1debc67dda2837da810de06e8" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_b6923da0f1e80e36ed724d7930240ab0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_408be2b8c6034a613b1211f2ecf9b661" level="file">
        <did>
          <unittitle>TML, 42-29 - Calcium citrate vs Calcium carbonate calcium supplements</unittitle>
          <unitdate type="inclusive">2000 April 3</unitdate>
          <container id="aspace_14bbd5ee7e910c4c4c946e201dffab81" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_40cb80ecaff4132da6c2e381bba61c15" parent="aspace_14bbd5ee7e910c4c4c946e201dffab81" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_f012aa712ae69a791944518eafe15ae9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_3335c85c5f584c0623918d305860bba9" level="file">
        <did>
          <unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="aspace_f663bb7fe2935584b701c315d53283a4" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_88e3523fbf579c3ee3c2e46fd8993d43" parent="aspace_f663bb7fe2935584b701c315d53283a4" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_55427e8bb48ad2b8315333c1ff339476">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_c6d41dc2321b4992a2ce79264290f903" level="file">
        <did>
          <unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="aspace_d28788c4d597c27b32a6f8bd5d77e530" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_95b6674d708c79117c2c639251340a0f" parent="aspace_d28788c4d597c27b32a6f8bd5d77e530" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_a4945089c03fcb0a219bdaccf387431a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_1ff03efd208b21a2efb1beeeca59fbe2" level="file">
        <did>
          <unittitle>TML, 42-41 - Dofetilide for atrial fibrillation</unittitle>
          <unitdate type="inclusive">2000 May 15</unitdate>
          <container id="aspace_99514c91a6ab18e1eb694bd7d5c920e4" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_8da357f07d92b7809bb71811eb8ce5a0" parent="aspace_99514c91a6ab18e1eb694bd7d5c920e4" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_f05aa84b2f28b6ffb33fe96ec43cd992">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_97e9932d34799dd8520be9e13f8a01ce" level="file">
        <did>
          <unittitle>TML, 40-102 - Colesevelam (Welchol) for hypercholesterolemia</unittitle>
          <unitdate type="inclusive">2000 October 30</unitdate>
          <container id="aspace_36bf184618d317780843615ea148595c" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_0b5dfac9f361b4f610d9ed890d7a6137" parent="aspace_36bf184618d317780843615ea148595c" type="folder">5</container>
        </did>
        <accessrestrict id="aspace_349dee1a0f2981a7afaffa486ad92400">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_b1e989f44b7978ab2b1aaaf201f34aeb" level="file">
        <did>
          <unittitle>TML, 42-108 - Docosanal cream (Abreva) for recurrent herpes labialis</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="aspace_a945a28a26cea3001697e3ad2a462e78" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_dcc00be816938b60a80ddd743e6b7e28" parent="aspace_a945a28a26cea3001697e3ad2a462e78" type="folder">6</container>
        </did>
        <accessrestrict id="aspace_086b94bfdd5ebcae1564c66a07d71bf4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_e0e61fb5a1e14299b5769bb3645966af" level="file">
        <did>
          <unittitle>TML, 42-106 - Temecteplase (TNKASE) for thrombolysis</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="aspace_1c3673a29a93db31e6dc2454b8a61fb5" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_de519d9d1fc17b9dc0e2eae6dc4fbbe1" parent="aspace_1c3673a29a93db31e6dc2454b8a61fb5" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_6881f1eb6305a22e4485bcca7bf92f20">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_3d342507f2c128f34587c4f458c47ae3" level="file">
        <did>
          <unittitle>TML, 42-113 - Valproate and other anticonvulsants for psychiatric disorders</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="aspace_00aaeb4db434c137e33b982495813f5c" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_167da35665031070956a1209c85e081c" parent="aspace_00aaeb4db434c137e33b982495813f5c" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_175706ce1b1be1373cdbf4234daea11e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_89f1be4de95ddec6822bda7f0e83b385" level="file">
        <did>
          <unittitle>TML, 42-8 - Prevention of malaria</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="aspace_d78e0474a574b0678f079102c9f3c6a1" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_7341a814b73847d96ccdac41111ef37a" parent="aspace_d78e0474a574b0678f079102c9f3c6a1" type="folder">15</container>
        </did>
        <accessrestrict id="aspace_9af6ac60aa40dc6005ce4edb57dc6970">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_da557a8aeefe93b11b7b65ef3275ee26" level="file">
        <did>
          <unittitle>TML, 42-37 - Lyme disease</unittitle>
          <unitdate type="inclusive">2000 May 1</unitdate>
          <container id="aspace_6524e7f21ee540a363cc6b3131c2ec91" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_80dafcdca8f8cfe3d05037bbae3ba25d" parent="aspace_6524e7f21ee540a363cc6b3131c2ec91" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_50f594b6d9dec7b83b3b83386b475dcd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_b9d25758af7747ace6aaf80757aac85f" level="file">
        <did>
          <unittitle>TML, 42-18 - Aspirin for primary prevention of cardiovascular disease</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="aspace_bb8f476ebed798f0f99c94fa20bcd49f" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_3e8504e6dc46408d178cba3f0f1f874c" parent="aspace_bb8f476ebed798f0f99c94fa20bcd49f" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_bd7e6d6a5d2765181060a6c4e5bc8024">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_8827ef8acb277df2d477589d43015ed3" level="file">
        <did>
          <unittitle>TML, 42-73 - Drugs for pain</unittitle>
          <unitdate type="inclusive">2000 August 21</unitdate>
          <container id="aspace_0cc663ec0a85eeed82a718cf02087ebe" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="aspace_a306b5b78bede9fb2c2cacec6a8de870" parent="aspace_0cc663ec0a85eeed82a718cf02087ebe" type="folder">1-6</container>
        </did>
        <accessrestrict id="aspace_45351d67ab671d76012768894632e65f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_7ca68fc3cc569b193dc410a094f9a61f" level="file">
        <did>
          <unittitle>TML, 42-19 - Drugs for Asthma</unittitle>
          <unitdate type="inclusive">2000 March 6</unitdate>
          <container id="aspace_f437e1ba501e81f338c676dd754f9c2b" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="aspace_4cc4f2444875c728567d449a6aac19ab" parent="aspace_f437e1ba501e81f338c676dd754f9c2b" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_843840cc3a1f4f944dcd68fb679ac778">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_11f2fac87764b93bfe43bd87321c6e78" level="file">
        <did>
          <unittitle>TML, 42-49 - Androgel</unittitle>
          <unitdate type="inclusive">2000 June 1</unitdate>
          <container id="aspace_c59ff113677c7606ccc00035c743a014" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="aspace_4b26da3d6f18ad53d1e43cc7c68f4964" parent="aspace_c59ff113677c7606ccc00035c743a014" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_373b10f2aaf453294914d4fe78b9487f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_f519c54c8f624fc16003fa1c04fa88f0" level="file">
        <did>
          <unittitle>TML, 42-97 - Drugs for prevention and treatment of postmenopausal osteoporosis</unittitle>
          <unitdate type="inclusive">2000 October 16</unitdate>
          <container id="aspace_5d426b0468304cf75fe8ce6594cf1879" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="aspace_3716b7608830739147c6f89dcd3a3106" parent="aspace_5d426b0468304cf75fe8ce6594cf1879" type="folder">14-18</container>
        </did>
        <accessrestrict id="aspace_f6c66097c55fc7906c4f0813a2f589d8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_da9eaff7a676c3ce93fb52a83c4df992" level="file">
        <did>
          <unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="aspace_ff902af5f77d06301e1bb29992052239" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="aspace_755aa6abae2efde0a7a09dad4fa9f434" parent="aspace_ff902af5f77d06301e1bb29992052239" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_0b717ab0083f68384631636b834fec64">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_f307fe5a6bafa6083a914965f47c224f" level="file">
        <did>
          <unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="aspace_0691d6394683da3a3ab0cc66ac0d8443" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_3b9edca010de253294b03405ce3ddb22" parent="aspace_0691d6394683da3a3ab0cc66ac0d8443" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_dc26934d88198182e177b592f4868a43">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0d88056c01b79b6a4d890ffb52ef26d7" level="file">
        <did>
          <unittitle>TML, 42-31 - Bexrotene</unittitle>
          <unitdate type="inclusive">2000 April 3</unitdate>
          <container id="aspace_779edd84e061105186a9fcf9eaee8ff6" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_813b8fa91b2863bddf20c8fa058ab51a" parent="aspace_779edd84e061105186a9fcf9eaee8ff6" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_9a8c86a85c6d5ea077e55d9b7597d55f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_78aad480d71976b1ac63856f8414b2de" level="file">
        <did>
          <unittitle>TML, 42-116 - Portable Defibrillators</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="aspace_620463a2fa30ac7f3ddb1db751ec85be" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_7151179b99216c08663041128060046d" parent="aspace_620463a2fa30ac7f3ddb1db751ec85be" type="folder">5-6</container>
        </did>
        <accessrestrict id="aspace_da50ccc68a37dbb555145dfbcf8f1e7c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_8856ac6d297ba039f5f59b8393406463" level="file">
        <did>
          <unittitle>TML, 42-111 - Drugs that may cause cognitive disorders in the elderly</unittitle>
          <unitdate type="inclusive">2000 November 27</unitdate>
          <container id="aspace_cb1bbef11bc9b91687e84aa7397d63f3" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_e89fe1a4dfc2b64bbbfe7cc89f3fe3e4" parent="aspace_cb1bbef11bc9b91687e84aa7397d63f3" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_2247b3013b5d4bd66554d265282ec46f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_d791d0f324ea7d0ebc4dcab430fc3a36" level="file">
        <did>
          <unittitle>TML, 42-36 - Substituting for troglitazone (Rezulin)</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="aspace_c8e044972afd4ebdb56c73404d1bc0d1" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_8bf343df521ede6cdb7fa54e17cd1c3e" parent="aspace_c8e044972afd4ebdb56c73404d1bc0d1" type="folder">11</container>
        </did>
        <accessrestrict id="aspace_35757c84324de4837de836a4d664e4bd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_390553fd7a4eea2f5cbee5002f2322bc" level="file">
        <did>
          <unittitle>TML, 42-109 - Atovaquone - Proguanil (Malarone) for malaria</unittitle>
          <unitdate type="inclusive">2000 November 27</unitdate>
          <container id="aspace_e7587142df4bcc92866f3f9ad5a1b4e8" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_0bf60125a9fae90a0bd1bac646995874" parent="aspace_e7587142df4bcc92866f3f9ad5a1b4e8" type="folder">12-15</container>
        </did>
        <accessrestrict id="aspace_717bd1e1f90c70ff656382467cc26f89">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_102174d0143d0b7b46d5dbdfb6ee2e6c" level="file">
        <did>
          <unittitle>TML, 42-39 - Ketotifen and Pemirlostat - New drugs for allergic conjunctivitis</unittitle>
          <unitdate type="inclusive">2000 May 1</unitdate>
          <container id="aspace_e104ecac0a882a2aaa38ee2fac70bf73" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_ecbec74115eda6c6831cebb0d75bc686" parent="aspace_e104ecac0a882a2aaa38ee2fac70bf73" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_c0dedfa65ff00b42eaec283e7dbe5ee3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_968dfa06d929ab040463fb621fb94e15" level="file">
        <did>
          <unittitle>TML - HAT - Systemic antifungal</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_1bd37b2b5c38bc9d80c90b297a93f17c" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_f379e1633d5fca021c0a2f08529b5984" parent="aspace_1bd37b2b5c38bc9d80c90b297a93f17c" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_a7608b2e6d21017e82cac99f4c300d04">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_ffb773729eccb5c024461cb32728a1f5" level="file">
        <did>
          <unittitle>TML - HAT - Systemic antifungal</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_27a64f366cc2e0677f45fee267b56d8d" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_7214047c50d48e7ad624259d47e7337f" parent="aspace_27a64f366cc2e0677f45fee267b56d8d" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_fc274c9d6d48168ac3a11ea6067869e0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_b5adf750afaa8fb0be9aa2061a43e3b8" level="file">
        <did>
          <unittitle>TML, 42-96 - Eflornithine cream for facial hair reduction</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="aspace_eed3a57bace5972103a1f2127f8b1be6" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_2f9a9dc9934a0008c25ceb40822a222f" parent="aspace_eed3a57bace5972103a1f2127f8b1be6" type="folder">3</container>
        </did>
        <accessrestrict id="aspace_97998d665049bfafbdf7f044ef962ac2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_c88b481d9cf92fe516e086aa696f2759" level="file">
        <did>
          <unittitle>TML, 42-67 - Gemtuzumab for relapsed acute myeloid leukemia</unittitle>
          <unitdate type="inclusive">2000 July 24</unitdate>
          <container id="aspace_a94d4587bab55a4c8377ccfb4b33c2c9" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_1f38868654a415e9a9ed831bbaaf15c5" parent="aspace_a94d4587bab55a4c8377ccfb4b33c2c9" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_8158423ad1861ed096a1f762bea5ed19">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_d316d036d1c1c8b5e65cc5a3309c50cf" level="file">
        <did>
          <unittitle>TML, 42-52 - Atkin's diet</unittitle>
          <unitdate type="inclusive">2000 June 12</unitdate>
          <container id="aspace_3e76d7ee078862056a8667e35118ffc4" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_f164df06a8dcb41e56e0c64cad27cd5d" parent="aspace_3e76d7ee078862056a8667e35118ffc4" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_0024c5f9b90643b42da0ff940f490484">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_f039186b802088d6736b63d8692ff877" level="file">
        <did>
          <unittitle>TML, 42-71 - Hypnotic drugs</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="aspace_076021b9b3b639b3ad975e4e09576a48" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_3334a3d83a0fe5ed746b7ec4d1cb4d4b" parent="aspace_076021b9b3b639b3ad975e4e09576a48" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_66081d4df14137512de48118dd485bfc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_ddaac639270ba0e3369ea6c5bef18c02" level="file">
        <did>
          <unittitle>TML, 42-79 - Influenza update 2000-2001</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="aspace_2717ca0a2d960513d8942cb097a2be71" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_b110874ee34536fe851b97e9126c6a31" parent="aspace_2717ca0a2d960513d8942cb097a2be71" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_2370a9ec5de5c8b19f6823b89c720366">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_3b89f483901c2a204aeb8a707d5f619e" level="file">
        <did>
          <unittitle>TML, 42-35 - Exemestane for advanced breast cancer</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="aspace_4c17736285b3b87aff26d4f2fa5fbc1a" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_2f678fb03c0e1e01ed15dfbb0555c252" parent="aspace_4c17736285b3b87aff26d4f2fa5fbc1a" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_908ae2bf04aa596e7e5c1b4a0b435a1a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_5b4d37f27c36f2cf78b12c02f16d9dd0" level="file">
        <did>
          <unittitle>TML, 42-12 - Epirubicin for adjuvant therapy in node-positive breast cancer</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="aspace_b9e93af00a0db173a7d27e03f2e8afe3" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_82a6cd391708b316ab74f6d619bb8f4b" parent="aspace_b9e93af00a0db173a7d27e03f2e8afe3" type="folder">18-20</container>
        </did>
        <accessrestrict id="aspace_231c8f3761cd29bf8b9da59c1db76773">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_ea21c93279b7213ac4ebcf26ac90ac01" level="file">
        <did>
          <unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="aspace_e47c3d8e5e80ead80ffb084f012712e5" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_f7af12fc0a7113743e4fa84d00eab75d" parent="aspace_e47c3d8e5e80ead80ffb084f012712e5" type="folder">21</container>
        </did>
        <accessrestrict id="aspace_ecde6f626cda50967973b161a20fcc74">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0670855c3da978011ef91e63b94b8614" level="file">
        <did>
          <unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="aspace_c41ae700be510336ee1c1309a27911bf" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_3e60d7d9939dc4008a0377bddfdc6288" parent="aspace_c41ae700be510336ee1c1309a27911bf" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_b1545fba52ccf81c38c8688169dab34a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_b9f3b0c3756751d471fc83952e9cdb9e" level="file">
        <did>
          <unittitle>TML - HAT - Adverse Effects</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_48211d10746c7f04f3833363efb7c218" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_ace6e34ee1de303b9788e524b2ff94e1" parent="aspace_48211d10746c7f04f3833363efb7c218" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_f035a5812a9a5ba9f187b537f909316a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f64e1cb70a81058fe2a570f1ccb8c4a" level="file">
        <did>
          <unittitle>TML - Perinopril - A new ACE inhibitor for hypertension</unittitle>
          <unitdate type="inclusive">2000 May 26</unitdate>
          <container id="aspace_589f4457691b72e4e76c569fdf6d790c" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_4be3db6c164038ca42a95681ff2032a9" parent="aspace_589f4457691b72e4e76c569fdf6d790c" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_8e19dab12d3196a7486bcf0f13a7475f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_9370ffe6e8855002d778fc797c644238" level="file">
        <did>
          <unittitle>TML, 42-65 - Pantoprazole (Protonix)</unittitle>
          <unitdate type="inclusive">2000 July 24</unitdate>
          <container id="aspace_92b851587f27ce81d1afc34cd8eef677" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_b97e464317a17fb6664c83a3a54e5ad1" parent="aspace_92b851587f27ce81d1afc34cd8eef677" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_a1015b3acc8c847466def1105f15644b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_354614b4cdeb7c25dce7323acfe3837f" level="file">
        <did>
          <unittitle>TML, 42-15 - Gatifloxacin and Moxifloxacin - Two new fluoroquinolones</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="aspace_5b82013b28b64375b8572c09b95343b3" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_ac4e8f41e1391e082049d34496148706" parent="aspace_5b82013b28b64375b8572c09b95343b3" type="folder">13-18</container>
        </did>
        <accessrestrict id="aspace_5bf74d558644f64e23255ce061463c78">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_ee26dc57604d2e8beb15f5282094c199" level="file">
        <did>
          <unittitle>TML, HAT - Antimicrobial Dosage</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_c53c2dbe4effbee3804a1e99a9a5efd7" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_bf8dcf72b32722b1ec5f120d87032908" parent="aspace_c53c2dbe4effbee3804a1e99a9a5efd7" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_11c3455a2f2e87c2b16773aa9e6aea7c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_a088080df443869d26625b88cfb8357c" level="file">
        <did>
          <unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="aspace_6d461541fff49907c214b08741e26332" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_c42ca37ca97384a46b6d54203893284e" parent="aspace_6d461541fff49907c214b08741e26332" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_204852f90f3648c6b6e5e6274cb652ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_4786db2a3aa9c724f7f60dcf4fcf9164" level="file">
        <did>
          <unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="aspace_157214b1ca3a9e7704412f8305aada76" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_720a4f1448b86115658d0eac6b034304" parent="aspace_157214b1ca3a9e7704412f8305aada76" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_19470d2540faf3143d53c5e0f0f04553">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_ff8898d4bdb05f23855cdb33eaefc878" level="file">
        <did>
          <unittitle>TML, 42-53 - Alosetron (Lotronex) for irritable bowel syndrome</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="aspace_b8aaa96c9935a7d4b401cd88730f4765" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_95b8e60c75dde8f7f4355846ce784f6e" parent="aspace_b8aaa96c9935a7d4b401cd88730f4765" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_a92fba8d7b374bd5ed2b6377d7f5dfcf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_c83dbfe7a53fd4d335c81b6902eff92d" level="file">
        <did>
          <unittitle>TML, 42-25 - Conjugated pneumococcal vaccine for infants and children</unittitle>
          <unitdate type="inclusive">2000 March 20</unitdate>
          <container id="aspace_9219595f6400c0678593a2592e62152e" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_c6d274452c0b51730faad079d9346635" parent="aspace_9219595f6400c0678593a2592e62152e" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_aee461894cb0482b20c2792522b46e12">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0c6944c64d3e895d17a92cb7a840b2cc" level="file">
        <did>
          <unittitle>TML, 42-69 - Meningococcal vaccine - College students</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="aspace_9b418189328bc9a482390fb2e23e965a" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_5ea4bfd2a12f93ef0210f55099741a3a" parent="aspace_9b418189328bc9a482390fb2e23e965a" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_df37cebc2f1268161ba89264e0aa24c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_f8521e46162fc0e16135537e8fe60e0e" level="file">
        <did>
          <unittitle>TML, 42-80 - A new long-acting methylphenidate</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="aspace_09515823f7d0d47e091f672bb005a8e8" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_11f314a47aa5bf103024a9ce4727c3fd" parent="aspace_09515823f7d0d47e091f672bb005a8e8" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_a4aa4fa7be7331aba5f8a5db5ecf9418">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_77d873ab9fa6653d75e07ecd29388474" level="file">
        <did>
          <unittitle>TML, 42-17 - Entacapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="aspace_f1c1e9066326eb0939b16cadf317ea2e" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_07a834744c481accbc901a04f17e64c2" parent="aspace_f1c1e9066326eb0939b16cadf317ea2e" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_c4cc72e54e77645b47ebceda334dae90">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_2c3c36361f7d26d6245b10967d53cba6" level="file">
        <did>
          <unittitle>TML, 42-45 - Linezolid (Zyvox)</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="aspace_81fbb93220cd70682d946a3de2fcfebe" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_85be6a33129065f1a12f73e67729f035" parent="aspace_81fbb93220cd70682d946a3de2fcfebe" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_134bd94a116d4a00868b6be7c821b669">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_f3db800fbd8c30fd18c0ce7421c0675c" level="file">
        <did>
          <unittitle>TML, 42-1 - Drugs for HIV</unittitle>
          <unitdate type="inclusive">2000 January 10</unitdate>
          <container id="aspace_64c0366cb450d370679aace782ef3f46" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_392de5c190c48c11fd7a8078fe0ca054" parent="aspace_64c0366cb450d370679aace782ef3f46" type="folder">19-21</container>
        </did>
        <accessrestrict id="aspace_6357a8604ec2f14301f33a46a3a3ee64">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_c29c016865d236b6f578b647c46a6676" level="file">
        <did>
          <unittitle>TML, 42-1 - Drugs for HIV</unittitle>
          <unitdate type="inclusive">2000 January 10</unitdate>
          <container id="aspace_6ba6cf2d764bffc78e1617c7e7493c61" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="aspace_e2a59f8ce8d5932882b10032b7d5e8b0" parent="aspace_6ba6cf2d764bffc78e1617c7e7493c61" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_8e3afc9c0897bcf7957059afb787d613">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ef84e9be7c32e14ccb4cf39bfd45359" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_f59216e872fa8db6c83b0081a62365b9" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="aspace_fc4aa45dcea12a2ceef59ddc8df7e5b4" parent="aspace_f59216e872fa8db6c83b0081a62365b9" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_9bb37702887fbb2a3b6b04978a2797eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_cc6bb16d28e33a08e3172f055c9bc2b1" level="file">
        <did>
          <unittitle>TML, 42-11 - Aggrenox - A combination of antiplatelet drugs for stroke prevention</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="aspace_5a890fb5ede9443b00eb6aca5bb5f958" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="aspace_80b3c00e427fb02d1979e5a467f5ee8c" parent="aspace_5a890fb5ede9443b00eb6aca5bb5f958" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_b6c3f76765c91d59d07d1942830fb182">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_7fc91d920ef13c04bcd488ff67fb27eb" level="file">
        <did>
          <unittitle>TML - 42-54 - Beta Blockers for heart failure</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="aspace_aef5f2fb80c807388ea1f36cd1a9cf99" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="aspace_ae3ea0cfab860d820519614f840817cd" parent="aspace_aef5f2fb80c807388ea1f36cd1a9cf99" type="folder">9-13</container>
        </did>
        <accessrestrict id="aspace_ddd4e956f4e4703f485c6e09538b3de5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_2659d96c29ea4c72cecf071a3ffe82cf" level="file">
        <did>
          <unittitle>TML, 42-83 - Drugs of Choice - Cancer chemotherapy</unittitle>
          <unitdate type="inclusive">2000 September 18</unitdate>
          <container id="aspace_de30d0b6b6097a7573c4095cd0c270fd" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="aspace_65fe1c531928b5642c6c9ca0296ddf9a" parent="aspace_de30d0b6b6097a7573c4095cd0c270fd" type="folder">14-18</container>
        </did>
        <accessrestrict id="aspace_fdc72de4846ddb965722a850fb816e7f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_85452dc178e1dadec0332fe42563215d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Tuberculosis</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_fc654240c35e3594568e2c497ea63ac0" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="aspace_c6b74b78169ce994825b5d2f250290e4" parent="aspace_fc654240c35e3594568e2c497ea63ac0" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_f9bcd6fc9775a8cd44d753ed67359607">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c48a5236a35ed8f3ce7136401b6da9e" level="file">
        <did>
          <unittitle>TML, 42-101 - Mifepristone (RU 486)</unittitle>
          <unitdate type="inclusive">2000 October 30</unitdate>
          <container id="aspace_ad22920a224c75c4dbf9a726601dbaa6" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="aspace_124645396e72c1102216f3fa814629a1" parent="aspace_ad22920a224c75c4dbf9a726601dbaa6" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_512097af868e6310c2ef7aa3a3ab7af5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_41cb55e32ff2281af228fcf98e48db43" level="file">
        <did>
          <unittitle>TML - Osteoporosis - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_46cb94a1f435033512bbbb65b98e15f2" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="aspace_33c8f031ed9f7c2b721f7edd0a450d7f" parent="aspace_46cb94a1f435033512bbbb65b98e15f2" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_a1eb04973eb4447d22f3324b1056f9bf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_669d4a856fe8af2c5b04130d94fa8d3e" level="file">
        <did>
          <unittitle>TML - Asthma - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_73acc4efb684167dec9eb91c708d3424" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="aspace_38643184bfab22a4621232c8cfbf462b" parent="aspace_73acc4efb684167dec9eb91c708d3424" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_38e2af006895a52bd2de3eb894293ec3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ec6c4e753e63df5926b6bb8dc0ec41d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_def170f8fdabb3de10224e90ffc7219f" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="aspace_4fe940ddd0dbdbb663eb8e7ef39c6574" parent="aspace_def170f8fdabb3de10224e90ffc7219f" type="folder">17-20</container>
        </did>
        <accessrestrict id="aspace_d8d94d63528159d44953c7215892b5f2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_1716a9979d5479baf368216eb3017f50" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_60aa934f5e686e5756dee731fce71724" label="Mixed Materials (A0000000075899)" type="box">57</container>
          <container id="aspace_32573c14b6a6cf5db134f6ac56d1d5f4" parent="aspace_60aa934f5e686e5756dee731fce71724" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_7be18115960dc69ccd463738ce3438d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_296856f8c0a6139989dec83e2967a3f6" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_9307b272c0bc71606770923f4b311898" label="Mixed Materials (A0000000075899)" type="box">57</container>
          <container id="aspace_eb0babaa07ff5d1284dcb812ac038f0b" parent="aspace_9307b272c0bc71606770923f4b311898" type="folder">5</container>
        </did>
        <accessrestrict id="aspace_44a20fdcc0c5ee5bc8f27d1eb7439095">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_41a4f1b5ec21dcacfcb1590a26be0255" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_21065376b08c50f57b19aaef3bb1539c" label="Mixed Materials (A0000000075900)" type="box">58</container>
          <container id="aspace_dd55ead4190928dfed7ed5bee89ae828" parent="aspace_21065376b08c50f57b19aaef3bb1539c" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_aae3719b7a851cb67c17470197b044d1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_8d745390980b9c7fe7639600ac855496" level="file">
        <did>
          <unittitle>TML, 43-92 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">2001 October 29</unitdate>
          <container id="aspace_5698188c1cafada4169f4c3f7e7fc61b" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="aspace_aa9d99e53f982148e8d81efb61e67f40" parent="aspace_5698188c1cafada4169f4c3f7e7fc61b" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_08c08b71a5f549bb03c9e539391bf0c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_c8e27cfe3b70673df671446dc0f171dd" level="file">
        <did>
          <unittitle>TML, 43-43 - Choice of Lipid-lowering drugs</unittitle>
          <unitdate type="inclusive">2001 May 28</unitdate>
          <container id="aspace_9867ae5d1905a12dac1cdb46ee0966f3" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="aspace_fbbf371269079fbeaf0c22696c03c68c" parent="aspace_9867ae5d1905a12dac1cdb46ee0966f3" type="folder">4-10</container>
        </did>
        <accessrestrict id="aspace_12c485e70ce77057b564f5f005de3180">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_b12b140d39cce8b86f62018ce31197dd" level="file">
        <did>
          <unittitle>TML, 43-1 - Lopinavir - Ritonavir - A protease-inhibitor combination</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="aspace_b4b85c275e33b54a44cb33c883c0e429" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="aspace_6deb483c8519ca98ce5af22fb4f65ecb" parent="aspace_b4b85c275e33b54a44cb33c883c0e429" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_cb4f314cadf4551b7cb834b70eadf1cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_f3e4fd1faa4faa99ba52ed68b8dde6c9" level="file">
        <did>
          <unittitle>TML, 43-87 - Drugs and vaccines against biological warfare</unittitle>
          <unitdate type="inclusive">2001 October 19</unitdate>
          <container id="aspace_a1eb7f8defde909176179256faa9ddab" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="aspace_95bf6ec3d20afbbc2c2c7ab05c8f0354" parent="aspace_a1eb7f8defde909176179256faa9ddab" type="folder">14-17</container>
        </did>
        <accessrestrict id="aspace_19d192e97e549e2b446276124a3eb6b6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_f8fecc1cfd922fa2df867ba43e2d95e6" level="file">
        <did>
          <unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="aspace_3745e05970f1316f1d58654ff69de761" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="aspace_8ed1ddfd0231c0c5828c796eb8b6549f" parent="aspace_3745e05970f1316f1d58654ff69de761" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_bf0a0b9053f30a04f40935cc85ba1264">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_3283e79cbed2dd24ba8423865f0e23c0" level="file">
        <did>
          <unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="aspace_97a071b51da5dd93b3931ecbed0bde11" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_3648afa0ea71ca1c2c2d2d7500178896" parent="aspace_97a071b51da5dd93b3931ecbed0bde11" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_f2c531fe46fbd0a55fbf3a371d0cfb12">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_b08aa5d6ed86fd5fceee0126fd84fd06" level="file">
        <did>
          <unittitle>TML, 43-9 - Beta-Blockers</unittitle>
          <unitdate type="inclusive">2001 February 5</unitdate>
          <container id="aspace_e8c82935f8a548e05cbfa8521246899a" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_3f4ad6fa3cf8433a18a9cc7dfa341c98" parent="aspace_e8c82935f8a548e05cbfa8521246899a" type="folder">2-6</container>
        </did>
        <accessrestrict id="aspace_6048933eb3a55f5f2d6a90721d4dd65f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_efb930d3872ae9d77c1298a07d7d5921" level="file">
        <did>
          <unittitle>TML, 43-62 - Balsalazide (Colazal) for ulcerative colitis</unittitle>
          <unitdate type="inclusive">2001 July</unitdate>
          <container id="aspace_b2b63b71e742668e08403cc5db3fd639" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_23c2c3c6c9f6895533dc17aa1d03247f" parent="aspace_b2b63b71e742668e08403cc5db3fd639" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_a454b4aa29b54507db7a4b31bd4c8d5f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_b522bd1a5159bd2d2194d2263cc22904" level="file">
        <did>
          <unittitle>TML, 43-11 - Argatroban for treatment of heparin-induced thrombocytopenia</unittitle>
          <unitdate type="inclusive">2001 February 5</unitdate>
          <container id="aspace_10afd29bd7b1bccbceffcf99134fa224" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_1ddf1e0e114bd6dc6f2ea72201bed9c9" parent="aspace_10afd29bd7b1bccbceffcf99134fa224" type="folder">10-12</container>
        </did>
        <accessrestrict id="aspace_a20e6edf2b912e65b1924e6cbfaf7256">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_46514d81205269c17a4b19d49a573235" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_7f9e47c8881a77650fcf39ef1825812c" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_9be5e63f0ec3973c230e5be45b8864a0" parent="aspace_7f9e47c8881a77650fcf39ef1825812c" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_0ac715d063832982eec2283c964a4110">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_6dc4850ed3f15e6085336df184251532" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Osteoporosis</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_85e7b7b69a1b55ed502c26ae640845f0" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_2c314399ab91056c8f9f4b5219a99c5c" parent="aspace_85e7b7b69a1b55ed502c26ae640845f0" type="folder">16</container>
        </did>
        <accessrestrict id="aspace_a5d61d385919f6ecefd5058c2bf3e8d5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_02fc378d7f3b4b93e45c3eef89379858" level="file">
        <did>
          <unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle>
          <unitdate type="inclusive">2001 August 20</unitdate>
          <container id="aspace_541eef4dee08866803ca1857afb1d604" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_a6cadb78fde6e2cf1aa530f4c604a0fe" parent="aspace_541eef4dee08866803ca1857afb1d604" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_a1e5c73ef6115e61a317948cb85a9927">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2c6bff42d1f14c6a829324e9782c498a" level="file">
        <did>
          <unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle>
          <unitdate type="inclusive">2001 August 20</unitdate>
          <container id="aspace_33c8f70d918673384fe6c4208fced8b1" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_0fb2066ca938326e8a7176c4e694cc01" parent="aspace_33c8f70d918673384fe6c4208fced8b1" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_5b52a18cd7491854824957b6528aa161">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_6bf6928a0695a21bf35c621f43a5b338" level="file">
        <did>
          <unittitle>TML - Antimicrobial prophylaxis and Endocarditis - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_0d1fe44c111c18a1d6402fbd33439ec7" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_3f653b49eaab4e292ed631f4ac52c3c5" parent="aspace_0d1fe44c111c18a1d6402fbd33439ec7" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_7c855f662c00758a77e6169900e656ac">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_e83ae1dbb9d2dcd79b2efc11e8415787" level="file">
        <did>
          <unittitle>TML - AIDS - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_6362bff99a4a8df2d95eff1ab0784937" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_72b7ffdf75182c43a3d52018b7687afc" parent="aspace_6362bff99a4a8df2d95eff1ab0784937" type="folder">7-11</container>
        </did>
        <accessrestrict id="aspace_6f3b8da68a968edcf7612c6c7ab0d96d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_c6e64d3eb72280cbc65604fd0d1ef63b" level="file">
        <did>
          <unittitle>TML, 43-91 - Post Exposure Anthrax prophylaxis</unittitle>
          <unitdate type="inclusive">2001 October 29</unitdate>
          <container id="aspace_2eb7a28714fa049a88c034d00930caa3" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_f4434675ba2c386689e71c827c63575c" parent="aspace_2eb7a28714fa049a88c034d00930caa3" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_c107fed35cdd31085f732308990ad842">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_41aa0763a7e36f6ce380706ce01181e3" level="file">
        <did>
          <unittitle>TML, 43-54 - PEG-Intron for chronic Hepatitis C</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="aspace_adb5c006a414dbdf7d9e724e81da283a" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_32b3ac9d2840ea7d503d1869255b7920" parent="aspace_adb5c006a414dbdf7d9e724e81da283a" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_10b78f31b326647359759629918503ac">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_21f79f7c6b4acd8a596b33dacb48841b" level="file">
        <did>
          <unittitle>TML, 43-110 - Insulin Glargine - a new long-acting insulin</unittitle>
          <unitdate type="inclusive">2001 August 6</unitdate>
          <container id="aspace_47b84b9b9fcd5322809d02f908148199" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_4919534e1db027e16eb9343055dc6b81" parent="aspace_47b84b9b9fcd5322809d02f908148199" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_ce544613fec94a632b764ccaa6155e27">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2eed515acb400c24339036029a7a8f49" level="file">
        <did>
          <unittitle>TML, 43-29 - Nateglinide for Type 2 diabetes</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="aspace_d8539fee76a644256a22a09a04c84083" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_44f0616eb72e5058641243e795147fd7" parent="aspace_d8539fee76a644256a22a09a04c84083" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_7bf007b3c2f616cf82e76b675923a0ae">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ccba2cedcccf56cdefa0e205fc19e877" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cancer</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_b528d2eeb37089cd4013a195ae42c630" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_0b569cbe19ed497cc36ed14806f3f478" parent="aspace_b528d2eeb37089cd4013a195ae42c630" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_d687a473729a78247a1c380123065159">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_8b4de852b3dcabc7ad6e003cb57745bf" level="file">
        <did>
          <unittitle>TML, 43-100 - Nesiritide for decompensated congestive heart failure</unittitle>
          <unitdate type="inclusive">2001 November 12</unitdate>
          <container id="aspace_5d53abb6821c29c996b8d97735c02c22" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_a645c93461f9c5d27cb6a14f223abe9c" parent="aspace_5d53abb6821c29c996b8d97735c02c22" type="folder">6-9</container>
        </did>
        <accessrestrict id="aspace_60722a1253dc5c989a1fb84363bf8347">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ae81e26ee03016b7e8a19efe2323b2b6" level="file">
        <did>
          <unittitle>TML, 43-35 - Non-Sedating Antihistamines</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="aspace_9c15e93f4067bed7f662e385b1a16cfd" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_682c3e6688264475d9e25b45ccfd7d1d" parent="aspace_9c15e93f4067bed7f662e385b1a16cfd" type="folder">10-13</container>
        </did>
        <accessrestrict id="aspace_e3c9df3f442f047a5b6b393b36042f5b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ebbf6e65860c02f436f6ca0982c14e3e" level="file">
        <did>
          <unittitle>TML, 43-17 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">2001 March 5</unitdate>
          <container id="aspace_d7e02cc4d13d22722659ec062c69072e" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_1ba3484d15c798ad76340d162a1ad8c5" parent="aspace_d7e02cc4d13d22722659ec062c69072e" type="folder">14-18</container>
        </did>
        <accessrestrict id="aspace_3e2fa8d34c5d3f85b91b8b755235d673">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_dc20397e0f8fc97006ecdf0d5f679b73" level="file">
        <did>
          <unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="aspace_10bf666ee4c3184affb010c57c8e533a" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_4769c7b11fe92635373480cf36c70d03" parent="aspace_10bf666ee4c3184affb010c57c8e533a" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_bedf8436e8ecc88cef43b4466703321f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2a3e11c7291578855058677f583ba4cc" level="file">
        <did>
          <unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="aspace_a0cdab1a4e7f11bcb79b2b8ed4d49207" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_fe6b722cfee1ae5f7408ca0ad7e6400f" parent="aspace_a0cdab1a4e7f11bcb79b2b8ed4d49207" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_1faf2fbe4c747499b17f777c7da8d367">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_7aeba34ec44547fe9581d43a0fc4043e" level="file">
        <did>
          <unittitle>TML, 43-6 - Nebulized Budesonide for Asthma in children</unittitle>
          <unitdate type="inclusive">2001 January 27</unitdate>
          <container id="aspace_d5ebfe575e283e811eb75ac5a3ff945d" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_336003bd6acefe59632622749d649b8b" parent="aspace_d5ebfe575e283e811eb75ac5a3ff945d" type="folder">3-7</container>
        </did>
        <accessrestrict id="aspace_d1f83bcd9d1dba630ab83fe624589365">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9011b2319d9d385461bdca83ff03a269" level="file">
        <did>
          <unittitle>TML, 42-2 - Cool Click - a needle-free device for growth hormone delivery</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="aspace_ad7e662e89594d004de77332b2beb2a0" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_de2606925a5086b96071ca7ac40b8402" parent="aspace_ad7e662e89594d004de77332b2beb2a0" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_d1142cfc576dc71445c5513786f60e47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_43f128e719abd7716a8b552dab41b4ca" level="file">
        <did>
          <unittitle>TML, 43-84 - Cord Blood Banks</unittitle>
          <unitdate type="inclusive">2001 October 1</unitdate>
          <container id="aspace_89ee96a2b3e3eae05dd9438b3d613c71" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_7d4fbc91c39c10148d47b5e5013f722c" parent="aspace_89ee96a2b3e3eae05dd9438b3d613c71" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_d355e32a24f6cffb35162f5a565f8aad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2ca4ec46f32a50a21f55760304d5080b" level="file">
        <did>
          <unittitle>TML, 43-59 - Initital treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="aspace_1251b1a5a503ec9a95624ceec51039d5" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_405616ff4e6700fa39fbf4f56055efb2" parent="aspace_1251b1a5a503ec9a95624ceec51039d5" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_12449f363aa33b967622999d1c656f25">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_f4881e412a79293a02fce06ab7ada62d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_13e89f014b624a9142ee701ec5588a4b" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_5ce4dbd91969e5941861573c39fc9a8f" parent="aspace_13e89f014b624a9142ee701ec5588a4b" type="folder">17-20</container>
        </did>
        <accessrestrict id="aspace_762520a711ae5cf2f881c37d75c585e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_076a7f8b55c4644de3dc62c6db843a72" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_f24c009b7d4818ae71b8625b2013d30a" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_57a5051fb7fa3ab71d76d31a9c477647" parent="aspace_f24c009b7d4818ae71b8625b2013d30a" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_0e6e931602cabb1fe060a758f1e09d3e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_98d5e522f0e12ef676f68b6296b375c4" level="file">
        <did>
          <unittitle>TML, 43-61 - Lung Cancer screening</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="aspace_2be64508416f17df1c1d211869241bda" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_133ab4550c8db77cffc4d0152d42890e" parent="aspace_2be64508416f17df1c1d211869241bda" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_1fa9376a18b8cabf3a1ced8db4bc6995">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_bbfbf04fd92af083cfe5f2803138df54" level="file">
        <did>
          <unittitle>TML, 43-7 - Mirena</unittitle>
          <unitdate type="inclusive">2001 January 22</unitdate>
          <container id="aspace_da14cd42cd3fb8c73e0484586e7ec554" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_55a8943229ea5097ba4f491ee7efef04" parent="aspace_da14cd42cd3fb8c73e0484586e7ec554" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_6eb2c131de0d820a3d57bfd6b90300e6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_3b86dfd5896dc8ed385111ad16cbd218" level="file">
        <did>
          <unittitle>TML, 43-109 - Darbopoetin (Aranesp) - a long acting erythropoietin</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="aspace_bf948c4d338110ada75a7997dfdb6ead" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_2c035456faeaafeb4ceaa6f96bffdad6" parent="aspace_bf948c4d338110ada75a7997dfdb6ead" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_f505d3982f99b3e642ccbf40fbd75883">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f9927bdf850374dd901cc030c68dc7c" level="file">
        <did>
          <unittitle>TML - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">2001 April 6</unitdate>
          <container id="aspace_b6f396328a6c99743d6b63bb7704e59c" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_48be1ade649b958362a2e6437a4edd99" parent="aspace_b6f396328a6c99743d6b63bb7704e59c" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_6be4b2a90096d23f4c7270994aa74f17">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_97fc093a6a8e4909bb2c604168b0b754" level="file">
        <did>
          <unittitle>TML, 43-58 - Caspofungin (Candidas) for aspergillosis</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="aspace_195ddacb189407057d3a221b9318c9cc" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_cbb0a0b9ebe677d02df0a5bdddb55f81" parent="aspace_195ddacb189407057d3a221b9318c9cc" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_f836855e02f4d6fe9f63b628886a4c85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_6da20ff4a72dc0604ae511c5634291e7" level="file">
        <did>
          <unittitle>TML, 43-55 - A new snake antivenin</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="aspace_37388ba5323ed0a7fa90dfdf8ebf1177" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_66a6268d11b306c24faa27a092140fa1" parent="aspace_37388ba5323ed0a7fa90dfdf8ebf1177" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_f08173f37c2607c4d273372be7fedab1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ede8d569017eb650ffb86947aa817ebe" level="file">
        <did>
          <unittitle>TML, 43-110 - Zometa (Zoledronic Acid) for injection</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="aspace_7f637067c13eda86ad1b711a3b7cdc26" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_2a2145b3fbe5b353b64ac6e5dca6e4be" parent="aspace_7f637067c13eda86ad1b711a3b7cdc26" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_3a54c329c0d6d0bc229bdd0616332d9d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_a2f1959db87c3ed2aeb2a70eafd0d767" level="file">
        <did>
          <unittitle>TML, 43-51 - Ziprasidone (Geodon) for schizophrenia</unittitle>
          <unitdate type="inclusive">2001 June 11</unitdate>
          <container id="aspace_41bca7e4d98519ad33f564d2cd113928" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_3de8407cdb0b09332e310da0d71adc11" parent="aspace_41bca7e4d98519ad33f564d2cd113928" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_810ad5d825ba01f69c55af09b52e33af">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_8068f52546b65b321ac2f5fa6a731f4c" level="file">
        <did>
          <unittitle>TML, - Drugs for depression and anxiety</unittitle>
          <unitdate type="inclusive">2001 February 14</unitdate>
          <container id="aspace_797653428697bbe377a7e11ded6eab81" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_b912fefeb9551893e5320f26a22592db" parent="aspace_797653428697bbe377a7e11ded6eab81" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_67940cb71724cb07bb1c047808a223cf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_55a8ca16b598343eb87537a2d296ecd1" level="file">
        <did>
          <unittitle>TML, 43-15 - PC-Spes</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="aspace_bdd333c924c0bb0a144b9b0709749265" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_1bb6ef723b7fb24993a7f61e4f847459" parent="aspace_bdd333c924c0bb0a144b9b0709749265" type="folder">11-12</container>
        </did>
        <accessrestrict id="aspace_75c2794ebd1f11660bcef03019daccd2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ebe0e5315e3cdfa6495aed9cdada44d6" level="file">
        <did>
          <unittitle>TML, 43-83 - Metadate (Extended-Release Methylphenidate)</unittitle>
          <unitdate type="inclusive">2001 October 1</unitdate>
          <container id="aspace_9a4fba20948eb93f4b2aed80c1c1ab05" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_b25158e17dbf3a32acef9c2e6e1b299f" parent="aspace_9a4fba20948eb93f4b2aed80c1c1ab05" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_07f8b933648e23ed47138c1bef096df8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_833ebff3fb7c7c45c0c064414304d04f" level="file">
        <did>
          <unittitle>TML, 43-49 - Gleevec (STI-571) for chronic myeloid leukemia</unittitle>
          <unitdate type="inclusive">2001 June 11</unitdate>
          <container id="aspace_19fd7e564a5aed94d8001932299fd1b1" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_b6f0cf6d2a085d535c42ecf8d4d83668" parent="aspace_19fd7e564a5aed94d8001932299fd1b1" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_8a48c9bb323707808cd2699c098b90df">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_e579c81ba72fe1f002ea554c42ec0eb7" level="file">
        <did>
          <unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="aspace_e7f5522e82e107317fccfce8faf1c6cb" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_9ddcf66e6f04c9d32a609f9c0c17e21e" parent="aspace_e7f5522e82e107317fccfce8faf1c6cb" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_5b72b0c715fd854e87ba957e71353a88">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2c8e55774a1bb77e5eb47e4cd5592dca" level="file">
        <did>
          <unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="aspace_fd3a17cf4f17119cd08978a2bc7bf8ef" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_15cffe281c8dff60a0ee7447ea80b959" parent="aspace_fd3a17cf4f17119cd08978a2bc7bf8ef" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_45e2eef135b65b2a4bc8bfac6895eae6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_a3e98844edbadfd1126f96dcee9fa072" level="file">
        <did>
          <unittitle>TML, 43-89 - Insulin Aspart - a new rapid-acting insulin</unittitle>
          <unitdate type="inclusive">2001 October 15</unitdate>
          <container id="aspace_968ab6cc8295e92f2a122563499c5f29" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_d76a71a7fd30b3f2ec4d945b6dd396c3" parent="aspace_968ab6cc8295e92f2a122563499c5f29" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_95db9e419544c222951aae12dd139e45">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2330e815d4bdfd9c12c459306864dcca" level="file">
        <did>
          <unittitle>TML, 43-103 - Drugs for HIV infection</unittitle>
          <unitdate type="inclusive">2001 November 26</unitdate>
          <container id="aspace_5fb4470cf9592e0e893a1ec671740068" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_786a736f8ec562bfc02719b54144f0d0" parent="aspace_5fb4470cf9592e0e893a1ec671740068" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_ba5d1519c239af0bb83357cd9431cc00">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_c9e718e37292bcb43f7c0f24dd8175bb" level="file">
        <did>
          <unittitle>TML, 43-26 - Once-a-Week Alendronate (Fosamaz)</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="aspace_71c3020af2b0c014720cd4e37fa0e9b8" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_31adc61303756a02f745b28324e9df28" parent="aspace_71c3020af2b0c014720cd4e37fa0e9b8" type="folder">8</container>
        </did>
        <accessrestrict id="aspace_3aaad115d37c1f7c6a8b419cea0284e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ce9f44342b0f523de0bfcb639e0134e8" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Migraine - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_02c8e4309d6bd292c928a1be3a99393e" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_d6d07e4eb713cff9f7b11da464fb76fe" parent="aspace_02c8e4309d6bd292c928a1be3a99393e" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_9d4ad8765f4f79883181f256eb7f9879">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_8c50daa78ebe0875cf14c75e503ea1c1" level="file">
        <did>
          <unittitle>TML, Drugs of Choice - Pain</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_9f8027241bc2bb910de6bdc25b4b69fe" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_0368e251654b540e28486e4073ccda65" parent="aspace_9f8027241bc2bb910de6bdc25b4b69fe" type="folder">11</container>
        </did>
        <accessrestrict id="aspace_3b2728fff814b6aa47a93b6386e34381">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_468e734f765a9be3853dd86c21c17c5d" level="file">
        <did>
          <unittitle>TML, 43-25 - Direct-to-Consumer advertisements for Glucophage XR</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="aspace_de377386b556c16a5d13e7cf9b685693" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_788201100a325bb07ab9ae93b8baedd1" parent="aspace_de377386b556c16a5d13e7cf9b685693" type="folder">12</container>
        </did>
        <accessrestrict id="aspace_82bce5eadd0f640bbbd014ce96f624b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_d63b61dd440fbe48748ed3adaaa153a3" level="file">
        <did>
          <unittitle>TML, 43-13 - Palivizumab update</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="aspace_e7465c338bf699f92b722e75991e8dcc" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_701f9dde7985409b24d101e55f4bb476" parent="aspace_e7465c338bf699f92b722e75991e8dcc" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_a7dd4884d34880dfc26867a2d2428bf1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_07c5a88addbecee925056539789a95ce" level="file">
        <did>
          <unittitle>TML, 43-14 - Tinzaparin for treatment of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="aspace_da482a3ffc53690c9d451a26d752d7bc" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_deb4ad2e0c1781269f68c69d35f0993d" parent="aspace_da482a3ffc53690c9d451a26d752d7bc" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_e9948bb5cd6966ff6405e6dc4196d47e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_3c99102c3cbe6573776800745f8ae469" level="file">
        <did>
          <unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="aspace_f1da3f9a947baca8bc301456d903df89" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_d32be74458b4f298415119343bc95c8d" parent="aspace_f1da3f9a947baca8bc301456d903df89" type="folder">18-20</container>
        </did>
        <accessrestrict id="aspace_0e83e8dd8e86709df7f972ac81515598">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_c6baca4f86fe997597684780a50afb04" level="file">
        <did>
          <unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="aspace_dda64d568f3d086f51185284f35d8cff" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_74af30fefda0f825f4e82970ec968ca5" parent="aspace_dda64d568f3d086f51185284f35d8cff" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_a04d9293e94b60a9e39c9b4189abc925">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_21563c371ed6d15964e3cc6b122e8325" level="file">
        <did>
          <unittitle>TML, 43-31 - Advair "Diskus" - A combination of fluticasone and salmeterol for asthma</unittitle>
          <unitdate type="inclusive">2001 April 6</unitdate>
          <container id="aspace_a9a39574ce22b541ba2eea8bd24d9bb3" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_31750c5a60df2e77b59c67557fbdb87b" parent="aspace_a9a39574ce22b541ba2eea8bd24d9bb3" type="folder">2-5</container>
        </did>
        <accessrestrict id="aspace_591f5ce0464ac805e58c930e1f206114">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_a56fc8ba008f5ec96cb059f94525d216" level="file">
        <did>
          <unittitle>TML, 43-5 - Fluoxetine (Sarafem) for premenstrual dysphoric disorder</unittitle>
          <unitdate type="inclusive">2001 January 22</unitdate>
          <container id="aspace_5f6c9e6fd4854f68541605deb311f961" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_6522d238e38576581d5486fa64aeae4f" parent="aspace_5f6c9e6fd4854f68541605deb311f961" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_516c40c3c42f23a1ef834fac3280423d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_29dd0d00d8ca1ffa9497a61ade7fcac7" level="file">
        <did>
          <unittitle>TML, 43-57 - Levothyroxine</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="aspace_d39690b2f5088706630c062deca8f63b" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_9250e76ce2724dbee75ebc0c2d829244" parent="aspace_d39690b2f5088706630c062deca8f63b" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_5e4d50d8e1cee2179d409a4d58ebfe39">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_d2d95b76affb3a4c9b22a381ae08576d" level="file">
        <did>
          <unittitle>TML, 43-28 - Detrol LA and Ditropan XL for overactive bladder</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="aspace_053e697edc3ee61ed0c5de558ab441cc" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_7ed158f9bf77bf8f401e5d990d68e053" parent="aspace_053e697edc3ee61ed0c5de558ab441cc" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_c2a600b167a1d8ec49922e49f096e4ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_bf76f78ab4a4977fe44b60003b8f05f2" level="file">
        <did>
          <unittitle>TML, 43-27 - Prozac Weekly</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="aspace_b77f70c46cbebabcb74f15503c8d1240" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_87293598b02020512adc8c1318e018b2" parent="aspace_b77f70c46cbebabcb74f15503c8d1240" type="folder">14</container>
        </did>
        <accessrestrict id="aspace_154ff78d3302dfb71a0c20f63e7f510f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_d6b0a2f70273ff0516f8b345cdc4f512" level="file">
        <did>
          <unittitle>TML - Drugs for migraine</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_340d279e3034ea26223f32d63f15e095" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_0b36ad99ec285ed293d16f8bd173491a" parent="aspace_340d279e3034ea26223f32d63f15e095" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_81584269571599c2534c39747bee7f6e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ab3c9b20ba673d3a09626a2131dfbd70" level="file">
        <did>
          <unittitle>TML - Drugs for migraine</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_b937944a1fa3da7946fbb8b0e04e1206" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_659916526a28226f117ed84e3ef82afe" parent="aspace_b937944a1fa3da7946fbb8b0e04e1206" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_33ca4d5589e42adbdeba4c14888b39e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ce9d0ae7e21eaea0c4687dae309cfee9" level="file">
        <did>
          <unittitle>TML, 43-67 - Twinrix - A combination Hepatitis A and B vaccine</unittitle>
          <unitdate type="inclusive">2001 August 6</unitdate>
          <container id="aspace_e7a4e238478677afc3b8525c8200af8e" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_f7f80f353a6db3cd4557020c21618bca" parent="aspace_e7a4e238478677afc3b8525c8200af8e" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_c860c07bca67d0f682cba26ca6577767">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_50348bc86f79794dd7d3880f772dc9fb" level="file">
        <did>
          <unittitle>TML, 43-81 - Influenza prevention 2001-2002</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="aspace_ac00729048c9d771c17730326e5d839f" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_505b14bd2a2a88c3349ea2390ee7328c" parent="aspace_ac00729048c9d771c17730326e5d839f" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_1bbd28b63a91d7783c47a3da12aa5197">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_3b16d2ad8da51e66ff96ab39df1d0aac" level="file">
        <did>
          <unittitle>TML, 43-33 - Topical tacrolimus treatment for atopic dermatitis</unittitle>
          <unitdate type="inclusive">2001 April 16</unitdate>
          <container id="aspace_fe03d7e58db0046c7737b69e07dfec94" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_9ed5cfbb320a895c784c9ed0dba7fe0c" parent="aspace_fe03d7e58db0046c7737b69e07dfec94" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_524857adc52fa0f183b069d3ae7050b5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_41122ea5a6e7981f0132dc387c47d526" level="file">
        <did>
          <unittitle>TML, 43-42 - Glucowatch Biographer - A noninvasive glucose monitoring device</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="aspace_346d3093ef17acbec6a49d0509d11f50" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_ae94b8bd42d9e32b3a71fbfffaf14826" parent="aspace_346d3093ef17acbec6a49d0509d11f50" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_8a2f04b8e85fd19c93d31127f994912c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_1f33fb25dbc24b2e3a9cc4123daa4b4c" level="file">
        <did>
          <unittitle>TML, 43-99 - Cardiovascular Safety of COX-2 Inhibitors</unittitle>
          <unitdate type="inclusive">2001 November 12</unitdate>
          <container id="aspace_aeeaab403538434049688eae09c8a509" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_77d19ca220051c8ba2e9ec9977811c8d" parent="aspace_aeeaab403538434049688eae09c8a509" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_ed26092ce8449e46cf63b80b2a291816">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c5905505fca4831e512fb2648100be7" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Hypertension and Heart Failure</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_6eeefd9af7f10811aeab1fe2be8e40cf" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_8d1fde00e402ea304cbff0e520e35887" parent="aspace_6eeefd9af7f10811aeab1fe2be8e40cf" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_75c6bb282a1bebd46a6a30af50403e35">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_d83158c1d6d2339140e8e837daa705b4" level="file">
        <did>
          <unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="aspace_df872c5b5b118c452167b1110947b2b9" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_4d17c095e7ce3d083fd41b76029fb6b9" parent="aspace_df872c5b5b118c452167b1110947b2b9" type="folder">19-21</container>
        </did>
        <accessrestrict id="aspace_a70ce5ed30190ec1d7686f21b89b6372">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_45a1a372dc6189c488cbf6dbf95adb8d" level="file">
        <did>
          <unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="aspace_a6f56bcc00c2bc7bbd5d782fb86dccab" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_b772529251082b8e7ea38a0e8d8c84ee" parent="aspace_a6f56bcc00c2bc7bbd5d782fb86dccab" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_a1903924a041556ee7b26f4c2b26ac5e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_4cdec89511203afd4fe2dc98bb7107a3" level="file">
        <did>
          <unittitle>TML, 43-3 - Drugs for Vulvovaginal Candidiasis</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="aspace_86b653f50337c4ad9b5fb909f3521d11" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_600b20ea67075ab658fe65527564a790" parent="aspace_86b653f50337c4ad9b5fb909f3521d11" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_721d15062edf16474f8c9615e7343c9b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c93f14bdbe03244367dc9260f841c8a" level="file">
        <did>
          <unittitle>TML, 43-40 - Epoetin - Erythropoietin (Procrit; Epogen) Revisited</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="aspace_fd2bc3a5cf7ed06fa84b93f69a06a3cd" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_4d5cdca56393e81a6ba2891b0d880d49" parent="aspace_fd2bc3a5cf7ed06fa84b93f69a06a3cd" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_0834865471315b83cd87445af0b5d964">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_8c1db8b64ee78c1dea2315fd90476615" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_5d28baaa77f69734fa78d1d9bee56cc0" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_08159db2e000d4a3de9a0601dfc04ff0" parent="aspace_5d28baaa77f69734fa78d1d9bee56cc0" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_0b08c7f91d343d75d562eb65c74f54bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_42c85fbc002a3352f01a11a7e4a6f54d" level="file">
        <did>
          <unittitle>TML, 43-36 - Esomeprazole (Nexium)</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="aspace_c49f398321e5d1149ed1595b2e83979c" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_2396c9e5492ca09653d052a917e69821" parent="aspace_c49f398321e5d1149ed1595b2e83979c" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_cc2db5a946dc97445662edf403135cfe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_dde7a8f4a1c15dd762a0160728804b73" level="file">
        <did>
          <unittitle>TML, 43-111 - Update on glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="aspace_d20fce10875ec1f68a83782191f8412e" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_8aa9797a4d71733498e8af974c65391d" parent="aspace_d20fce10875ec1f68a83782191f8412e" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_5b2a4f2cbe109ddd0b02adec46206e8d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9666394f9b7e1594ab6d9d740833bf6d" level="file">
        <did>
          <unittitle>TML, 43-53 - Galantamine (Reminyl) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="aspace_b1fd65077a634d8455482ec331bef672" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_b5df592222d393be6d1ea78dab9107f9" parent="aspace_b1fd65077a634d8455482ec331bef672" type="folder">18-20</container>
        </did>
        <accessrestrict id="aspace_64351c947d34d22cef39ad4007296824">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9e514faa1eb026a69873e6b610137535" level="file">
        <did>
          <unittitle>TML, 43-80 - Oxycodone and Oxycontin</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="aspace_f50b4a50fb58fbcc5c43f7bcfb1ccd9f" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_181b96d19914ca9b021a10369590ed49" parent="aspace_f50b4a50fb58fbcc5c43f7bcfb1ccd9f" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_71c26f172f9a9a3876c7b24d11cc0db1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9bf44e00458f50d0ecc17dc1d13c078a" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Asthma - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_23f75f7a676962c945424bbaecf093ae" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_692b160049549acba960a800df1c25a9" parent="aspace_23f75f7a676962c945424bbaecf093ae" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_753a55d97a80d113ee2476718a3d1661">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_0dc13b68cd4edd9b7be7bd34aad97ff0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Hypertension - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_06e6912165e02ad09f3e0d5cb18d08fb" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_9e215877780dd57722414b5fff038d41" parent="aspace_06e6912165e02ad09f3e0d5cb18d08fb" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_d504ebc62c5421f5e1d907042650019a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_28985057e383ceb12ff871b5d26e61da" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_556cf8c923673452f307b7c5acc4c220" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_e845f13c913dd7baefe35e05366c6aaf" parent="aspace_556cf8c923673452f307b7c5acc4c220" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_22fbfc715602ec37fdf0114b7cb13cbe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_e9eaa9b717e217af3529d05e6f9fbd9e" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Arthritis - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_70d361a9bc8a631dacf38e4f6edf741c" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_96f57fe69c7ffd13104d0023e0617c1e" parent="aspace_70d361a9bc8a631dacf38e4f6edf741c" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_b5d06faa04330361ca1ca75b21c017fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_a8579ee641a8d372e5b92c341780d2f0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Depression and Anxiety</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_c8f6eed7dd7fe2b61f017d2d6424130d" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_af20730e05276e910aed7be3aaf8e201" parent="aspace_c8f6eed7dd7fe2b61f017d2d6424130d" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_85e3914a93c77fea32c035bd079cdf38">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_d1091da187ca03263e9fbe06a0c8e8b9" level="file">
        <did>
          <unittitle>TML, 44-105 - Adefovir (Hespera) for chronic Hepatitis B infection</unittitle>
          <unitdate type="inclusive">2002 December 9</unitdate>
          <container id="aspace_33f1ee51c3fb123ee9295caca4c090c1" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_1d706eae6cbd9336fd1f792f568a27ff" parent="aspace_33f1ee51c3fb123ee9295caca4c090c1" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_5e9a358af553725b2b7a0e754e583db4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_a52ad11ec1e3f4d9273267e959212194" level="file">
        <did>
          <unittitle>TML, 44-67 - Alosetron (Lotronex) revisited</unittitle>
          <unitdate type="inclusive">2002 August 5</unitdate>
          <container id="aspace_c3d4327a4e4218e7f4e70ff53b309030" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_03dcee02b628d1eed6cc026aaa9f9505" parent="aspace_c3d4327a4e4218e7f4e70ff53b309030" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_44f937981b03e47fe5b48832e2bc3c06">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_524bcd1ef0983fc228db57fdceccbd8a" level="file">
        <did>
          <unittitle>TML, 44-1 - Prevention and treatment of injury from chemical biological warfare</unittitle>
          <unitdate type="inclusive">2002 January 7</unitdate>
          <container id="aspace_025a011ccc35e827ce22ab6061850567" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_24ccc4d16f2b75baa02e43fa2d5562d3" parent="aspace_025a011ccc35e827ce22ab6061850567" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_41a008738c8b0cf8972cf6b24432d838">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_bad1e6f9e4ec0f760e77c31253787c34" level="file">
        <did>
          <unittitle>TML, 44-18 - Anakinra (Kineret) for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="aspace_70f20324748cea5d86a56901d1d138e8" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_dbf1a42e0734710a7e500917c13322ab" parent="aspace_70f20324748cea5d86a56901d1d138e8" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_5283c1dbc9ae363bd049db90b8c9f8d8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_ba78803aaafb030f1962308400163490" level="file">
        <did>
          <unittitle>TML, 44-19 - Almotriptan (Axert) and Frovatriptan (Friva) for migraine</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="aspace_a6b64eb86f21b29a2ed662473996b725" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_078c03d472c88ae5e15805b5156a16b8" parent="aspace_a6b64eb86f21b29a2ed662473996b725" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_261eac7e701cc4253a133eadd4895b0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_bb6077375b3a6ffeb4bb53556a4f4c3c" level="file">
        <did>
          <unittitle>TML, 44-110 - Hemolysis from Ceftriaxone</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="aspace_a80fe9d80a1f7dc989a52ec246d74a9c" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_d0411e94ded5b6f49f215d699291065a" parent="aspace_a80fe9d80a1f7dc989a52ec246d74a9c" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_06663a53b51c9f32469146874e6a53fd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_a4e45a144c74f16ab14378047e5576f1" level="file">
        <did>
          <unittitle>TML, 44-6 - Budesonide (Entocort EC) for Crohn's disease</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="aspace_2eae3f99df5f20f3c20cb19d33ad4242" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_9b1d67e4bfd50b705c1bcfc92d812b11" parent="aspace_2eae3f99df5f20f3c20cb19d33ad4242" type="folder">20-21</container>
        </did>
        <accessrestrict id="aspace_344623fd522ad204005bd4713a3a7eaa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_9f13d0adec34e41920a5e68ddd64292c" level="file">
        <did>
          <unittitle>TML, 44-109 - Dustateride (Avodart) for benign prostatic hyperplasia</unittitle>
          <unitdate type="inclusive">2002 December 23</unitdate>
          <container id="aspace_284575a829b8eed99191eb1e809082da" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_46a0c8bbac60f48e68bf92c8da960e20" parent="aspace_284575a829b8eed99191eb1e809082da" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_867284bb3e82161ed3ce13cf85bb50cf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_9263ee3a396996d1f6c92f91c990e8b4" level="file">
        <did>
          <unittitle>TML, 44-55 - Yasmin - an oral contraceptive with a new progestin</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="aspace_039daaad9a74306c74d78fdecc1c6660" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_840db64dccdaadf96de659885931acdf" parent="aspace_039daaad9a74306c74d78fdecc1c6660" type="folder">2-7</container>
        </did>
        <accessrestrict id="aspace_c400e4bb55cfe7ea165cfb2d2dc99c6b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_fec2a29720e66cc581b066877ffa632d" level="file">
        <did>
          <unittitle>TML, 44-8 - Othro Evra - A contraceptive patch</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="aspace_bbc41e2aa91a53741553c1e2b1307609" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_566517aef2767258f7823352e3f91d95" parent="aspace_bbc41e2aa91a53741553c1e2b1307609" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_f89be5a42a6e7c9142c05161a1bb4330">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_ea19cfea9c41aa789e87a27139849cc9" level="file">
        <did>
          <unittitle>TML, 44-42 - Copyright violations</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="aspace_4cb7c449272239b787c455c5d93e3ca9" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_54fcc90f692586609858a90b225b42e0" parent="aspace_4cb7c449272239b787c455c5d93e3ca9" type="folder">10</container>
        </did>
        <accessrestrict id="aspace_ec1aa5a5bbffa7071d0ee4e1725ec096">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_573b9aa7949c2b6064549d58f22d1ef4" level="file">
        <did>
          <unittitle>TML, 44-89 - Generic drugs</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="aspace_fd2f28f42ae4a3b14e2739255ee294db" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_92dde4f1afbc33d190a65409ba0c9e18" parent="aspace_fd2f28f42ae4a3b14e2739255ee294db" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_5b1243a2f3ac837601682945b4ad6a9e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_eca6e6e8880da77ade266c114c4c3ef8" level="file">
        <did>
          <unittitle>TML, 44-77 - Gefitinib (Iressa) for advanced non-small cell lung cancer</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="aspace_4349da6f8071d9ccd203426e638b21cf" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_e86bd2e7c180a1ce43c2ff707b01778f" parent="aspace_4349da6f8071d9ccd203426e638b21cf" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_e52979497dde6f1c31a59d9d3764a403">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_a5125bf7e9b481c9cf3b474c751ee55e" level="file">
        <did>
          <unittitle>TML, 44-103 - GHB for nacolepsy</unittitle>
          <unitdate type="inclusive">2002 December 9</unitdate>
          <container id="aspace_693a88c5a27a59a6c83fc77bbc6178ad" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_25730c0e3f63534fabe3629d3d73844a" parent="aspace_693a88c5a27a59a6c83fc77bbc6178ad" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_0fce222a44f0f4d669d6446bfe4d0948">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_5f1f43a60e3a918e61f1524dd78e1670" level="file">
        <did>
          <unittitle>TML - Fungal Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_496eecb72c6971ceb6b1cfab2f793f16" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_d3692e3a92aa5bc0127b4446605480f0" parent="aspace_496eecb72c6971ceb6b1cfab2f793f16" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_43b31e9dd0e56b4393c587638541da8a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_d0277fd8830f2d769496c88f15bb859c" level="file">
        <did>
          <unittitle>TML - Fungal Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_7ea2a4a18cd1b5c7fa08610497c302ac" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_a54241b9c925bddafc4f3c2186431aa1" parent="aspace_7ea2a4a18cd1b5c7fa08610497c302ac" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_0374c695f899676ae2f0f4ab46c32079">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_38f15317a1ab04ccab7ddf87c59865ca" level="file">
        <did>
          <unittitle>TML, 44-65 - Fulvestrant (Faslodex) for advanced breast cancer</unittitle>
          <unitdate type="inclusive">2002 July 22</unitdate>
          <container id="aspace_20e9cf546a8868464246adc9fa78b39f" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_b1704352d911afd4b3be3db07cb60137" parent="aspace_20e9cf546a8868464246adc9fa78b39f" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_ce879f9aa1fe59c4646fb8a958d249d1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_c2dd44962d67176662e4db78dd0a66d1" level="file">
        <did>
          <unittitle>TML, 44-5 - Cefditoren (Spectracef) - A new oral cephalosporin</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="aspace_b687112ec75662c2d36b1f1c78c23fea" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_aaa2cf7de35d01bc46a123da41e9cdd0" parent="aspace_b687112ec75662c2d36b1f1c78c23fea" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_a137a040fd97e7017313ae9a82d2fe86">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_70993f6f906adca6d28b7cec87c5cbab" level="file">
        <did>
          <unittitle>TML, 44-93 - Drugs past their expiration date</unittitle>
          <unitdate type="inclusive">2002 October 28</unitdate>
          <container id="aspace_fc857cb589531b94ff45d695902c82f5" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_1caa605af767bd3178681c00a93aa41c" parent="aspace_fc857cb589531b94ff45d695902c82f5" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_e06690c5813977cdcc6c8a5a7653718f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_f9bc602671296cc3d2de922401f1986e" level="file">
        <did>
          <unittitle>TML, 44-83 - Escitalopram (Lexapro) for depression</unittitle>
          <unitdate type="inclusive">2002 September 30</unitdate>
          <container id="aspace_05c56cf1e8859e19a0c5baf1d6e457dd" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_7ebea50417279a06ac2ee827aa391b18" parent="aspace_05c56cf1e8859e19a0c5baf1d6e457dd" type="folder">11-12</container>
        </did>
        <accessrestrict id="aspace_fdb13be24c2193fa8c3289e7d5ad654a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_88bf2c423e244a87d79645badbf2e9f3" level="file">
        <did>
          <unittitle>TML, 44-43 - Fondaparinux (Arixtra) - a new anticoagulant</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="aspace_759684b22e9c8a9c2d354ba754e4cf60" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_140f2645d9f3fb07670eb6e5778add3b" parent="aspace_759684b22e9c8a9c2d354ba754e4cf60" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_bbbdd53df2b8ebd0612902a21d46a748">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_05b64e3022467a23598c9201bc74dfdf" level="file">
        <did>
          <unittitle>TML - Cefepime</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_6a56d05a8345ab93499b668709653373" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_40473528ffb193eb3ffa5ea4d0ba8b2a" parent="aspace_6a56d05a8345ab93499b668709653373" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_394b3115bcff39760eac5c39dc81bdb6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0b79a2b45ac5a48beb03988b3255f34c" level="file">
        <did>
          <unittitle>TML, 44-126 - Eratapenem - a new parenteral carbapenem</unittitle>
          <unitdate type="inclusive">2002 March 18</unitdate>
          <container id="aspace_464f64c0e92700ba9063821088078080" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_4355d2eb2d4f69110b3ec756030a5acd" parent="aspace_464f64c0e92700ba9063821088078080" type="folder">19-21</container>
        </did>
        <accessrestrict id="aspace_556a688586b09ef7523a269879e4d606">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_2ab8dcb85ae9ce0ddd2d1fdc51a02ee6" level="file">
        <did>
          <unittitle>TML - Echinacea</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_7adac82993590f809b904bbcfe0bcbbb" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="aspace_9388f55678739425e762f0c77cfc89e8" parent="aspace_7adac82993590f809b904bbcfe0bcbbb" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_dc18fb2ef4fb05f2fdaba6355d199ff6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_af85bd11efe07fd729751c8c218f32d2" level="file">
        <did>
          <unittitle>TML, 44-47 - Botulinum Toxin (Botox Cosmetic) for frown lines</unittitle>
          <unitdate type="inclusive">2002 May 27</unitdate>
          <container id="aspace_cd655060885abe024213d788df6bcbf4" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="aspace_de9eff061d73b7635be01a52d3c34411" parent="aspace_cd655060885abe024213d788df6bcbf4" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_e67c688500af00baeca0146003fa4b6f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_45aa8fe42fd0ddc4536be77350df4b57" level="file">
        <did>
          <unittitle>TML - Fungal Infections - Reprints</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_970a9f7d7c28b65674f720b6eac71cfd" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="aspace_2d4b78bc5d6c8f4c78f020ea4c66cdd1" parent="aspace_970a9f7d7c28b65674f720b6eac71cfd" type="folder">7</container>
        </did>
        <accessrestrict id="aspace_1f1099e38699970b363bae0c6975a70b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_2e47b4ee1607009a90bcdea23b07a404" level="file">
        <did>
          <unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_069276c7a75d6f0f01f5e06a61d9df52" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="aspace_79ae97446d8724c1e756f008370f20fb" parent="aspace_069276c7a75d6f0f01f5e06a61d9df52" type="folder">8-19</container>
        </did>
        <accessrestrict id="aspace_831283e78ef78563e6f6b9e3060a60fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_f41b47c09c3e11ca72cf6fe9fcfca8b2" level="file">
        <did>
          <unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_90b645e213217ce9833478776f133da7" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_551ed069bbdb8b273e2e81f75b7b92ac" parent="aspace_90b645e213217ce9833478776f133da7" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_37075cc131616efa32d821ddec70e19a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0785dbde88fe25acb019e68e53796851" level="file">
        <did>
          <unittitle>TML, 44-73 - Neotame - a new artificial sweetner</unittitle>
          <unitdate type="inclusive">2002 August 19</unitdate>
          <container id="aspace_4aea509c19f69a6f99df6c1d94d99a65" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_fbb445588f04af52b15cf35686515f10" parent="aspace_4aea509c19f69a6f99df6c1d94d99a65" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_423a699022dfc41e5a19356b8ede358f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_daec721a5877ed667e3be025c5b3972b" level="file">
        <did>
          <unittitle>TML, 44-95 - Valacyclovir (Valtrex) for herpes labialis</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="aspace_4fbc58c5ecfe94492abe8bf6075e3e0e" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_50aa6515459185ee2745d33f5e617e77" parent="aspace_4fbc58c5ecfe94492abe8bf6075e3e0e" type="folder">5-6</container>
        </did>
        <accessrestrict id="aspace_65275a0edfafc2779f6f3b12b167613d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_daaa98dacc14a33f7dd8c3607f43fabe" level="file">
        <did>
          <unittitle>TML - Drugs for prevention and treatment of postmenopausal osteoporosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 November 1</unitdate>
          <container id="aspace_5cca72f8c4592c761d8d596d8f12a5de" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_870b15220a201e25fa579f2844828a26" parent="aspace_5cca72f8c4592c761d8d596d8f12a5de" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_66fca14cfc643877b243d938549ef683">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_6c5c80d095e7afd1c721854326e0f8cc" level="file">
        <did>
          <unittitle>TML, 44-9 - Drugs for Non-HIV viral infections</unittitle>
          <unitdate type="inclusive">2002 February 4</unitdate>
          <container id="aspace_aac6682a8819a774fef4f4792cfe3eb6" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_a056e097c751a9566d3024e5fa0c6a40" parent="aspace_aac6682a8819a774fef4f4792cfe3eb6" type="folder">11-17</container>
        </did>
        <accessrestrict id="aspace_bdf05fc38d86db9b72f37658b33c4730">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_bcfed60146a9353c15a7810e066eb562" level="file">
        <did>
          <unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="aspace_32eb1d56e8fba1ea2c8a39c6a8152c4e" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_5ea37b2544f765f9fc120acd50123e81" parent="aspace_32eb1d56e8fba1ea2c8a39c6a8152c4e" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_3f36d4c0ac7dd42dca225464d90a4a7b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_26f9f680797154013e700d36b1ee02cc" level="file">
        <did>
          <unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="aspace_91e045b7f7c4a4ed4de9e5fcbc96299a" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="aspace_bd59bf99d0d9e9ed6fd77b506f802303" parent="aspace_91e045b7f7c4a4ed4de9e5fcbc96299a" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_538e6db36155fc336b5cd7453b267830">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_87edb03339d8ce2c8587c9b08fa0c33c" level="file">
        <did>
          <unittitle>TML, 44-52 - Tazarotene (Tazorac) for acne</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="aspace_06469fedfa3ed48723d8c1ed6a3c44c3" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="aspace_425c380b6b991d798b3d23bc39d9dae1" parent="aspace_06469fedfa3ed48723d8c1ed6a3c44c3" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_009827e7a43d5b337cbe6459416c7913">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_4e2f11c3afbd278cc01889db51cc3594" level="file">
        <did>
          <unittitle>TML - Safety of antimicrobials in pregnancy</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_1b67b07af3d6ced3b26585daaa1ca1f1" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="aspace_78c5e7c767bf61d77517fc0d1e6f2e31" parent="aspace_1b67b07af3d6ced3b26585daaa1ca1f1" type="folder">6-9</container>
        </did>
        <accessrestrict id="aspace_4077280e1fc84a55fa2f33342e312820">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_d9af5da201c75753edd17152b98006c9" level="file">
        <did>
          <unittitle>TML, 44-63 - Voriconazole</unittitle>
          <unitdate type="inclusive">2002 July 22</unitdate>
          <container id="aspace_0c39ec279143a298424dfabb9edffeb4" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="aspace_14c15e7acd1a54663302a504a69f0471" parent="aspace_0c39ec279143a298424dfabb9edffeb4" type="folder">10-14</container>
        </did>
        <accessrestrict id="aspace_7f7313cf1c86daf164b8b5b1d2c47390">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_f449d0ea0cb02a16dc4bb161afd0e8e1" level="file">
        <did>
          <unittitle>TML - Cardiovascular drugs in the ICU - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 December</unitdate>
          <container id="aspace_c199f367a7b3a2457c6c764dafed86ed" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="aspace_54aa17c4a5f8a6c2657ab5177685bba4" parent="aspace_c199f367a7b3a2457c6c764dafed86ed" type="folder">15-20</container>
        </did>
        <accessrestrict id="aspace_d78727a12815fb45316cee4c1bb66369">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_4536f53d88709a34f9764f238002f522" level="file">
        <did>
          <unittitle>TML, 44-51 - Triptorelin Pamoate (Trelstar)</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="aspace_00e73bf1d9fc4a0f7be46f40e9f776c2" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_73054adb63d87b86ffde11c92afae6cf" parent="aspace_00e73bf1d9fc4a0f7be46f40e9f776c2" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_3f564956f49faf84f827624973a86572">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_8319ac1e74f3772c55f953d49d1fe802" level="file">
        <did>
          <unittitle>TML - Drugs for Tuberculosis</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_479ae833283fe1d9c0eb4a7fa3917ed9" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_12cd8ad9db4e50ae6cdab8d278cb087b" parent="aspace_479ae833283fe1d9c0eb4a7fa3917ed9" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_6e3e6b2b8bab0f3a6559d5327bba741c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_c61123a9a767eb2a2f0665b7e710f056" level="file">
        <did>
          <unittitle>TML, 44-80 - Tepostinil (Remodulin) for pulmonary arterial hypertension</unittitle>
          <unitdate type="inclusive">2002 September 16</unitdate>
          <container id="aspace_218def567361e6af33756a8592d563b8" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_1e336cc9d1bb6738919d7fa9ed6834b3" parent="aspace_218def567361e6af33756a8592d563b8" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_96d0a14409c624606417824206c572f4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c1edb72ecb57f4a5cf544ab8a33f1ca" level="file">
        <did>
          <unittitle>TML, 44-59 - Drugs that may cause psychiatric symptoms</unittitle>
          <unitdate type="inclusive">2002 July 8</unitdate>
          <container id="aspace_e7888e096e18040a6c562ecdf62267d1" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_3d8d7348e910a9f2b66442af19fe96cd" parent="aspace_e7888e096e18040a6c562ecdf62267d1" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_049b266831555277c80bf92411b09f0b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_83c1e0a1fb9e3488cec1e298480b45b9" level="file">
        <did>
          <unittitle>TML, 44-79 - Tegaserod Maleate (Zelnom) for IBS with constipation</unittitle>
          <unitdate type="inclusive">2002 September 16</unitdate>
          <container id="aspace_bbd7331cae2de2c8b9a57dfb8d88be8a" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_f52305951aadd06dc22955521e6f3500" parent="aspace_bbd7331cae2de2c8b9a57dfb8d88be8a" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_6b6e7ca2998642d620f912e4ae273e58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_702df7b3933e28f25249b7010b1efc23" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_687f01859ea7158a21779f5ac50c5bf4" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_c6c2ff705a29174155084afbaf2be5db" parent="aspace_687f01859ea7158a21779f5ac50c5bf4" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_21f8d786633e1a74c8baaec02b6e69c6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_fbd9f3d2b393e963f637e86d90ca6f0c" level="file">
        <did>
          <unittitle>TML - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_657e2fed0d047e683f9daf835bd4c9ae" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_41d983a0765997afe848c12a28638d71" parent="aspace_657e2fed0d047e683f9daf835bd4c9ae" type="folder">21</container>
        </did>
        <accessrestrict id="aspace_8c19ab74e7734be86d15ccfc2ffd8632">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_3238875c71befee0c843bfb578b0af6f" level="file">
        <did>
          <unittitle>TML - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_682ee829e1e05ba966f950f12c0e98c4" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_663b11121632abec3642e835a862d087" parent="aspace_682ee829e1e05ba966f950f12c0e98c4" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_f07baa851539686de763d2f786c2177e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f73f901dbd4ead91b01d80ceed67c30" level="file">
        <did>
          <unittitle>TML, 44-75 - Influenza prevention 2002-2003</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="aspace_4815ae9642aa1c45a542bdbf961b2e77" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_bdd85c9a2974d7d0481aff03447d3f6b" parent="aspace_4815ae9642aa1c45a542bdbf961b2e77" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_f979eb1f784b0838d5a64de4d9ac9da1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_23ee674858aa228c8597cb11a5363b5d" level="file">
        <did>
          <unittitle>TML, 44-33 - Advice for travelers</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_96f6db82155d37d29966b004ad0ae6c8" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_2cef7475c50d7d6fb6f53a6b5cf196da" parent="aspace_96f6db82155d37d29966b004ad0ae6c8" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_687d9c16855007cc90b89408873e9116">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_c3ff86733b644974c019ea29b403f49f" level="file">
        <did>
          <unittitle>TML, 44-97 - Potassium Iodine for thyroid protection in a nuclear accident or attack</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="aspace_d6df05e62af61bb99073c9cccb1f8144" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_6974bd493eb331faef91a79cf105cdf2" parent="aspace_d6df05e62af61bb99073c9cccb1f8144" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_ae3d1b9904d63ec7a442b7bf1ecd8dc5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_24af9a9128ef19b87942303f71c93a4b" level="file">
        <did>
          <unittitle>TML, 44-91 - Acetaminophen safety</unittitle>
          <unitdate type="inclusive">2002 October 28</unitdate>
          <container id="aspace_75c8c9c37f83e4301e83b08521b7973f" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_a4463cadb7f19fdf46d84bee93450ecd" parent="aspace_75c8c9c37f83e4301e83b08521b7973f" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_7768a5d75ddf57469eb3bbdfec0f20af">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_b3aae1ba9f482e9eeee3c33251fd33f7" level="file">
        <did>
          <unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="aspace_33e79353d31ff9d38e48697298779121" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_49d1e832fb3404532250a78b13ec6dd2" parent="aspace_33e79353d31ff9d38e48697298779121" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_afa4af3e07bce4f2fa04d79ed2a8e09b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_8104e8da1a3aff8455ce0008f38fee5a" level="file">
        <did>
          <unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="aspace_2f0afceb84ce946fb16267a0d12cb037" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_2e795ef12f37ba9a0a8d76f5a67d1184" parent="aspace_2f0afceb84ce946fb16267a0d12cb037" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_aca0e4a78b7223c626fd6a43994f5d31">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_02479e2c1173076c05f34aa17007ba49" level="file">
        <did>
          <unittitle>TML, 44-21 - Acute reactions of drug abuse</unittitle>
          <unitdate type="inclusive">2002 March 4</unitdate>
          <container id="aspace_dce520000cc079cc1672889ab9677309" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_25161605b96fd312c9612b83da1c1cb8" parent="aspace_dce520000cc079cc1672889ab9677309" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_c95f7f827b4be73752d104280c14ae0c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_d1098818233489d81f3ee9a35c491fda" level="file">
        <did>
          <unittitle>TML, 44-71 - Tests for drug abuse</unittitle>
          <unitdate type="inclusive">2002 August 19</unitdate>
          <container id="aspace_69000a081479bea8321814dc769f4e80" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_26640a8b8f4bfe2b4420e7ef232e616a" parent="aspace_69000a081479bea8321814dc769f4e80" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_6b5deed194656d7a78e4584eaf23da1c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_a2d97df9926c22348169dc85fc2da466" level="file">
        <did>
          <unittitle>TML, 44-82 - Accutane</unittitle>
          <unitdate type="inclusive">2002 September</unitdate>
          <container id="aspace_163bbfe2b04e2072d006e1fe4db960b7" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_7b9fea6f1f6024c99014ebd12cce7360" parent="aspace_163bbfe2b04e2072d006e1fe4db960b7" type="folder">11-12</container>
        </did>
        <accessrestrict id="aspace_811a73112a0f3db0c61460c6f50c3a83">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_77f6dda8f57e4d024c751d9255cb8084" level="file">
        <did>
          <unittitle>TML, 44-50 - Spinal Manipulation</unittitle>
          <unitdate type="inclusive">2002 May 22</unitdate>
          <container id="aspace_9635bf7ad6adc18a4cc11ac67334921b" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_e7b7c90ed2f77bbca8902b7f431d957e" parent="aspace_9635bf7ad6adc18a4cc11ac67334921b" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_c6a5678b6a97ed4390bd98a720535a47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_09411c4ec2cd0e10526be529fdbb7c1d" level="file">
        <did>
          <unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="aspace_daf79ec9f0d9839b996176baf5ca8b71" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_246c6a55bb3358557ba01bc8b29cd4c0" parent="aspace_daf79ec9f0d9839b996176baf5ca8b71" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_1fde5116b8525bf37872775d4c998b9e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_2af7784d4333e1386ceb5387b0141573" level="file">
        <did>
          <unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="aspace_b4233023b7441d11ba83136cf54804e3" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_92f830c7c1c6da913eea581a2f5a8c8e" parent="aspace_b4233023b7441d11ba83136cf54804e3" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_b2d240752dac7c5d6b161365b06fbe2d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_45b86f5c46903225f479639e02061c91" level="file">
        <did>
          <unittitle>TML, 44-17 - Drotecogin - Activated Protein C (Xigris) for Severe Sepsis</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="aspace_eb5347dc264ce7da41727700ec7b3bdc" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_11f3404e2147f417d80275000d9bf924" parent="aspace_eb5347dc264ce7da41727700ec7b3bdc" type="folder">3-7</container>
        </did>
        <accessrestrict id="aspace_c6644b7dd17dbfbedd1d1af2963340f4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_2df9fa1b1dadedbd80d056c6d1eb7e1b" level="file">
        <did>
          <unittitle>TML, 44-78 - Hormone replacement therapy</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="aspace_a7bb2d2613f2734e39c12749a6af4c9b" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_d5155941dbd821d73a8e4efb95e17d80" parent="aspace_a7bb2d2613f2734e39c12749a6af4c9b" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_25fbac45d92806e8263c700a8600b817">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_79ecc959704f5a99033f6383c71d5e2b" level="file">
        <did>
          <unittitle>TML, 44-30 -Bosentan (Tracleer) for pulmonary arterial hypertension</unittitle>
          <unitdate type="inclusive">2002 April 11</unitdate>
          <container id="aspace_03e65161edb31802e1e45ac12d7d373b" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_68487eda7028cca107226ff48561a78a" parent="aspace_03e65161edb31802e1e45ac12d7d373b" type="folder">10-12</container>
        </did>
        <accessrestrict id="aspace_c218a513a6535a5ceb72241f53f1083c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_ebeb0b87fb29433a1b670b6a4d5aa5fc" level="file">
        <did>
          <unittitle>TML, 44-45 - Dexmethylphenidate (Focalin) for ADHD</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="aspace_f3bd8646109d1530997c87d8bfb229e7" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_933cb00e9a772d2c28aa47523629f1a4" parent="aspace_f3bd8646109d1530997c87d8bfb229e7" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_daa9fc43588271721e9668e6387b1ecc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_9cf28c7502d38a3253794dc0aff81d12" level="file">
        <did>
          <unittitle>TML, 44-53 - Droperidol Risk - Arrhythmias</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="aspace_2a04e777ad3dbf45989b7ac5a2166895" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_91a889698ebe8b8544415d01dd422f6a" parent="aspace_2a04e777ad3dbf45989b7ac5a2166895" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_9343665bbaab14cdc391de9fbda39aab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_037a4523e063f09b403c4b86b056b0b9" level="file">
        <did>
          <unittitle>TML, 44-84 - Herbal Products - Problems with dietary supplements</unittitle>
          <unitdate type="inclusive">2002 September 30</unitdate>
          <container id="aspace_7aec61a04f3583f2814949f0e104dea6" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_deb96b74e6192d0ae894ee4076f50cde" parent="aspace_7aec61a04f3583f2814949f0e104dea6" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_2fdc328774c9f82ce8ebb61aee7387a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_606c2c7591fb4c21ba3d38fc6c7462b0" level="file">
        <did>
          <unittitle>TML, 44-96 - Rasburicase</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="aspace_5fa74ba8d1d770ad0f2e90904ea51e5f" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_5015e875ba4def27a19c273a07339404" parent="aspace_5fa74ba8d1d770ad0f2e90904ea51e5f" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_6dd42fdac95221294c398b8dad4d3a7e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_b3d8e525fd2c6ceabdefb1c16c80e100" level="file">
        <did>
          <unittitle>TML, 44-88 - Three beta-interferons for MS</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="aspace_513d730e3c3d6fd1a06d8711a8400cb8" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_370898e483dacd0d8b5577057fff70ac" parent="aspace_513d730e3c3d6fd1a06d8711a8400cb8" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_de5073ebce08ff223cdc3bac4b44096d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_cd35b74adb66fbee3caa77d502914319" level="file">
        <did>
          <unittitle>TML, 44-99 - Indications for an implantable cardioverter defibrillator</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="aspace_c1368c29bb6cc0f1ea10560624130480" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_a07cbb9ba5ab6940bdefa59cd04d69ea" parent="aspace_c1368c29bb6cc0f1ea10560624130480" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_44a756d7626a6484624c170f3c9fe601">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_caba3d20cbb6ac2bcf0fffb6486cd172" level="file">
        <did>
          <unittitle>TML - Drugs for Diabetes - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 September</unitdate>
          <container id="aspace_4081315409fe2e1010cc1276e1dba4cb" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_36e824e4624642cadca83b4b140c596d" parent="aspace_4081315409fe2e1010cc1276e1dba4cb" type="folder">10-13</container>
        </did>
        <accessrestrict id="aspace_27fb92f6dcd523eaebbcb18be6a423a5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0cdc8024ee854934a00a2e6cc658127c" level="file">
        <did>
          <unittitle>TML, 44-87 - Once-a-Week risedronate (Actonel)</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="aspace_273ca0a2590cdf4ba7b181402dedd692" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_d545c0ccb192eb33157f9df1a36da671" parent="aspace_273ca0a2590cdf4ba7b181402dedd692" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_3c69c2eda4cf5e33f151894a6dae98fa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_6373e1ea574b03380381b604f8f317ea" level="file">
        <did>
          <unittitle>TML, 44-48 - Topical Primecrolimus (Elidel) for treatment of atopic dermatitis</unittitle>
          <unitdate type="inclusive">2002 May 27</unitdate>
          <container id="aspace_536df22fd12d529fd5b4f8c2167baf7d" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_f65f19a0b3899d2cdbe1190904cb184b" parent="aspace_536df22fd12d529fd5b4f8c2167baf7d" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_c8982cc8907e5273994dc146b1a74168">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0a43de1bea99678d0bd3f43b5c8e3aab" level="file">
        <did>
          <unittitle>TML, 44-107 - Metaglip and Avandamet for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2002 December 23</unitdate>
          <container id="aspace_d5aae8fed91ca5736a6d59a335a187a5" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_75cdc42ed4a2b5a3198b40f9500ddf83" parent="aspace_d5aae8fed91ca5736a6d59a335a187a5" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_77f5cb2d5690ac4fb8b1401da5ce42c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ad024dbe91f78abe8bfbef002c6b1ff" level="file">
        <did>
          <unittitle>TML, 44-27 - Desloratadine</unittitle>
          <unitdate type="inclusive">2002 March 18</unitdate>
          <container id="aspace_ce9ad1f03398e0bde31e205befa2c261" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_39c81690d19054d91bb588cd2eca5190" parent="aspace_ce9ad1f03398e0bde31e205befa2c261" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_36a5c8671473d8ebde644f9ea2a482bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_b7991b9a56fe105d30e6587c04553698" level="file">
        <did>
          <unittitle>TML, 44-41 - Pantoprazole (Protonix IV)</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="aspace_74559d395aaa986e1beff6f21b70dd07" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_3aa8bc6404b72b882e9bbe5955ed5b99" parent="aspace_74559d395aaa986e1beff6f21b70dd07" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_ecf59515bb41f3b93d8d69d9976e28b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_e886d7140f04a51e798f5685595d8a64" level="file">
        <did>
          <unittitle>TML, 44-69 - Olmesartan (Benicar) for hypertension</unittitle>
          <unitdate type="inclusive">2002 August 5</unitdate>
          <container id="aspace_72822e8fbd37f201f0d3caaf33495505" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_c5fd740f4f5850a0f952ab059f297408" parent="aspace_72822e8fbd37f201f0d3caaf33495505" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_74dedc4bdd750d18fabe19b677cbe4fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_a62ab234ffcd38be2c7ecb1b5105a478" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_5450f24979437a133e67fe72df6a6e7a" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_d47202eaf89ea129c2e78d841ad8af22" parent="aspace_5450f24979437a133e67fe72df6a6e7a" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_a1761f494a6aadd735240b5f6234da0c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_334f7d2fdf7bebf0df4dbded68f76c8d" level="file">
        <did>
          <unittitle>TML, 44-44 - Pegfilgrastin (Neulasta) for prevention of febrile neutropenia</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="aspace_b94f8a18b79e39b22d623befaa3c4598" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_5f3b0f2bd84d9b7942d7d7d426b75457" parent="aspace_b94f8a18b79e39b22d623befaa3c4598" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_a69e5af2889f08c295264781d0dc1080">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_f777550cceb72905734014265970ba2d" level="file">
        <did>
          <unittitle>TML, 45-25 - Adalimumab (Humira) for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2003 March 31</unitdate>
          <container id="aspace_d34d358eb5ab1219006faf39167dad14" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_259ae9ee43d01e73af4a81e93cf7faac" parent="aspace_d34d358eb5ab1219006faf39167dad14" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_843488d272c7cd2629b6cfaf3ea233ef">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_755a5cb278c5674c278d62217583d0dc" level="file">
        <did>
          <unittitle>TML, 45-31 - Alefacept (Amevive) for treatment of psoriasis</unittitle>
          <unitdate type="inclusive">2003 April 14</unitdate>
          <container id="aspace_b887c3a7f18aa889c84a4e7776236b76" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_f5002dbc165e566082fe066c74133bfc" parent="aspace_b887c3a7f18aa889c84a4e7776236b76" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_a72cbce0a6c64d80126a119167b5dc50">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_9a2ad2a43a1bd9b6c3ff840aca327639" level="file">
        <did>
          <unittitle>TML, 45-43 - Alprazolam XR for panic disorder</unittitle>
          <unitdate type="inclusive">2003 May 26</unitdate>
          <container id="aspace_9cea5b194690c9899089d6e1e2ba2970" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_72d8ff92989e7e5c1d8eac466624cc95" parent="aspace_9cea5b194690c9899089d6e1e2ba2970" type="folder">7</container>
        </did>
        <accessrestrict id="aspace_7facc30ebfc92bd3e698021dbdeb21fe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_32827b05df08c432fb2cbb3d952c316a" level="file">
        <did>
          <unittitle>TML, 45-15 - Aripiprazole (Abilify) for schizophrenia</unittitle>
          <unitdate type="inclusive">2003 February 17</unitdate>
          <container id="aspace_526720cc926e3480bbd221fa7c7e93fe" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_9538e4c7d84fbbcddfd9732501fa0423" parent="aspace_526720cc926e3480bbd221fa7c7e93fe" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_e9db4aba5feb72c13178e46e3f2599e5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_2dcb5260bf184933786c79514811276a" level="file">
        <did>
          <unittitle>TML, 45-5 - Augmentin XR</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="aspace_b263bf477b6d00d24e1e0676e6b77513" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_9805dceb770ada7bda6a43bf1fbd551d" parent="aspace_b263bf477b6d00d24e1e0676e6b77513" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_352c7f8bef5faa523d50be8830568d03">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_6719542efa0dd7e6ff2199fb0fc45784" level="file">
        <did>
          <unittitle>TML, 45-50 - Blue Light (Clearlight) for acne vulgaris</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="aspace_a934c32d14bc64f911b4c22d010955c2" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_713d63a9d6707d19bdaef86decc7b395" parent="aspace_a934c32d14bc64f911b4c22d010955c2" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_dd3798d0577bb9e1fc29332ed3c1ed16">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_face99254c656f96b64bf580e5f85bcf" level="file">
        <did>
          <unittitle>TML, 45-57 - Bortezomib for multiple myeloma</unittitle>
          <unitdate type="inclusive">2003 July 21</unitdate>
          <container id="aspace_d03273494e0bfa7789b30a5ab31b8657" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_ed3bb20c7495bb7399453a934eeb8a8d" parent="aspace_d03273494e0bfa7789b30a5ab31b8657" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_5b737b9395121e3828a6f6fa407666da">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_9ec231ed3611900061caae3128c95513" level="file">
        <did>
          <unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="aspace_1a9359aad31cbc7ab54b04b643415cd2" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_fd5d19c6d3107114f02bbe7b77ffed59" parent="aspace_1a9359aad31cbc7ab54b04b643415cd2" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_e0dca88a43ebdabbfbf835cde2da0a4f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_c6404194bb02ecf2496bacd146a0cc60" level="file">
        <did>
          <unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="aspace_bb7e215e303a56d9751623c7517423f1" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_17ba8e40d3db1e624ad2ffaded178377" parent="aspace_bb7e215e303a56d9751623c7517423f1" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_ff3d2237bfc8f29c4712b54bf885e9be">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_2ddbc741772355d7dce54b4b63ef6749" level="file">
        <did>
          <unittitle>TML, 45-97 - Efalizumabe (Raptiva) for treatment of psoriasis</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="aspace_d4692318b78761b119235d52bcbe64e0" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_7ea9e51acf7fc7cbf7d741c0df928464" parent="aspace_d4692318b78761b119235d52bcbe64e0" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_6eb237f5b70a5174ed44b4dc845e1439">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f45b082b3a08c7cce74229a00644b02" level="file">
        <did>
          <unittitle>TML, 45-97 (45-333) - Eletriptan (Replax) for migraine</unittitle>
          <unitdate type="inclusive">2003 April 28</unitdate>
          <container id="aspace_b1d7348d408485dd57a657b982a6433d" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_339ad8c2ed2ea1c504d3d52bfe7cc587" parent="aspace_b1d7348d408485dd57a657b982a6433d" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_f517a35e209156fcce5cddbc43b68b14">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_94948e6e42424f89ec840de91511a768" level="file">
        <did>
          <unittitle>TML, 45-49 - Enfuvirtide (Fuzeon) for HIV infection</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="aspace_8337cd27f34a9a7231e7c96e47edd6e1" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_3568ef39c761d0acb679d95e340a663f" parent="aspace_8337cd27f34a9a7231e7c96e47edd6e1" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_a3551a188d335a0b903727fcd2a48fa4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_48f4b3c522fa705a3ae202735e45ac3b" level="file">
        <did>
          <unittitle>TML, 45-89 - Growth hormone for normal short children</unittitle>
          <unitdate type="inclusive">2003 November 10</unitdate>
          <container id="aspace_19a80029442df239f73b80b38737680a" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_5f1efcea0751447a26c545273a2ff61f" parent="aspace_19a80029442df239f73b80b38737680a" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_3229644ce53e8795f97a65d5d61f18e8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_780d425bdbd53ceafd83133223d279a7" level="file">
        <did>
          <unittitle>TML, 45-67 - Omalizumab (Xolair) for Asthma</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="aspace_47fd30638575b8fc346732d11cba2d2b" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_5ccdc688da8623e1696fa96ec0b8fb15" parent="aspace_47fd30638575b8fc346732d11cba2d2b" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_12994eea68e1f09108df54e255ae8cff">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3e27a4c127b0269848618ade1805962f" level="file">
        <did>
          <unittitle>TML, 45-7 - Oxalipatin</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="aspace_d756f191f2b7f461fcf55ba90248d1ed" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_f563b7d55f12c83035ef7a5125624eb8" parent="aspace_d756f191f2b7f461fcf55ba90248d1ed" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_319e1cb1c4d5a539efc2e6af94af005a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_732aaf61ce82ace45c4354ea0038b752" level="file">
        <did>
          <unittitle>TML, 45-7 - Oxalipatin</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="aspace_a40128072ffb8f136d20d68ffb5e9ee4" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_bc19c060625b3705abfffee7df4c1a9f" parent="aspace_a40128072ffb8f136d20d68ffb5e9ee4" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_c716c8d0ab4facf419cf7e7c4082202e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_c4617feb74a721aa21a7112babed977f" level="file">
        <did>
          <unittitle>TML, 45-38 - Oxbutynin trandermal (Oxytrol) for overactive bladder</unittitle>
          <unitdate type="inclusive">2003 May 12</unitdate>
          <container id="aspace_ba44a89126ef1f4e7c5aedc19b736166" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_0ff387fcb87cbeff8607145a512492fb" parent="aspace_ba44a89126ef1f4e7c5aedc19b736166" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_09ded828b852ae6c86297bc23c88adc0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_8486f3e9d9968bc9f1dce0df7483cd4b" level="file">
        <did>
          <unittitle>TML, 45-54 - Rapid tests for HIV infection</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="aspace_cbfe7bd9961a376832dad00dae8ec50b" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_ef817f869ef902891e9a79384636b649" parent="aspace_cbfe7bd9961a376832dad00dae8ec50b" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_9d74192e21e6502b4dff990dec4cbb50">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_e54b07dbb6cb8e75aad0e568c11cae0a" level="file">
        <did>
          <unittitle>TML, 45-77 - Vardenafil (Levitra) for erectile dysfunction</unittitle>
          <unitdate type="inclusive">2003 September 29</unitdate>
          <container id="aspace_9fa7717abb399e8f001049f2c6619c4c" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_06ac4c2c830654f28bf14e0a5d5bacf3" parent="aspace_9fa7717abb399e8f001049f2c6619c4c" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_f6350ccd6ef35a9adb3c39e7c7bf3a3c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_fdd62d893c6f422fd7c183e65efa7835" level="file">
        <did>
          <unittitle>TML, 45-11 - Atomoxetine (Strattera)</unittitle>
          <unitdate type="inclusive">2003 February 3</unitdate>
          <container id="aspace_1a17feeb3661b1f84e9b33840c0bd840" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_b650f3f3241bcf3f3ab04b0edbeda31e" parent="aspace_1a17feeb3661b1f84e9b33840c0bd840" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_36610a7149adbc1f92cfdc7751128db1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_35402d0a4356ba61f6f491a96f89217a" level="file">
        <did>
          <unittitle>TML, 45-15 - Buprenorphine - an alternative to methadone</unittitle>
          <unitdate type="inclusive">2013 February 17</unitdate>
          <container id="aspace_0483faef05dbc0cc12a743bb687ab104" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_7b44ce6eafc37be3f8e8e986d203fd27" parent="aspace_0483faef05dbc0cc12a743bb687ab104" type="folder">16-20</container>
        </did>
        <accessrestrict id="aspace_136a1315a2303fa111e5d01cb0517e7d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3fc7a0238f453d851bcf8a694afaf2ab" level="file">
        <did>
          <unittitle>TML, 45-74 - Agalsidase beta (Fabrazyme) for Fabry disease</unittitle>
          <unitdate type="inclusive">2003 September 15</unitdate>
          <container id="aspace_7dad773fc02f0ef1269243eef3538b6c" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_0ce28e008f6503a1172727082b053dcc" parent="aspace_7dad773fc02f0ef1269243eef3538b6c" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_aab1089a7327f8fc78a2fc319190599a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_5569c52b23e7d7eeddf53f7c2b84a996" level="file">
        <did>
          <unittitle>TML, 45-39 - Eplerenone (Inspra)</unittitle>
          <unitdate type="inclusive">2003 May 12</unitdate>
          <container id="aspace_dcc56929100cc9dc59ddfa1f88cbac58" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_8554aa5c6c5b9c75b28dd7eb3fb0a2ec" parent="aspace_dcc56929100cc9dc59ddfa1f88cbac58" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_4fc1e68dd96cabb133f171a2e6a52471">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_19fc064c09e3806caaddbb51b70e4090" level="file">
        <did>
          <unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="aspace_8ebd09d2b6182a952671a5a36818afc0" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_d10a7bbada16622294743c753d2d8466" parent="aspace_8ebd09d2b6182a952671a5a36818afc0" type="folder">5A-6A</container>
        </did>
        <accessrestrict id="aspace_60b6213d43e89633056c4a067f8c54e8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_f0a8b264973dfe8db5fe8da9b49f6e58" level="file">
        <did>
          <unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="aspace_e7c24409ead641110f1b73a619441e2a" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_688ae11a53cc4f6827f9202d714147ab" parent="aspace_e7c24409ead641110f1b73a619441e2a" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_7a45da012d9d8375ab9c62d057d20b13">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_d1e93fdc68ebf64e073b0d53c908f073" level="file">
        <did>
          <unittitle>TML, 45-101 - Tadalafil (Cialis) for Erectile dysfunction</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="aspace_442405d32019e3d452d2c4f56cfa8c7e" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_8173c3d8d803b335f241e1301d2b3869" parent="aspace_442405d32019e3d452d2c4f56cfa8c7e" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_a187e298156d35ecb24bf62acbaa2162">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_bf6ed6095bb9e6efdcac9a21b49e00e9" level="file">
        <did>
          <unittitle>TML, 45-95 - Tattoo Removal</unittitle>
          <unitdate type="inclusive">2003 November 24</unitdate>
          <container id="aspace_4d84fdd9b63bf3604cf646980b65bcfb" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_208170bb5b0cc5df494d83fcdd94242c" parent="aspace_4d84fdd9b63bf3604cf646980b65bcfb" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_1cb8774dfbec0195c1be0234b77205c6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_a857cbd537b23d5351b0c89499d70d8e" level="file">
        <did>
          <unittitle>TML, 45-51 - Priloscec, Nexium and stereoisomers</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="aspace_665a11c90747206f5f5f5460888d5839" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_54624b100be11fd9e0402718b942e31a" parent="aspace_665a11c90747206f5f5f5460888d5839" type="folder">14</container>
        </did>
        <accessrestrict id="aspace_4b2308536bb701384ee28edb8995985a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_1ed11b7c73752bdb0689383a30c1baf5" level="file">
        <did>
          <unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="aspace_d82a6ef448f38b80568efdfe89a05ff0" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_08c652c4535b23842278ccb31a5bccb9" parent="aspace_d82a6ef448f38b80568efdfe89a05ff0" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_4ae7a8a3386cf59e0586622b1db28e61">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_c48f05a528d95bdfee4855de30cb54e2" level="file">
        <did>
          <unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="aspace_ffd379cea1fa81b92b2601e5d84955e5" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_36ffd3b69fffe24bda64e7f8f8d1ae98" parent="aspace_ffd379cea1fa81b92b2601e5d84955e5" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_d1a19b29c41ed450efa6dd0a35b030ad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3e6aff84359c7cdd06669d9d72f8c12a" level="file">
        <did>
          <unittitle>TML, 45-21 - Montelukast (Singulair) for allergic rhinitis</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="aspace_67fba7769ecec0c55ec1d39a0b934208" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_3c5a90573c72738c7ec2a0ab4f961781" parent="aspace_67fba7769ecec0c55ec1d39a0b934208" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_2b573db89b3a7e7ffb7bbe4571d64e85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_7d40fbe976113721e79b64dd1d00e27d" level="file">
        <did>
          <unittitle>TML, 45-3 - OTC Loratadine</unittitle>
          <unitdate type="inclusive">2003 January 6</unitdate>
          <container id="aspace_3be93b868ef25aa167013f83600fcd86" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_e883bd7bb7576ad6be680f8edbd4de12" parent="aspace_3be93b868ef25aa167013f83600fcd86" type="folder">5</container>
        </did>
        <accessrestrict id="aspace_68d83db5324a44659c1dd3f51c2e2864">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_1823eedc9d0074c8a4265ac61efdfda5" level="file">
        <did>
          <unittitle>TML, 45-41 - Insect repellents</unittitle>
          <unitdate type="inclusive">2003 May 26</unitdate>
          <container id="aspace_d4676fae5f7bfda800df4c7cebbec053" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_1e417ed3aaf33dbf727a4f63bb7c37ba" parent="aspace_d4676fae5f7bfda800df4c7cebbec053" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_fd9f974ca565c85df29a51348d8fb4a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_2f3bcea3a484b983f63233e648e58d71" level="file">
        <did>
          <unittitle>TML, 45-81 - Rosuvastatin - a new lipid-lowering drug</unittitle>
          <unitdate type="inclusive">2003 October 13</unitdate>
          <container id="aspace_8b8fb228038b7607267dab1c9e194234" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_dc588eb796475f691c1e18ade2c12da3" parent="aspace_8b8fb228038b7607267dab1c9e194234" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_43bf4f6f81d3fbdf04c68bbc454e9040">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_ba56ad48c3bef0d702fff7fdda72fa22" level="file">
        <did>
          <unittitle>TML, 45-35 - Insulin-sensitizing drugs for polycystic ovary syndrome</unittitle>
          <unitdate type="inclusive">2003 April 28</unitdate>
          <container id="aspace_b9676a6f73043f63e4b51d264786a716" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_5d16be4fc6a54049ea10c207af75882c" parent="aspace_b9676a6f73043f63e4b51d264786a716" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_68c074ca5c7b85d99e37109be8f03f26">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3d9fbb15ae7446c6c645d70bd47fbf3b" level="file">
        <did>
          <unittitle>TML, 45-73 - Memantine for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2003 September 15</unitdate>
          <container id="aspace_307ea57e5ec634dc161350c333ff0af5" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_503fd21400f1e8b45dcbe0dfd6e8e73b" parent="aspace_307ea57e5ec634dc161350c333ff0af5" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_349dea74056b705fe12a6e58b6be4a61">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_11bdec471c430a38763f1ea9a86eab38" level="file">
        <did>
          <unittitle>TML, 45-58 - Treatment of heat injury</unittitle>
          <unitdate type="inclusive">2003 July 21</unitdate>
          <container id="aspace_5a324900e3dbf895c92699c914bac64e" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_bdcad4ffae51a082d0598e6266181fe4" parent="aspace_5a324900e3dbf895c92699c914bac64e" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_b32e89185eafe8ec72db09448de5ce28">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_806d8942533d66de734e65e88b3304ee" level="file">
        <did>
          <unittitle>TML, 45-90 - Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV infection</unittitle>
          <unitdate type="inclusive">2003 November 10</unitdate>
          <container id="aspace_8ff7b40e249ec2c390ff4234c95efab9" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_c03d24bc391f46b73480b2a6e5edd700" parent="aspace_8ff7b40e249ec2c390ff4234c95efab9" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_d90cbf0a7351c28f0b2d1347edc27949">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_04dee614a81cacb32c43ef5b0a88af03" level="file">
        <did>
          <unittitle>TML, 45-88 - Aldurazyme (Laronidase)</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="aspace_f01915ed5c337c90cbcaf46f40c18eaf" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_624ae33ab97ce4c703213bde6e246fef" parent="aspace_f01915ed5c337c90cbcaf46f40c18eaf" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_b53a56596e6cd54c520d93ec764edd68">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_9233509af152396c7a0be4f4a4690cec" level="file">
        <did>
          <unittitle>TML, 45-46 - Drug Interactions</unittitle>
          <unitdate type="inclusive">2003 June 9</unitdate>
          <container id="aspace_835aa0031119b6c3ed797d4094683e76" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_8b86da3574d01449c5fd277955d64005" parent="aspace_835aa0031119b6c3ed797d4094683e76" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_7b355cfd23bf5faae7008b6d8dfcd613">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_95a2b9eb73be12648888070a03ead474" level="file">
        <did>
          <unittitle>TML, 45-85 - Lowering Plasma Homocystein</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="aspace_debd7d42b670df6e4a1c2b3c2ed3e0b6" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_b749d92aeef6ae0ccbf70e87b15b9afb" parent="aspace_debd7d42b670df6e4a1c2b3c2ed3e0b6" type="folder">13-17</container>
        </did>
        <accessrestrict id="aspace_150bc9e4636bdbb6ef444d31120758f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_dad27947e40b662edd3cc5a90a0be625" level="file">
        <did>
          <unittitle>TML, 45-83 - Lp-Pla2 - A new marker of Vasular Risk</unittitle>
          <unitdate type="inclusive">2003 October 13</unitdate>
          <container id="aspace_629bb1ec761e32f0f1d0d47180f7ab61" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_a06d469c7a861c7ccadb2f86622f26b0" parent="aspace_629bb1ec761e32f0f1d0d47180f7ab61" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_7bacb749d5cace7b77c6d20686088469">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_e617e6eea5f9996628c705dd200e1ffa" level="file">
        <did>
          <unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="aspace_4278804bb3a2b8a534628c277f3e5733" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_0ffb3763bded5000db5dbb1ef6c82129" parent="aspace_4278804bb3a2b8a534628c277f3e5733" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_8c291adc86b1ece8d63fe68ecf028b3e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_9fd8a0d9db61f711e261afe6ec4c49ea" level="file">
        <did>
          <unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="aspace_286548b861b1a0c3510f315acf37ee10" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_6e593e75a9913cdda42f63045213d862" parent="aspace_286548b861b1a0c3510f315acf37ee10" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_bce92c80f15ffaccbaa401c6170b83ed">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_edaf8bc319227fe95dce9ce1973f3621" level="file">
        <did>
          <unittitle>TML, 45-86 - Iodine-131 - Tositumomab (Bexxar) for treatment of Lymphoma</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="aspace_c78a24d3fdeb7d9d4c9f2076c6323102" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_ec3b8b5dc52f6f188c4b1d2108112ada" parent="aspace_c78a24d3fdeb7d9d4c9f2076c6323102" type="folder">5-9</container>
        </did>
        <accessrestrict id="aspace_a9e5f083314a82f3692a841eac51a5ca">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_f8dc69e4bf109c9986cc722051633070" level="file">
        <did>
          <unittitle>TML, 45-27 - Pneumococcal Conjugate Vaccine</unittitle>
          <unitdate type="inclusive">2003 March 31</unitdate>
          <container id="aspace_c97514e28783852cb312258874c1805c" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_0b2e455e84e54556515344e8287774f8" parent="aspace_c97514e28783852cb312258874c1805c" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_e59f218612780c21cd1831f3c38ec08e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_cc9f06be346fedef1f6102477bee9cb2" level="file">
        <did>
          <unittitle>TML, 45-78 - Influenza Prevention</unittitle>
          <unitdate type="inclusive">2003 September 29</unitdate>
          <container id="aspace_80e69ee33ece2c45faca9556d4cdefa2" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_9d251f388bdb76f2c4ca47f79287dec4" parent="aspace_80e69ee33ece2c45faca9556d4cdefa2" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_cc6daf505d9a0ea7ee4c3ea324aa8478">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_39d9d76dedec7d6057d3eb65d8744ded" level="file">
        <did>
          <unittitle>TML, 45-19 - Peginterferon alfa (Pegasys) for Chronic Hepatitis C</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="aspace_9324bf8eee83110e4caecbf18f611b91" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_a8f261f3fedd4b49dc91023b2cb1ad29" parent="aspace_9324bf8eee83110e4caecbf18f611b91" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_4cfe15ffe7bdd2742771ed54d3c1d07c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_efd0e7eb3789a0bc30a68f63ca9b430c" level="file">
        <did>
          <unittitle>TML, 45-55 - Pegvisomant (Somavert) for Acromegly</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="aspace_f81011da747673d8e1dd134edce60544" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_41e031e0cdd17e9f555bde3fe5df1717" parent="aspace_f81011da747673d8e1dd134edce60544" type="folder">17-20</container>
        </did>
        <accessrestrict id="aspace_565dbbbdc9cf527d50ca1536a406a58f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_e809ce901af88811ad1fd0cb5bc5882c" level="file">
        <did>
          <unittitle>TML, 45-9 - Teriparatide for Osteoporosis</unittitle>
          <unitdate type="inclusive">2003 February 3</unitdate>
          <container id="aspace_558e6764a166430a86e9f8e59f259bc2" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="aspace_e38be35e8f4f60fa090415ef5599ebb2" parent="aspace_558e6764a166430a86e9f8e59f259bc2" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_662bdc9f7dbb54b08b4950ea34c176c4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_acd944256fa6e191f50b1c636b7b7bf4" level="file">
        <did>
          <unittitle>TML, 45-70 - Testim and Striant - two new testosterone products</unittitle>
          <unitdate type="inclusive">2003 September 1</unitdate>
          <container id="aspace_971f058d2fa2203745586e23739fb6be" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="aspace_a04d61f58568f98023237a5d0e6cd26a" parent="aspace_971f058d2fa2203745586e23739fb6be" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_56655a641344d4055a005097ec27c5cb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_fbdf4b7f30d77eaf33b84599e0a5e6e6" level="file">
        <did>
          <unittitle>TML, 45-1 - Smallpox vaccine</unittitle>
          <unitdate type="inclusive">2003 January 6</unitdate>
          <container id="aspace_659954c48313832b123f28c0f33fdb6a" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="aspace_8296949a3064562d0751c46469a23312" parent="aspace_659954c48313832b123f28c0f33fdb6a" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_df814d1bfcebe53223f1d57c2a6776e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_d9642438ec124cd82d8e135b0198ede7" level="file">
        <did>
          <unittitle>TML, 45-69 - Minimal surgery for treatment of GERD</unittitle>
          <unitdate type="inclusive">2003 September 1</unitdate>
          <container id="aspace_89cdcb782839a8e98865e81251ab4483" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="aspace_f59acda81cb3b2b76df4a22638494fdb" parent="aspace_89cdcb782839a8e98865e81251ab4483" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_572b2a0e74e3c89c9169b31576cc0b55">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_0e7f3c8cc41ff780e30caa2e1cd3c245" level="file">
        <did>
          <unittitle>TML, 45-23 - Drug-eluting Stents</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="aspace_9fca8b88f70c3fc2f2c0a2a414e7a2bb" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="aspace_634ab82f167e9215a1cf1b44fd3241fd" parent="aspace_9fca8b88f70c3fc2f2c0a2a414e7a2bb" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_91472bcb765db5980f76960bca69f7bb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_4cbcc7808efc65afe1e68d84b33f1bea" level="file">
        <did>
          <unittitle>TML, 45-23 - Drug-eluting Stents</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="aspace_7cfad2ac5bea7106037d281deece525b" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="aspace_5a0e04d508455aacf8870f6d973d657f" parent="aspace_7cfad2ac5bea7106037d281deece525b" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_ad37cdcd99a2044624e749e1cd39779d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_f9a9c4fc1896553a888be142b1758016" level="file">
        <did>
          <unittitle>TML, 45-61 - Omeprazole (Prilosec) (OTC)</unittitle>
          <unitdate type="inclusive">2003 August 4</unitdate>
          <container id="aspace_e39a56df1ac6cd8dc7efd9ad157fa5f7" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="aspace_16bf086124687880c041cf8763e9e509" parent="aspace_e39a56df1ac6cd8dc7efd9ad157fa5f7" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_d9a5d8493c3334bb1cda4ff7afb8a52c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_839fb8691411f959bd1aac5c4ebf7d26" level="file">
        <did>
          <unittitle>TML, 45-29 - Nitazoxanide (Alina) - a new anti-protozoal agent</unittitle>
          <unitdate type="inclusive">2003 April 14</unitdate>
          <container id="aspace_a730adba3a7107b20c25128ba50c2182" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="aspace_4208d785479152de3168fd03d06d7d68" parent="aspace_a730adba3a7107b20c25128ba50c2182" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_ba825ee552c2bf91acd8b458e0a15d2d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_55365ce4b3ea2d58db64e9416965cb4e" level="file">
        <did>
          <unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="aspace_32f4c3d488c0b00bd54a21b6283b9bf7" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="aspace_e73c1c97d830384b27ac4660fdcd9e11" parent="aspace_32f4c3d488c0b00bd54a21b6283b9bf7" type="folder">6-17</container>
        </did>
        <accessrestrict id="aspace_0ed20f41fac45d1a638a3740752cb703">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_668d7e7e07b5750eb2c823e11c095964" level="file">
        <did>
          <unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="aspace_7c0955223356badfa7fecacac3655a27" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="aspace_7be44e8ef2366dd0ce229bf686519b99" parent="aspace_7c0955223356badfa7fecacac3655a27" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_c2b71f78c735a86ad9547e6e3d24546c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_c171f13c04b5ef1cf3b3fe5e96a9ef03" level="file">
        <did>
          <unittitle>TML - Weight Loss - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 December</unitdate>
          <container id="aspace_e495ff9555b0dddf3f5a821806f85717" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="aspace_e5c967dcde6355ba7354221eed23d097" parent="aspace_e495ff9555b0dddf3f5a821806f85717" type="folder">5-13</container>
        </did>
        <accessrestrict id="aspace_6dd9eece4a3c89e40bca2442781a600d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_ee60c4bf66a25475983425024da14c39" level="file">
        <did>
          <unittitle>TML - Heart Failure - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 April</unitdate>
          <container id="aspace_c6b53fb6904cb1bb569ef7f526a443ab" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="aspace_d93da300a2c7655c213b3eb94a7ce87f" parent="aspace_c6b53fb6904cb1bb569ef7f526a443ab" type="folder">14-18</container>
        </did>
        <accessrestrict id="aspace_957488be5b6a3b3f5fb3aca8638e23b6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_0be1e684fc9e69b20bc9867cc0b7288f" level="file">
        <did>
          <unittitle>TML - Drugs for rheumatoid arthritis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="aspace_4ad69ef68e772ca33469f7e864db3d7c" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="aspace_69da2099ca77430d05ebd552176c9ed9" parent="aspace_4ad69ef68e772ca33469f7e864db3d7c" type="folder">1-7</container>
        </did>
        <accessrestrict id="aspace_fea0a477360238ce0c79c9e79ad6d39a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_c0978c508033828e366f1d55950a308e" level="file">
        <did>
          <unittitle>TML - Drugs for Psychiatric Disorders</unittitle>
          <unitdate type="inclusive">2003 July</unitdate>
          <container id="aspace_a0a70a4d955c07b93b653b82d4ce77b5" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="aspace_6732d279c114642e6c8516d26b5a0f29" parent="aspace_a0a70a4d955c07b93b653b82d4ce77b5" type="folder">8-18</container>
        </did>
        <accessrestrict id="aspace_03781a219ff982acf63e0290b3b87f0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_a9906d72f32382fa1bb39c1ccd388091" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="aspace_2a6f9c17d3719b89844b5ddd135c9a04" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="aspace_ade8d1d6c5648f3a00919d76755698f2" parent="aspace_2a6f9c17d3719b89844b5ddd135c9a04" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_a19ba7012ef7e238dc26e208ad0c53df">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_9d1257d4a4ba512b1aa0bb0a4c07fdcd" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="aspace_0bb6a39750dd39194a76c4b4142d75ee" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="aspace_6cfca3f6249d984195638608f3930715" parent="aspace_0bb6a39750dd39194a76c4b4142d75ee" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_2097ee7f9bd39cd5ea6f974d3df6ff1f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_380c664090534851fbc806e0558fde2f" level="file">
        <did>
          <unittitle>TML - Assisted Reproduction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 October</unitdate>
          <container id="aspace_b3b75d8c658f7ae16df9237bce500e16" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="aspace_92c04585e8e764d1efca12a82026f8db" parent="aspace_b3b75d8c658f7ae16df9237bce500e16" type="folder">5-13</container>
        </did>
        <accessrestrict id="aspace_69fb416fcc934ed0c8b1f96140cd08e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_dfe820ca0d9eb165533f652cbc41ee32" level="file">
        <did>
          <unittitle>TML - Drugs for Hypertension - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 February</unitdate>
          <container id="aspace_a8db8c6ca3c0909a95dba9812b703e57" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="aspace_e327194c3b19888175d0e1ac2d561e44" parent="aspace_a8db8c6ca3c0909a95dba9812b703e57" type="folder">14-17</container>
        </did>
        <accessrestrict id="aspace_5a63fa0917343ef8eb141521fcb9e24e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3ce9ce08c457fba44042e2deea5066f7" level="file">
        <did>
          <unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="aspace_e39dbc07d6f618782e3da69b89de2aa6" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="aspace_2833fe1c270d72d4e9b13333d9bf59a0" parent="aspace_e39dbc07d6f618782e3da69b89de2aa6" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_43bc17de19e0d00f4e7031362b3b3efc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_d475b54c5095880adce7b8263966fe2d" level="file">
        <did>
          <unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="aspace_a89baec6f38f5865c722406e5e6fd477" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="aspace_de1fbc715916077ec14efb44d8c133ec" parent="aspace_a89baec6f38f5865c722406e5e6fd477" type="folder">1-8</container>
        </did>
        <accessrestrict id="aspace_d727ecc0d3636f553591f418559bc721">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_a6efb00d5c63c6a2ccedf6563ae43110" level="file">
        <did>
          <unittitle>TML - Drugs for Epilepsy - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 May</unitdate>
          <container id="aspace_1adaebff9a809bb3bbcdfe8a06cf3971" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="aspace_0b3020836d4c84e4f5543372beb3d0e2" parent="aspace_1adaebff9a809bb3bbcdfe8a06cf3971" type="folder">9-14</container>
        </did>
        <accessrestrict id="aspace_ae7bd45c44b6a19a25f101af3b5a211a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_5a5ba60bec4d0b97fddcd00799fd7626" level="file">
        <did>
          <unittitle>TML - Drugs for Lipid Disorders - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 August</unitdate>
          <container id="aspace_89f25f5cc44ae2b428fad7bdf9974064" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="aspace_01fbd463b50081eb10c46e7cce66de72" parent="aspace_89f25f5cc44ae2b428fad7bdf9974064" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_334e64660b4fc298f4d1c26e9a76a343">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3c1aea5febbafdf8b5e437a8e97b9218" level="file">
        <did>
          <unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="aspace_4d69ed2b7928a930e1e3059ca6d2e66d" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="aspace_0d6ad99c15cc4ab86fe1ef8d0ca3984b" parent="aspace_4d69ed2b7928a930e1e3059ca6d2e66d" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_7cdf942787e0cbed8326189a2020f299">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_ddf6b73987ce0637989f66584610c6ea" level="file">
        <did>
          <unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="aspace_340563b327ffb83167152d67836a4b22" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="aspace_12f3973bab326f940cae7f9f1afdd7dd" parent="aspace_340563b327ffb83167152d67836a4b22" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_2b960cecbba771988110df8a9cd33742">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ca468433bcdc6006e7fb9b0ef21814e" level="file">
        <did>
          <unittitle>TML, 45-93 - Which SSRI</unittitle>
          <unitdate type="inclusive">2003 November 24</unitdate>
          <container id="aspace_409a72d9f817d5b0682a6c4bc9d9edde" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="aspace_1766862a838b7d26621c34ea170c8f2b" parent="aspace_409a72d9f817d5b0682a6c4bc9d9edde" type="folder">2-5</container>
        </did>
        <accessrestrict id="aspace_72e10bfbf01df945876de61f8480a08b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_1e5a72f232d4e116685aff32e9ed9f87" level="file">
        <did>
          <unittitle>TML - Drugs for Allergic Disorders - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 November</unitdate>
          <container id="aspace_af7d0b823a6c9dbf226f56af017efdb2" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="aspace_548e3bdd5b9137dc3037649a354bc9d4" parent="aspace_af7d0b823a6c9dbf226f56af017efdb2" type="folder">6-9</container>
        </did>
        <accessrestrict id="aspace_ce922dcf8bde445758a34a54106e0ec6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_7621ca9e85272fb03e367f6102650bf9" level="file">
        <did>
          <unittitle>TML - Drugs for Pneumonia - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 September</unitdate>
          <container id="aspace_8a9a9e642226de56bdaf7b202a0cc361" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="aspace_470e161707db0380f643e805a1879086" parent="aspace_8a9a9e642226de56bdaf7b202a0cc361" type="folder">10-17</container>
        </did>
        <accessrestrict id="aspace_429d1928e15342d8a9639e6b6a92e6d4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_68e729c691bb49c8be35f332fbb1e32b" level="file">
        <did>
          <unittitle>TML - Antimicrobial Prophylaxis for Surgery - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="aspace_9256da56d17e98181a9dd3a03b0daf4e" label="Mixed Materials (A0000000075939)" type="box">97</container>
          <container id="aspace_fe9f74ade05cc2c8efe5c4d786266c88" parent="aspace_9256da56d17e98181a9dd3a03b0daf4e" type="folder">1-10</container>
        </did>
        <accessrestrict id="aspace_084a4278da0f4581918db07f8eb825b4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_07f19737b5f6d3009e9e85a8b0528533" level="file">
        <did>
          <unittitle>TML - Drugs for Cardiac Arrhythmias - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="aspace_0900585001b528fd2d0a7b1fc818e0dd" label="Mixed Materials (A0000000075939)" type="box">97</container>
          <container id="aspace_219ac3cfa2e6f9c3de2b9647b9a7a71a" parent="aspace_0900585001b528fd2d0a7b1fc818e0dd" type="folder">11-18</container>
        </did>
        <accessrestrict id="aspace_8f26a61c71898392ee05f246c39c61b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_c099bb967206188345dcdbf9c2975e6d" level="file">
        <did>
          <unittitle>TML - Advice for Travelers - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="aspace_109b6a3299fef4d5080a09b1771ef5c1" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="aspace_2d816e59a493a65837b807b73ac75488" parent="aspace_109b6a3299fef4d5080a09b1771ef5c1" type="folder">1-9</container>
        </did>
        <accessrestrict id="aspace_e0b7814bc924716eb27275e9522cf9ae">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_237497500e700200226282634e319af9" level="file">
        <did>
          <unittitle>TML - Drugs for Migraine - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="aspace_ad5576f5cd1a265ea2b16147a8362de2" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="aspace_78ba03e53dc9304dfc7c42ed6e2ad518" parent="aspace_ad5576f5cd1a265ea2b16147a8362de2" type="folder">10-15</container>
        </did>
        <accessrestrict id="aspace_00d75b64dab2398628516bc88ce53406">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_423b8c383be805c9a485a8fecfe9ddb1" level="file">
        <did>
          <unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 December</unitdate>
          <container id="aspace_f4ecaad53588ed7887ac0049b8b9cf50" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="aspace_18d8658c10ac538183fe16bb66f608e5" parent="aspace_f4ecaad53588ed7887ac0049b8b9cf50" type="folder">16</container>
        </did>
        <accessrestrict id="aspace_98f8b37e529ccb193a51c645e7d19af9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_26700edc7d4dff9bb83e29c005e8dedd" level="file">
        <did>
          <unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 December</unitdate>
          <container id="aspace_f4dbe90b91649b268f384bf9a5e695dc" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="aspace_4612b1362430e36197e31ed43c081b75" parent="aspace_f4dbe90b91649b268f384bf9a5e695dc" type="folder">1-5</container>
        </did>
        <accessrestrict id="aspace_ff906c4305f7b289ec47141f34c41d10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_bef1ef630d26c3d4f70cc63b2da9dbfa" level="file">
        <did>
          <unittitle>TML - Drugs for Sexually transmitted infections - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 October</unitdate>
          <container id="aspace_60da6c36b2373fadd3f492861fd7deeb" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="aspace_dbc9f0a7cd6b75522592476cbe03f084" parent="aspace_60da6c36b2373fadd3f492861fd7deeb" type="folder">6-12</container>
        </did>
        <accessrestrict id="aspace_6db6900a0738aa418a1db1239ba995f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_ef8b77a4a9168df66dbaa1d35328f051" level="file">
        <did>
          <unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 June</unitdate>
          <container id="aspace_80de7d9a7a34313cb5af395fc89c7166" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="aspace_a909c075c2297e46ba9c6ba957783c4f" parent="aspace_80de7d9a7a34313cb5af395fc89c7166" type="folder">13-18</container>
        </did>
        <accessrestrict id="aspace_d4257f7e3e2891eb7db697e7bd0a7fc7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_4122c98e47eb1d53ed958233e91ca5d6" level="file">
        <did>
          <unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 June</unitdate>
          <container id="aspace_5263c1a036b82998c4756784d02700e7" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_25f856aeb7464060f4ea8f89e50a3f33" parent="aspace_5263c1a036b82998c4756784d02700e7" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_4ac25a41ad51ce40a2b44624b0c6f458">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_1db0c21858cc9e616d5906c203e6860d" level="file">
        <did>
          <unittitle>TML, 46-22 - Abarelix (Plenaxis) for advanced prostrate cancer</unittitle>
          <unitdate type="inclusive">2004 March 15</unitdate>
          <container id="aspace_37dba882538f3b7f2d487ab0dddeeecb" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_d14c1582f1061a4006697d3d9186db20" parent="aspace_37dba882538f3b7f2d487ab0dddeeecb" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_d7dfc37db7d6c404c6134b6250ab6400">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_7f8aea6a2a9125acc397a2b721ccebdb" level="file">
        <did>
          <unittitle>TML, 46-9 - Daptomycin (Cubicin) for skin and soft tissue infections</unittitle>
          <unitdate type="inclusive">2004 February 2</unitdate>
          <container id="aspace_ccbbd1e3d2c1e74a673c7d2e719d13e6" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_78528e27236c305559f71ffec50a0778" parent="aspace_ccbbd1e3d2c1e74a673c7d2e719d13e6" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_8b64bb10092754b7b8a4c90c8deb7337">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_08fbdaa8a0871e1576f4bafb794f57f9" level="file">
        <did>
          <unittitle>TML, 46-10 - Emergency Contraception OTC</unittitle>
          <unitdate type="inclusive">2004 February 2</unitdate>
          <container id="aspace_31f736c990131e19a66ac4ea9081dc4c" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_583e9c9cb97953329e87f10feeab0699" parent="aspace_31f736c990131e19a66ac4ea9081dc4c" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_00f05ef1f3a72bb3da4ce317cb793c27">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_9ea3892837eec8429d01fe1dc14e6b41" level="file">
        <did>
          <unittitle>TML, 46-5 - Lasik and its alternatives - an update</unittitle>
          <unitdate type="inclusive">2004 January 19</unitdate>
          <container id="aspace_710aa703431c15437d0864d6b68f7884" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_50ab708dee9e8c48b0f29441c1ff158e" parent="aspace_710aa703431c15437d0864d6b68f7884" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_7815c3c9e1b402b4a02ed5022e168609">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_f1703fc66140060139d86d70ac0c3846" level="file">
        <did>
          <unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle>
          <unitdate type="inclusive">2004 February 16</unitdate>
          <container id="aspace_5e3f1e1724bb6d034069742a53b183ed" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_1a32b1373322885694359fecaeadbbd0" parent="aspace_5e3f1e1724bb6d034069742a53b183ed" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_dc0cf1e8ca62aefc4f65bdca678ea19e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_e8f33c13c32daa15598a2e144e9f900f" level="file">
        <did>
          <unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle>
          <unitdate type="inclusive">2004 February 16</unitdate>
          <container id="aspace_28cbe96906d97321eb6d3d2b4b48ef81" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="aspace_4ef53743c752c5f46d8bd71385253f89" parent="aspace_28cbe96906d97321eb6d3d2b4b48ef81" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_81a1621d7a2a2452c30a530869fc9bea">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_f1258ee39d7e2cce0fa124be57ed0634" level="file">
        <did>
          <unittitle>TML - Choice of Antibacterial Drugs - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 March</unitdate>
          <container id="aspace_b83958c6b486ab3577bb0b2195fc64ca" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="aspace_4a8b9734a60827dd3e82186c241397d0" parent="aspace_b83958c6b486ab3577bb0b2195fc64ca" type="folder">2-8</container>
        </did>
        <accessrestrict id="aspace_d14f31516858f5ff1d6ab38316a1acdf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_dcf6c003359f1d37afb6b89504a47763" level="file">
        <did>
          <unittitle>TML - Drugs for Peptic Ulcers - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 February</unitdate>
          <container id="aspace_957d1d15b15690f164f8a8cacad5564c" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="aspace_84214ce1d2354c25b8ff69a1c5dda772" parent="aspace_957d1d15b15690f164f8a8cacad5564c" type="folder">9-17</container>
        </did>
        <accessrestrict id="aspace_ee022307e7bb1d19942f259293477255">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ba4f3a6cf74e6af72c13dc1e491dbd6" level="file">
        <did>
          <unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 January</unitdate>
          <container id="aspace_e532716b1e275a1fcd02a21e4e07761c" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="aspace_75be0a5600d90d516019f6d3d7ccdd54" parent="aspace_e532716b1e275a1fcd02a21e4e07761c" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_cae76792326d54b966f74999980f0522">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_499346d5020cece037a74d774986c858" level="file">
        <did>
          <unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 January</unitdate>
          <container id="aspace_8c5b99299e3c4d62b7616329bdc56cb9" label="Mixed Materials (A0000000075944)" type="box">102</container>
          <container id="aspace_7677dbb42ce69921d8da5e02d7c3cc06" parent="aspace_8c5b99299e3c4d62b7616329bdc56cb9" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_78b76f282a6087796d952eea7ca3851b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_e2ff3268992aa759f09a842e60822ffb" level="file">
        <did>
          <unittitle>TML - Drugs for Pain - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 July</unitdate>
          <container id="aspace_5ffccfe44d554dc3bb19d3e954dd5b1a" label="Mixed Materials (A0000000075944)" type="box">102</container>
          <container id="aspace_b138eabe1ea6ba2a6612e9be6945ccda" parent="aspace_5ffccfe44d554dc3bb19d3e954dd5b1a" type="folder">5-14</container>
        </did>
        <accessrestrict id="aspace_04e11af6b467a1e7c10d7574675c44fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
    </dsc>
  </archdesc>
</ead>
